Processing 00000000.tx.1: Muscarinic Acetylcholine Receptors Induce the Expression of the Immediate Early Growth Regulatory Gene CYR61* Claudia Albrecht, Heinz von der Kammer, Manuel Mayhaus, Jaroslav Klaudiny, Michaela Schweizer, and Roger M. 

Phrase: "Muscarinic Acetylcholine Receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the Expression of the Immediate Early Growth Regulatory Gene CYR61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "* Claudia Albrecht,"

Phrase: "Heinz von der Kammer,"

Phrase: "Manuel Mayhaus,"

Phrase: "Jaroslav Klaudiny,"

Phrase: "Michaela Schweizer,"

Phrase: "and"

Phrase: "Roger M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Nitsch** From the Center for Molecular Neurobiology Hamburg, University of Hamburg, Martinistrasse 52,20246Hamburg, Germany, the Institute of Chemistry, Slovac Academy of Sciences, Dubravska Cesta 9,84238Bratislava, Slovakia, and the Department of Psychiatry Research, University of Zurich, August Forel Strasse 1,8008Zurich, Switzerland Received for publication, April 11,2000, and in revised form, June 7,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In brain, muscarinic acetylcholine receptors (mAChRs) modulate neuronal functions including long term potentiation and synaptic plasticity in neuronal circuits that are involved in learning and memory formation. 

Phrase: "Nitsch"

Phrase: "*"

Phrase: "*"

Phrase: "From the Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "for Molecular Neurobiology Hamburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0026379:Molecular Neurobiology [Biomedical Occupation or Discipline]

Phrase: "University of Hamburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Martinistrasse 52,"

Phrase: "20246Hamburg,"

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "the Institute of Chemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Slovac Academy of Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0000876:Academy [Organization]

Phrase: "Dubravska Cesta 9,"

Phrase: "84238Bratislava,"

Phrase: "Slovakia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206579:Slovakia [Geographic Area]

Phrase: "and"

Phrase: "the Department of Psychiatry Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587494:Psychiatry department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "University of Zurich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "August Forel Strasse 1,"

Phrase: "8008Zurich,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "April 11,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "June 7,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES In brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]

Phrase: "muscarinic acetylcholine receptors (mAChRs)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "neuronal functions"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   789 E C0027882:Neuron [Cell]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "long term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "synaptic plasticity in neuronal circuits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0027880:Neuronal Plasticity [Organ or Tissue Function]
   760   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: "that"

Phrase: "are"

Phrase: "involved in learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013621:learning [Educational Activity]
   790   C0023185:Learning [Mental Process]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "memory formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.3: To identify mAChR-inducible genes, we used a differential display approach and found that mAChRs rapidly induced transcription of the immediate early gene CYR61 in HEK 293cells with a maximum expression after 1h of receptor stimulation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "mAChR-inducible genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a differential display approach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approach [Spatial Concept]
   734   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that mAChRs rapidly induced transcription of the immediate early gene CYR61"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   763   C0013458:Early Gene Transcription [Genetic Function]
   749   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "in HEK 293cells"

Phrase: "with a maximum expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "after 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "of receptor stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.4: CYR61 is a member of the emerging CCN gene family that includes CYR61/CEF10, CTGF/FISP-12, and NOV; 

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "is"

Phrase: "a member of the emerging CCN gene family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086282:Family member [Family Group]
   767   C1611821:Family Member [Intellectual Product]
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "CYR61/CEF10,"

Phrase: "CTGF/FISP-12,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0385569:FISP [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1366521:FISP [Gene or Genome]
   827   C1413791:CTGF [Gene or Genome]
   827   C1705829:FISP [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: ";"
Processing 00000000.tx.5: these encode secretory growth regulatory proteins with distinct functions in cell proliferation, migration, adhesion, and survival. 

Phrase: "these"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "secretory growth regulatory proteins with distinct functions in cell proliferation,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0815043:functions proteins [Amino Acid, Peptide, or Protein]
   741   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0220905:regulatory [Regulation or Law]
   739   C1704735:Regulatory [Conceptual Entity]
   724 E C1527118:Protein Function [Molecular Function]

Phrase: "migration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]
Processing 00000000.tx.6: We found that CYR61, CTGF, and NOV were expressed throughout the human central nervous system. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: "were"

Phrase: "expressed throughout the human central nervous system."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0927232:Central Nervous System [Body System]
   814   C1269563:Central nervous system [Body System]
   778   C0027763:Nervous System [Body System]
   778   C0422837:NERVOUS SYSTEM [Finding]
   778   C1269560:Nervous system [Body System]
   748   C0027769:Nervous [Sign or Symptom]
   748   C0086418:Human [Human]
   748   C0205099:Central [Spatial Concept]
   748   C0449913:System [Functional Concept]
   748   C0599851:Nervous [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1879652:Central - [Laboratory Procedure]
   723 E C0205494:Neurologic [Qualitative Concept]
Processing 00000000.tx.7: Stimulation of mAChRs induced CYR61 expression in primary neurons and rat brain where CYR61 mRNA was detected in cortical layers V and VI and in thalamic nuclei. 

Phrase: "Stimulation of mAChRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "CYR61 expression in primary neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "rat brain where CYR61 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "detected in cortical layers V"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0442726:Detected [Finding]
   760   C0934502:layers [Body Part, Organ, or Organ Component]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C1522408:Layer [Qualitative Concept]
   726 E C1561599:Layer [Intellectual Product]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "and"

Phrase: "VI"

Phrase: "and in thalamic nuclei."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   770   C0039729:Thalamic [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   737   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.8: In contrast, CTGF and NOV expression was not altered by mAChRs neither in neuronal tissue culture nor rat brain. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by mAChRs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   806   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0026815:muscarinic [Pharmacologic Substance]
   760   C0392747:Altered [Functional Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "neither in neuronal tissue culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0040284:Tissue culture [Laboratory Procedure]
   760   C0010453:Culture [Idea or Concept]
   760   C0040300:Tissue [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1547928:Tissue [Intellectual Product]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3274651:Neither [Qualitative Concept]

Phrase: "nor"

Phrase: "rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.9: Receptor subtype analyses demonstrated that m1 and m3 mAChR subtypes strongly induced CYR61 expression, whereas m2 and m4 mAChRs had only subtle effects. 

Phrase: "Receptor subtype analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "that m1"

Phrase: "and"

Phrase: "m3 mAChR subtypes strongly induced CYR61 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "m4 mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0026815:muscarinic [Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "had"

Phrase: "only subtle effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.10: Increased CYR61 expression was coupled to mAChRs by both protein kinase C and elevations of intracellular Ca2+. 

Phrase: "Increased CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "coupled to mAChRs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   806   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0026815:muscarinic [Pharmacologic Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]

Phrase: "by both protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "elevations of intracellular Ca2+."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0702240:elevations [Spatial Concept]
   737 E C0439775:Elevation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: Our results establish that CYR61 expression in mammalian brain is under the control of cholinergic neurotransmission; 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that CYR61 expression in mammalian brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is under the control of cholinergic neurotransmission"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0027793:Neurotransmission [Cell Function]
   748   C0243148:control [Qualitative Concept]
   748   C0599668:cholinergic [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.12: it may thus be involved in cholinergic regulation of synaptic plasticity.  

Phrase: "it"

Phrase: "may"

Phrase: "thus"

Phrase: "be"

Phrase: "involved in cholinergic regulation of synaptic plasticity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1326639:regulation of synaptic plasticity [Organ or Tissue Function]
   748   C0599668:cholinergic [Functional Concept]
   748   C0678558:Plasticity [Natural Phenomenon or Process]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The cholinergic system in mammalian brain is involved in higher cognitive functions including attention, learning, and memory (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The cholinergic system in mammalian brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0684164:cholinergic system [Biologically Active Substance]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "is"

Phrase: "involved in higher cognitive functions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0392335:Cognitive functions [Mental Process]
   760   C0542341:Functions [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1516691:Cognitive [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726   C0205250:High [Qualitative Concept]
   726 E C0700205:FUNCTION [Classification]
   726   C1299351:High [Qualitative Concept]
   726 E C1705273:Function [Intellectual Product]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "attention,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: ","

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: A major source of the neurotransmitter acetylcholine are cholinergic neurons of the basal forebrain that innervate neurons throughout the cerebral cortex, the hippocampus, the amygdala, and some thalamic nuclei (2, 3). 

Phrase: "A major source of the neurotransmitter acetylcholine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449416:Source [Finding]
   748   C1705919:Source [Idea or Concept]

Phrase: "are"

Phrase: "cholinergic neurons of the basal forebrain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2333949:Cholinergic Neurons [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "that"

Phrase: "innervate"

Phrase: "neurons throughout the cerebral cortex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "the amygdala,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "some thalamic nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: The degeneration of cholinergic neurons in the basal forebrain is associated with Alzheimer's disease; 

Phrase: "The degeneration of cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "in the basal forebrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2331620:Basal forebrain [Body Part, Organ, or Organ Component]
   861   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]

Phrase: "is"

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.16: lesions within this brain region, as well as mAChR1 antagonists, impair cognitive functions in mammals (4-7). 

Phrase: "lesions within this brain region,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0221505:brain lesions [Disease or Syndrome]
   760   C0221198:lesions [Finding]
   726 E C1546698:Lesion [Intellectual Product]

Phrase: "as well as"

Phrase: "mAChR1 antagonists,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243076:antagonists [Chemical Viewed Functionally]
   827 E C0231491:Antagonist [Organ or Tissue Function]
   755 E C0680242:antagonism [Social Behavior]

Phrase: "impair"

Phrase: "cognitive functions in mammals"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0392335:Cognitive functions [Mental Process]
   770   C0542341:Functions [Functional Concept]
   770   C1516691:Cognitive [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "(4-7"

Phrase: ")."
Processing 00000000.tx.17: Muscarinic AChRs are G protein-coupled cell surface receptors with seven transmembrane topologies (8). 

Phrase: "Muscarinic AChRs"

Phrase: "are"

Phrase: "G protein-coupled cell surface receptors with seven transmembrane topologies"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   831   C1257634:seven-transmembrane G-protein-coupled receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0682972:G-Protein-Coupled Receptors [Amino Acid, Peptide, or Protein,Receptor]
   782   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   775   C0021699:Cell transmembrane protein [Amino Acid, Peptide, or Protein]
   760   C0699040:Cell surface [Cell Component]
   757   C0025252:protein surface [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0524983:G cell [Cell]
   757   C0597357:protein receptors [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   741   C1514760:Receptor Cell [Cell]
   739   C0007634:Cell [Cell]
   739   C0205148:Surface [Spatial Concept]
   739   C1269647:Cell [Cell]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.18: Five different subtypes are expressed in different brain regions on pre- and postsynaptic neuronal compartments (9). 

Phrase: "Five different subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "expressed in different brain regions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1273723:brain regions [Body Location or Region]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1705242:Different [Qualitative Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]
   720   C0682132:regional difference [Finding]

Phrase: "on pre-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332152:Pre [Temporal Concept]
  1000   C0740175:Pre [Qualitative Concept]
  1000   C2257086:PRE [Genetic Function]

Phrase: "and"

Phrase: "postsynaptic neuronal compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.19: They have excitatory and inhibitory effects on cholinergic synapses by modulating the conductance of K+ and Ca2+ ion channels (10-12) and by coupling to several intracellular second messengers as follows: mAChR subtypes m1, m3, and m5 activate protein kinase C (PKC) (13, 14), increase intracellular Ca2+ and cAMP (13-15), stimulate the MAP kinase pathway (16, 17), and activate the phospholipases A2 (18) and D (19). 

Phrase: "They"

Phrase: "have"

Phrase: "excitatory"

Phrase: "and"

Phrase: "inhibitory effects on cholinergic synapses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C3179175:Cholinergic Effects [Physiologic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "by modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the conductance of K+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C1159689:K+ conductance [Cell Function]

Phrase: "and"

Phrase: "Ca2+ ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "(10-12"

Phrase: ")"

Phrase: "and by coupling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C1948027:Coupling [Functional Concept]

Phrase: "to several intracellular second messengers"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   923   C0036522:Intracellular Second Messengers [Molecular Function]
           second messengers
   875   C0815029:intracellular messengers [Biologically Active Substance]
   861   C1508748:Second Messengers [Biologically Active Substance]
   812   C0169911:messengers [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0175996:intracellular [Cell Component]
   812   C0178719:Intracellular [Spatial Concept]
   812   C0205436:Second [Quantitative Concept]
   812   C0335218:messengers [Professional or Occupational Group]
   812   C0457385:Second [Temporal Concept]
   812   C0565930:/second [Quantitative Concept]
   812   C1561503:second [Idea or Concept]
   812   C1705190:Second [Qualitative Concept]
   741 E C0027627:secondary [Neoplastic Process]
   741 E C0175668:Secondary [Temporal Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "mAChR subtypes m1, m3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1300554:m3 [Quantitative Concept]
   812   C3484373:M3 [Intellectual Product]

Phrase: "and"

Phrase: "m5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "protein kinase C (PKC)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "cAMP (13-15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "stimulate"

Phrase: "the MAP kinase pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
   734   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(16,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the phospholipases A2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0031667:Phospholipases A2 [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1744635:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C3539768:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(18"

Phrase: ")"

Phrase: "and"

Phrase: "D ("

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.20: In contrast, m2 and m4 mAChRs inhibit adenylyl cyclase (13, 14, 16, 17, 20, 21). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "m4 mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0026815:muscarinic [Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "adenylyl cyclase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(13,"

Phrase: "14,"

Phrase: "16,"

Phrase: "17,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.21: The storage of long term memory is associated with the generation of long term potentiation and with changes in synaptic plasticity that are mediated by alterations in the expression of activity-dependent genes (22). 

Phrase: "The storage of long term memory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337174:Storage [Spatial Concept]
   753   C1698986:Storage [Functional Concept]
   753   C1753314:storage [Cell Component]

Phrase: "is"

Phrase: "associated with the generation of long term potentiation"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   800   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   800   C2984294:Long-term potentiation [Functional Concept]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0443252:Long-term [Temporal Concept]
   744   C0079411:Generation [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]
   744   C3146294:Generation [Activity]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and with changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in synaptic plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "that"

Phrase: "are"

Phrase: "mediated by alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   756   C1515926:Alteration [Idea or Concept]

Phrase: "in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of activity-dependent genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.22: These include immediate early transcription factors and activity-dependent genes with potential functions in modulating long term memory by structural modifications of preexisting synapses, in the generation of new neuronal connections, as well as in neurite extension and dendritic ramification (23-27). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "immediate early transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "activity-dependent genes with potential functions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0314627:function genes [Genetic Function]
   753   C0017337:Genes [Gene or Genome]

Phrase: "in modulating long term memory"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   923   C0423909:Memory, Long-Term [Mental Process]
   861   C0443252:Long-term [Temporal Concept]
   812   C0025260:Memory [Mental Process]
   812   C0205166:Long [Qualitative Concept]
   812   C0700327:memory [Finding]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C1706377:Memory [Manufactured Object]
   812   C2826302:TERM [Intellectual Product]
   756 E C0679055:mnemonic [Mental Process]

Phrase: "by structural modifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0581602:Structural modification [Therapeutic or Preventive Procedure]
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "of preexisting synapses,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0039062:Synapses [Body Space or Junction]
   827 E C0598501:Synapsis [Cell Function]
   827 E C1633000:Synapsis [Plant]

Phrase: "in the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of new neuronal connections,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449379:connections [Intellectual Product]

Phrase: "as well as in neurite extension"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0085103:Neurite [Cell Component]
   753   C0205170:Well [Qualitative Concept]
   753   C0231448:Extension [Functional Concept]
   753   C1880641:Extension [Conceptual Entity]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "dendritic ramification"

Phrase: "(23-27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.23: Cholinergic mechanisms are involved in learning and memory processes in that mAChRs promote the generation of long term potentiation (28) and activate the expression of the transcription factors c-fos, jun-B, Egr-1, Egr-2, Egr-3, and Egr-4 (29, 30). 

Phrase: "Cholinergic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "involved in learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013621:learning [Educational Activity]
   790   C0023185:Learning [Mental Process]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "memory processes in that mAChRs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0679052:memory process [Mental Process]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the generation of long term potentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the expression of the transcription factors c-fos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "jun-B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Egr-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1566493:EGR-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Egr-2,"

Phrase: "Egr-3,"

Phrase: "and"

Phrase: "Egr-4"

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.24: To identify mAChR-inducible genes, we established a differential display screen of genes activated in response to mAChR stimulation with the acetylcholine analog carbachol. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "mAChR-inducible genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a differential display screen of genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "activated in response"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C1879547:Activated [Activity]
   790   C2911692:Response [Mental Process]
   756 E C1515877:Activate [Functional Concept]

Phrase: "to mAChR stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with the acetylcholine analog carbachol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.25: We identified the immediate early gene CYR61 that encodes an extracellular signaling molecule to be differentially regulated by mAChRs. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the immediate early gene CYR61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1413896:CYR61 [Gene or Genome]
   756   C0206256:Immediate-Early Gene [Gene or Genome]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "an extracellular signaling molecule to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1519315:Signaling Molecule [Biologically Active Substance]
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: "be"

Phrase: "differentially"

Phrase: "regulated by mAChRs."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   806   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0026815:muscarinic [Pharmacologic Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.26: CYR61 belongs to the emerging CCN gene family (CYR61/CEF10, CTGF/FISP-12, NOV, ELM-1, COP-1, and WISP-3) of secreted growth regulatory proteins that bind to components of the extracellular matrix and the cell surface (31, 32). 

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "belongs to the emerging CCN gene family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1517488:Gene Family [Gene or Genome]
   748   C0015576:Family [Family Group]
   748   C0017337:Gene [Gene or Genome]
   748   C1704727:Family [Conceptual Entity]

Phrase: "(CYR61/CEF10,"

Phrase: "CTGF/FISP-12,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0385569:FISP [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1366521:FISP [Gene or Genome]
   827   C1413791:CTGF [Gene or Genome]
   827   C1705829:FISP [Gene or Genome]

Phrase: "NOV,"

Phrase: "ELM-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330531:Elm [Plant]
   861   C1140703:elm [Pharmacologic Substance]
   861   C2980688:ELM [Organic Chemical,Pharmacologic Substance]

Phrase: "COP-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0110658:Cop 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C0289884:COP-1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C0528008:COP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538830:COP1 [Gene or Genome]
  1000   C2681322:COP1 [Gene or Genome]

Phrase: "and"

Phrase: "WISP-3"

Phrase: ")"

Phrase: "of secreted growth regulatory proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]

Phrase: "that"

Phrase: "bind to components of the extracellular matrix"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0015350:Extracellular Matrix [Tissue]
   748   C0449432:Components [Manufactured Object]
   748   C0521119:Extracellular [Cell Component]
   748   C1145667:Bind [Activity]
   748   C1167622:bind [Molecular Function]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.27: CYR61 and CTGF (connective tissue growth factor) are both growth factor-inducible immediate early genes in fibroblasts (33, 34), whereas the protooncogene NOV (nephroblastoma overexpressed), involved in Wilms tumor, is expressed in quiescent cells and down-regulated after serum stimulation (35, 36). 

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "and"

Phrase: "CTGF (connective tissue growth factor"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   937   C0110610:connective tissue growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1413791:CONNECTIVE TISSUE GROWTH FACTOR [Gene or Genome]
   853   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1333522:TISSUE FACTOR [Gene or Genome]
   840   C0009780:Connective Tissue [Tissue]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1621966:Tissue Growth [Organ or Tissue Function]
           Growth
   804   C0018270:'growth' NOS [Organism Function]
   804   C0040300:Tissue [Tissue]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1547928:Tissue [Intellectual Product]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: ")"

Phrase: "are"

Phrase: "both growth factor-inducible immediate early genes in fibroblasts"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0206256:Genes, Immediate-Early [Gene or Genome]
   767   C0812325:Growth Factor Gene [Gene or Genome]
   742   C0017337:Genes [Gene or Genome]
   742   C0205253:Immediate [Temporal Concept]
   742   C0205548:Immediate [Temporal Concept]
   742   C1279919:Early [Temporal Concept]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the protooncogene NOV (nephroblastoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027708:Nephroblastoma [Neoplastic Process]

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: ")"

Phrase: ","

Phrase: "involved in Wilms tumor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0027708:Wilm's tumor [Neoplastic Process]
   833   C2697327:WILMS TUMOR [Gene or Genome]
   833   C3538905:Wilms Tumor [Intellectual Product]
   770   C0027651:Tumor [Neoplastic Process]
   770   C1314939:Involved [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]

Phrase: "is"

Phrase: "expressed in quiescent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "down-regulated after serum stimulation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0229671:Serum [Body Substance]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.28: Consistent with their expression kinetics, secreted CYR61 and CTGF proteins exhibit growth-promoting cellular functions (37, 38), whereas the overexpression of NOV protein has growth-inhibitory effects and is associated with normal differentiation of the central nervous system and kidney in general (35, 39, 40). 

Phrase: "Consistent with their expression kinetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "secreted CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "and"

Phrase: "CTGF proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "growth-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "cellular functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C0007613:Cellular Function [Cell Function]
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "(37,"

Phrase: "38"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the overexpression of NOV protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "has"

Phrase: "growth-inhibitory effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "associated with normal differentiation of the central nervous system"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   790   C0927232:Central Nervous System [Body System]
   790   C1269563:Central nervous system [Body System]
   764   C0027763:Nervous System [Body System]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C0422837:NERVOUS SYSTEM [Finding]
   764   C1269560:Nervous system [Body System]
   742   C0007589:Differentiation [Cell Function]
   742   C0027769:Nervous [Sign or Symptom]
   742   C0205099:Central [Spatial Concept]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0449913:System [Functional Concept]
   742   C0599851:Nervous [Functional Concept]
   742   C1511938:Differentiation [Clinical Attribute]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   742   C1879652:Central - [Laboratory Procedure]
   742   C2347086:% Normal [Quantitative Concept]
   742   C2945687:Differentiation [Functional Concept]
   709 E C0205494:Neurologic [Qualitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "kidney in general"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0022646:Kidney [Body Part, Organ, or Organ Component]
   790   C0227665:kidney [Body Part, Organ, or Organ Component]
   790   C1278978:Kidney [Body Part, Organ, or Organ Component]
   790   C1514845:KIDNEY [Tissue]

Phrase: "(35,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.29: CTGF gene is a downstream target of TGF-, mediating TGF--related actions in connective tissue cells during wound healing and skin disorders (41, 42), and both proteins, CYR61 and CTGF, are regulators of angiogenesis, mediating cellular adhesion and migration of endothelial cells in an integrin-v3-dependent manner (43, 44). 

Phrase: "CTGF gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413791:CTGF gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "a downstream target of TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "TGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "related actions in connective tissue cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441472:actions [Functional Concept]
   719 E C3266814:Action [Activity]

Phrase: "during wound healing"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "and"

Phrase: "skin disorders"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0037274:SKIN DISORDERS [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
   861   C0444099:Skin [Body Substance]
   861   C1123023:Skin [Body System]
   861   C1278993:Skin [Body System]
   805 E C0221912:Cutaneous [Spatial Concept]
   805 E C0221928:Dermal [Qualitative Concept]
   805 E C1522447:Cutaneous [Functional Concept]
   738 E C0011646:Dermis [Tissue]

Phrase: "(41,"

Phrase: "42"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "both proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "and"

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "are"

Phrase: "regulators of angiogenesis,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0182953:regulators [Medical Device]
   756 E C1704734:Regulator [Medical Device]
   756 E C1704735:Regulator [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cellular adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cellular Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "migration of endothelial cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   865   C1624612:endothelial cell migration [Cell Function]
   819   C1622501:cells migration [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "in an integrin-v3-dependent manner"

Phrase: "(43,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.30: Even though CYR61, CTGF, and NOV are expressed in the developing nervous system (40, 45), less is known about their function in adult brain. 

Phrase: "Even"

Phrase: "though"

Phrase: "CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: "are"

Phrase: "expressed in the developing nervous system"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "is"

Phrase: "known about their function"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0205309:Known [Qualitative Concept]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "in adult brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.31: We provide evidence that CYR61 and its family members CTGF and NOV are expressed throughout the mammalian brain and that transcription of CYR61, but not that of CTGF and NOV, is under the control of mAChR signaling in primary cortical neurons and in mammalian brain.  

Phrase: "We"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "and"

Phrase: "its family members CTGF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1413791:CTGF [Gene or Genome]
   734   C0086282:Family Members [Family Group]
   701 E C1611821:Family Member [Intellectual Product]

Phrase: "and"

Phrase: "NOV"

Phrase: "are"

Phrase: "expressed throughout the mammalian brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0024660:Mammalian [Mammal]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "that transcription of CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "that of CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV,"

Phrase: "is under the control of mAChR signaling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0037083:Signaling [Cell Function]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   748   C3537152:signaling [Biologic Function]

Phrase: "in primary cortical neurons"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   827   C0001613:Cortical [Body Part, Organ, or Organ Component]
   827   C0007776:Cortical [Body Part, Organ, or Organ Component]
   827   C0022655:Cortical [Body Part, Organ, or Organ Component]
   827   C0027882:Neurons [Cell]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   771 E C0234875:bark [Organism Attribute]
   771 E C2700441:Bark [Plant]
   743 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   743 E C0521390:Neuronal [Immunologic Factor]
   743 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and in mammalian brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0024660:Mammalian [Mammal]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.32: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Tissue Culture and Drugs-- Wild type HEK 293cells and 293cells stably transfected with muscarinic acetylcholine receptor subtypes m1, m2, m3, or m4 (13) were cultured in Dulbecco's modified Eagle's medium/Ham's F-12 supplemented with 10% fetal calf serum in a 5% CO2 atmosphere at 37C. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tissue Culture"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0040284:Tissue culture [Laboratory Procedure]
   861   C0010453:Culture [Idea or Concept]
   861   C0040300:Tissue [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1547928:Tissue [Intellectual Product]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "--"

Phrase: "Wild type HEK 293cells"

Phrase: "and"

Phrase: "293cells stably"

Phrase: "transfected with muscarinic acetylcholine receptor subtypes m1, m2,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0034826:Muscarinic Acetylcholine Receptor [Amino Acid, Peptide, or Protein,Receptor]
           Muscarinic Receptor
   789   C0384752:Muscarinic Receptor M2 [Amino Acid, Peptide, or Protein,Receptor]
           M2 receptor
   789   C0531859:Receptor, Muscarinic M1 [Amino Acid, Peptide, or Protein,Receptor]
           M1 receptor
   770   C0034792:Acetylcholine receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   744   C0026815:muscarinic [Pharmacologic Substance]
   744   C0449560:subtypes [Classification]
   744   C0457242:m2 [Quantitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "m3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "or"

Phrase: "m4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561479:M4 [Intellectual Product]

Phrase: "(13"

Phrase: ")"

Phrase: "were"

Phrase: "cultured in Dulbecco's modified Eagle's medium/Ham's F-12"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   745   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   742   C0009458:Medium [Intellectual Product]
   742   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   742   C0325564:Eagle [Bird]
   742   C0392747:Modified [Functional Concept]
   742   C0439133:(f) [Intellectual Product]
   742   C0439536:Medium [Quantitative Concept]
   742   C1551720:Eagle [Population Group]
   742   C1553038:[f] [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C3244283:medium [Intellectual Product]
   708   C0010453:Culture [Idea or Concept]
   708   C0220814:culture [Functional Concept]
   708   C0430400:Culture [Laboratory Procedure]
   708   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 10% fetal calf serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "in a 5% CO2 atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004178:Atmosphere [Natural Phenomenon or Process]
   827   C0678214:atmosphere [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.33: 500g/ml geneticin (G418, Life Technologies, Inc.) were added to the stably transfected cells. 

Phrase: "500g/ml geneticin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0119053:Geneticin [Organic Chemical,Pharmacologic Substance]

Phrase: "(G418,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "were"

Phrase: "added to the stably transfected cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C1524062:Added [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1883712:Add [Functional Concept]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.34: For experiments, cells were grown to a density of 80-90%, and they were serum-deprived in the absence of G418 16-48 h before drug treatments. 

Phrase: "For experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown to a density of 80-90%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0178587:density [Quantitative Concept]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "they"

Phrase: "were"

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "deprived in the absence of G418 16-48 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0052009:G418 [Antibiotic,Organic Chemical]
   742   C0332197:absence [Quantitative Concept]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "before drug treatments."
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.35: 1mM carbachol (Sigma), 10g/ml cycloheximide (Sigma), 10M atropine (Sigma), 1M phorbol 12-myristate 13-acetate (Sigma), 5M gallamine triethiodide (Research Biochemicals International), 1M GF109203X (bisindolylmaleimide I, Calbiochem), 30M H7 (1-(5-isoquinolinesulfonyl)-2-methylpiperazine2HCl, Calbiochem), 100M 8-bromo-cAMP (Calbiochem), 2.5g/ml mellitin (Calbiochem), 20M DEDA (7,7-dimethyl-5,8-eicosadienoic acid, Calbiochem), 1M ionomycin (Calbiochem), or 10% fetal calf serum were added at specific time intervals. 

Phrase: "1mM carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "10g/ml cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   771 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "10M atropine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
   861   C1161352:atropine [Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "1M phorbol 12-myristate 13-acetate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   879   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "5M gallamine triethiodide"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0016972:Gallamine Triethiodide [Organic Chemical,Pharmacologic Substance]
   845 E C0591515:Flaxedil [Organic Chemical,Pharmacologic Substance]
   827   C0016971:Gallamine [Organic Chemical,Pharmacologic Substance]

Phrase: "(Research Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205474:Biochemical [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "1M GF109203X"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]

Phrase: "(bisindolylmaleimide I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0091914:bisindolylmaleimide I [Organic Chemical,Pharmacologic Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "30M H7"

Phrase: "(1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(5-isoquinolinesulfonyl"

Phrase: ")-"

Phrase: "2-methylpiperazine2HCl,"

Phrase: "Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "100M 8-bromo-cAMP (Calbiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0000661:8-Bromo-cAMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "2.5g/ml mellitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "20M DEDA"

Phrase: "(7,"

Phrase: "7-dimethyl-5,"

Phrase: "8-eicosadienoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2348386:Eicosadienoic Acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "1M ionomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022020:Ionomycin [Lipid,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "10% fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "were"

Phrase: "added at specific time intervals."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   773   C0872291:Time Interval [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1524062:Added [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726 E C1883712:Add [Functional Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.36: Unstimulated cells, cultured in parallel from the same passages, were used as controls. 

Phrase: "Unstimulated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in parallel from the same passages,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.37: Effective receptor stimulation and transduction responses were verified by measuring carbachol-induced -amyloid precursor protein ectodomains released into the conditioned media as described (46). 

Phrase: "Effective receptor stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "transduction responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "verified by measuring carbachol-"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   770   C0444706:measuring [Qualitative Concept]
   770   C0449770:measuring [Quantitative Concept]
   770   C1711411:Verified [Functional Concept]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "amyloid precursor protein ectodomains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "released into the conditioned media"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   806   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0162867:Media [Tissue]
   760   C0391871:Released [Functional Concept]
   760   C1254021:Media [Tissue]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1705217:Medium [Substance]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]
   726 E C3244283:medium [Intellectual Product]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.38: Cortical Neurons-- Primary cell cultures from embryonic day 18rat brains were prepared according to the protocol from Segal and Manor (47). 

Phrase: "Cortical Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "--"

Phrase: "Primary cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "cultures from embryonic day 18rat brains"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0010453:Culture [Idea or Concept]
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0220814:culture [Functional Concept]
   753   C0332173:/day [Temporal Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "prepared according to the protocol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0442711:Protocol [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C2348563:Protocol [Intellectual Product]
   726   C1521827:Prepare [Functional Concept]

Phrase: "from Segal"

Phrase: "and"

Phrase: "Manor"

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.39: In brief, cerebral cortices were dissected in chilled Hanks' balanced salt solution (Life Technologies, Inc.) and mechanically dissociated with a fire-polished Pasteur pipette in small volumes of Hanks' balanced salt solution. 

Phrase: "In brief, cerebral cortices"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007776:Cortices, Cerebral [Body Part, Organ, or Organ Component]
           Cortex
   793   C1176472:Cortex [Body Part, Organ, or Organ Component]
   793   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "dissected in chilled Hanks' balanced salt solution"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   814   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   748   C0036140:Salt [Chemical Viewed Structurally]
   748   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0037633:Solution [Substance]
   748   C0205239:dissected [Functional Concept]
   748   C0205415:Balanced [Functional Concept]
   748   C0206136:Salt [Food,Inorganic Chemical]
   748   C0525069:Solution [Biomedical or Dental Material]
   714   C0085593:Chill [Sign or Symptom]
   714   C1423529:HANK [Gene or Genome]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "and"

Phrase: "mechanically"

Phrase: "dissociated with a fire-polished Pasteur pipette"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0491340:PIPETTE, PASTEUR [Medical Device]
   748   C0016141:Fire [Phenomenon or Process]
   748   C0182301:Pipette [Medical Device]
   748   C0220896:polished [Population Group]
   748   C0700614:Fire [Natural Phenomenon or Process]
   748   C0702194:Fire [Human-caused Phenomenon or Process]
   748   C1706407:Pipette [Medical Device]
   748   C1880775:FIRE [Event]

Phrase: "in small volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449468:volumes [Quantitative Concept]
   827 E C1690016:% volume [Qualitative Concept]
   827 E C1705102:Volume [Intellectual Product]
   827 E C2700258:Volume [Laboratory Procedure]

Phrase: "of Hanks' balanced salt solution."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   923   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0206136:Salt [Food,Inorganic Chemical]
   812   C0525069:Solution [Biomedical or Dental Material]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.40: Dissociated cells were suspended in 10% horse serum and minimal essential medium enriched with 0.6% glucose and were plated onto poly-L-lysine-coated glass coverslips in 6-well plates, at a density of about 106 cells per well. 

Phrase: "Dissociated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "suspended in 10% horse serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1518416:Serum, Horse [Immunologic Factor]
   760   C0019944:Horse [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C0242616:Horse [Mammal]
   760   C1265527:Horse [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1553389:suspended [Idea or Concept]
   760   C1553403:suspended [Idea or Concept]
   760   C1705537:Suspended [Functional Concept]

Phrase: "and"

Phrase: "minimal essential medium"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   827   C0009458:Medium [Intellectual Product]
   827   C0205224:Essential [Qualitative Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C0547040:Minimal [Qualitative Concept]
   827   C1524031:MINIMAL [Qualitative Concept]
   827   C1705217:Medium [Substance]
   827   C2945599:Minimal [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]
   755 E C1552614:minimum [Idea or Concept]
   755 E C2826545:MINIMUM [Quantitative Concept]

Phrase: "enriched with 0.6% glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0359583:enriched [Food]

Phrase: "and"

Phrase: "were"

Phrase: "plated onto poly-L-lysine-coated glass coverslips"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   744   C0017596:Glass [Manufactured Object]
   744   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0747726:POLY [Conceptual Entity]
   744   C1522408:Coated [Qualitative Concept]
   744   C1947936:Glass [Medical Device]
   711   C0005971:Plate [Medical Device]
   711 E C0453946:Coat [Manufactured Object]
   711   C1139930:plate [Medical Device]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]
   711   C3537155:Plate [Manufactured Object]

Phrase: "in 6-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of about 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "per well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.41: After 3h, plating media were replaced by minimal essential medium enriched with Earle's salts, 0.6% glucose, and Bottenstein's N2 supplements. 

Phrase: "After 3h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "plating"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0407295:Plating [Therapeutic or Preventive Procedure]
   966 E C0005971:Plate [Medical Device]
   966 E C1139930:plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "replaced by minimal essential medium"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C1299987:Replaced by [Functional Concept]
           replaced
   760   C0009458:Medium [Intellectual Product]
   760   C0205224:Essential [Qualitative Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C0547040:Minimal [Qualitative Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C1524031:MINIMAL [Qualitative Concept]
   760   C1705217:Medium [Substance]
   760   C2945599:Minimal [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "enriched with Earle's salts,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0036140:Salts [Chemical Viewed Structurally]
   770   C0359583:enriched [Food]
   737 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   737 E C0206136:Salt [Food,Inorganic Chemical]

Phrase: "0.6% glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "Bottenstein's N2 supplements."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0242295:Supplement [Food]
   793   C1947943:Supplement [Intellectual Product]
   793   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.42: In order to block the proliferation of glial cells, 3-4 days after plating media were exchanged for growth media supplemented with 0.5M cytosin--arabinofuranoside HCl (AracC). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the proliferation of glial cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1517553:Glial Cell Proliferation [Cell Function]
           glia proliferation
   781   C0596290:Cell Proliferation [Cell Function]
   760   C0334094:Proliferation [Pathologic Function]
   760   C1514485:Proliferation [Functional Concept]

Phrase: "3-4 days after plating media"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C1442459:3 Days [Temporal Concept]
   753   C0439228:days [Temporal Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]

Phrase: "were"

Phrase: "exchanged for growth media"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0162867:Media [Tissue]
   770   C0220844:growth [Physiologic Function]
   770   C1254021:Media [Tissue]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737 E C0439536:Medium [Quantitative Concept]
   737   C0678640:exchange [Social Behavior]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "supplemented with 0.5M cytosin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "--"

Phrase: "arabinofuranoside HCl (AracC"

Phrase: ")."
Processing 00000000.tx.43: Thereafter, growth media were exchanged once a week. 

Phrase: "Thereafter,"

Phrase: "growth media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0162867:Media [Tissue]
   861   C0220844:growth [Physiologic Function]
   861   C1254021:Media [Tissue]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "exchanged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678640:exchange [Social Behavior]

Phrase: "once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "a week."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332174:/week [Temporal Concept]
  1000   C0439230:week [Temporal Concept]
Processing 00000000.tx.44: After 9days in culture, subconfluent layers of primary cells were subjected to drug treatments, followed by RNA preparation or measurements of phosphoinositide turnover (48). 

Phrase: "After 9days"

Phrase: "in culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "subconfluent layers of primary cells"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0934502:layers [Body Part, Organ, or Organ Component]
   726 E C1522408:Layer [Qualitative Concept]
   726 E C1561599:Layer [Intellectual Product]

Phrase: "were"

Phrase: "subjected to drug treatments,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   770   C0013227:Drug [Pharmacologic Substance]
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C1254351:Drug [Pharmacologic Substance]
   737 E C0039798:treatment [Functional Concept]
   737   C0681850:Subject [Group]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737   C1550501:{Subject} [Idea or Concept]
   737 E C1705169:Treatment [Conceptual Entity]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
   737 E C3538994:TREATMENT [Research Activity]
   715 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   715 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "followed by RNA preparation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "or"

Phrase: "measurements of phosphoinositide turnover"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:measurements [Functional Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.45: The content of glial cells was estimated by immunohistochemistry with antibodies against glial fibrillary acidic protein and compared with neuronal staining with an antibody against tau, and it revealed that consistently more than 70% of the cultured cells had a neuronal phenotype. 

Phrase: "The content of glial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "estimated by immunohistochemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against glial fibrillary acidic protein"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1325793:glial fibrillary acidic protein [Cell Component]
  1000   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]
   812   C0001128:Acidic [Chemical]
   812   C0027836:Glial [Cell]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0202406:Acid [Laboratory Procedure]
   741 E C1087003:Glia [Plant]

Phrase: "and"

Phrase: "compared with neuronal staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0487602:Staining [Laboratory Procedure]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1704680:Staining [Finding]
   770   C1707455:Compared [Activity]

Phrase: "with an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "it"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that consistently more than 70% of the cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   764   C0007600:cultured cells [Cell]
   764   C0007635:Cultured Cells [Cell]
   764   C3282338:Cells, Cultured [Cell]
   745 E C0007585:cells culture [Laboratory Procedure]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708   C0010453:Culture [Idea or Concept]
   708   C0220814:culture [Functional Concept]
   708   C0430400:Culture [Laboratory Procedure]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708   C2242979:Culture [Laboratory Procedure]

Phrase: "had"

Phrase: "a neuronal phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.46: RNA Preparation and Reverse Transcription-- Total RNA was prepared by using either the RNeasy Kit (Qiagen) or Trizol reagent (Life Technologies, Inc.) following the manufacturer's instructions. 

Phrase: "RNA Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Reverse Transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "--"

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared by using either"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1524063:Using [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1521827:Prepare [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "the RNeasy Kit (Qiagen"

Phrase: ")"

Phrase: "or"

Phrase: "Trizol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.47: RNA was stored at 80C. 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "stored at 80C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.48: The RNA preparations from fetal rat lung (P1), adult rat thyroid, spleen, and brain were treated with DNase I (Roche Molecular Biochemicals) together with RNasin (Promega) for 30min, followed by phenol protein extraction, and ethanol precipitation. 

Phrase: "The RNA preparations from fetal rat lung"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0455052:Preparation [Health Care Activity]
   714   C1521827:Preparation [Functional Concept]

Phrase: "(P1"

Phrase: ")"

Phrase: ","

Phrase: "adult rat thyroid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1882881:Rat Thyroid [Body Part, Organ, or Organ Component]
   827   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]

Phrase: "spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "treated with DNase I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1148702:DNase I [Genetic Function]
   770   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "together with RNasin"

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "for 30min,"

Phrase: "followed by phenol protein extraction,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "ethanol precipitation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]
Processing 00000000.tx.49: 0.2g of RNA preparation was transcribed to cDNA by using the SuperScriptTMII ReverseTranscriptase (Life Technologies, Inc.) with equal amounts of one base anchor primers HT11A (5'TGCCGAAGCTTTTTTTTTTTA3'), HT11C (5'TGCCGAAGCTTTTTTTTTTTC3'), and HT11G (5'TGCCGAAGCTTTTTTTTTTTG3'). 

Phrase: "0.2g of RNA preparation"

Phrase: "was"

Phrase: "transcribed to cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SuperScriptTMII ReverseTranscriptase"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) with equal amounts of one base anchor primers HT11A"

Phrase: "(5'TGCCGAAGCTTTTTTTTTTTA3'"

Phrase: ")"

Phrase: ","

Phrase: "HT11C"

Phrase: "(5'TGCCGAAGCTTTTTTTTTTTC3'"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "HT11G"

Phrase: "(5'TGCCGAAGCTTTTTTTTTTTG3'"

Phrase: ")."
Processing 00000000.tx.50: Differential Display-- The differential display approaches were performed as described in detail by von der Kammer et al. 

Phrase: "Differential Display"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705417:Display [Manufactured Object]

Phrase: "-"

Phrase: "-"

Phrase: "The differential display approaches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]
   734   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "by von der Kammer et al."
Processing 00000000.tx.51: (49). 

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.52: h-CYR61 was identified as a differentially expressed gene by using the random primer DD20 (5'TGCCGAAGCTTTGGTCAT3') or DD32 (5'TGCCGAAGCTTGGAGCTT3') together with the anchor primer HT11A (5'TGCCGAAGCTTTTTTTTTTTA3'). 

Phrase: "h-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "was"

Phrase: "identified as a differentially expressed gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017337:Gene [Gene or Genome]
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the random primer DD20"

Phrase: "(5'TGCCGAAGCTTTGGTCAT3'"

Phrase: ")"

Phrase: "or"

Phrase: "DD32"

Phrase: "(5'TGCCGAAGCTTGGAGCTT3'"

Phrase: ")"

Phrase: "together with the anchor primer HT11A"

Phrase: "(5'TGCCGAAGCTTTTTTTTTTTA3'"

Phrase: ")."
Processing 00000000.tx.53: Northern Blotting-- 5-10 g of total RNA were separated in 1% formaldehyde-containing agarose gels, and the RNA was blotted onto nylon membranes (Hybond-N+, Amersham Pharmacia Biotech). 

Phrase: "Northern Blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005861:Northern Blotting [Molecular Biology Research Technique]
   983 E C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "--"

Phrase: "5-10 g of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "separated in 1% formaldehyde-containing agarose gels,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   762   C1706746:Agarose Gel [Research Device]
   748   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C0086972:Separated [Finding]
   748   C0332256:Containing [Functional Concept]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C2700400:Containing [Activity]
   714 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "the RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "blotted onto nylon membranes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0025255:Membranes [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0740034:Nylon [Biomedical or Dental Material]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(Hybond-N+,"

Phrase: "Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.54: Membranes were hybridized with [-32P]dCTP (NEN Life Science Products)-labeled cDNA probes that were generated by using the Megaprime DNA labeling kit (Amersham Pharmacia Biotech). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "hybridized with"

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(NEN Life Science Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0332070:Life Science Products [Health Care Related Organization]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: ")-"

Phrase: "labeled cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "that"

Phrase: "were"

Phrase: "generated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Megaprime DNA labeling kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.55: Membranes were washed under high stringency conditions, and x-ray films were exposed for 1-72 h. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed under high stringency conditions,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1548982:Washed [Idea or Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0441648:Wash [Activity]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "x-ray films"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0043303:X-Ray Films [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Films [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C2314876:ray [Fish]
   793 E C1561571:film [Biomedical or Dental Material]
   793 E C1561572:film [Substance]

Phrase: "were"

Phrase: "exposed for 1-72 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0700308:h 1 [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0332157:Exposed [Clinical Attribute]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.56: To control for equal loading of RNA, the identical membranes were probed with a 700-bp cDNA fragment of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), or with a -actin cDNA fragment (CLONTECH). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for equal loading of RNA,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205163:Equal [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1549782:Equal [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1708715:Loading [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "the identical membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with a 700-bp cDNA fragment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: "of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   937   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   888   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   884   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or with a -actin cDNA fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "(CLONTECH"

Phrase: ")."
Processing 00000000.tx.57: Construction of a m1 mAChR-stimulated ZAP Express cDNA Library-- HEK 293m1 mAChR cells were stimulated with carbachol for 1h, and poly(A+) mRNA was prepared from total RNA by using the Poly(A)TTract IV kit (Promega). 

Phrase: "Construction of a m1 mAChR-stimulated ZAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "Express"

Phrase: "cDNA Library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "--"

Phrase: "HEK 293m1 mAChR cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with carbachol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "for 1h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "and"

Phrase: "poly(A+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from total RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "TTract IV kit (Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.58: cDNA synthesis from poly(A+) mRNA was performed following a modified ZAP-cDNA synthesis protocol (Stratagene), and cDNA cloning into ZAP Express vector arms as well as preparation of the cDNA library were done according to the manufacturer's instructions (Stratagene). 

Phrase: "cDNA synthesis from poly(A+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: ")"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a modified ZAP-cDNA synthesis protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0442711:Protocol [Intellectual Product]
   804   C1507394:Protocol [Intellectual Product]
   804   C1522729:Protocol [Intellectual Product]
   804   C2348563:Protocol [Intellectual Product]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cDNA cloning into ZAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009015:Cloning [Research Activity]

Phrase: "Express"

Phrase: "vector arms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0206655:ARMS [Neoplastic Process]
   861   C0446516:Arm [Body Location or Region]
   861   C1269078:Arm [Body Part, Organ, or Organ Component]
   861   C1269612:Arm [Body Location or Region]
   861   C2681631:ARMS [Gene or Genome]
   805 E C0445456:Brachial [Spatial Concept]

Phrase: "as well as"

Phrase: "preparation of the cDNA library"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "done according to the manufacturer's instructions"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1272695:Done [Qualitative Concept]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C2746065:Done [Temporal Concept]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.59: A library screen of 4104 clones was performed with a radiolabeled human CYR61 cDNA probe following the ZAP Express protocol (Stratagene). 

Phrase: "A library screen of 4104 clones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "was"

Phrase: "performed with a radiolabeled human CYR61 cDNA probe"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086418:Human [Human]
   744   C0182400:Probe [Medical Device]
   744   C0884358:Performed [Functional Concept]
   744   C1413896:CYR61 [Gene or Genome]
   744   C1527121:Radiolabeled [Qualitative Concept]
   744   C1704681:Probe [Gene or Genome]
   744   C2347609:Probe [Chemical Viewed Functionally]
   744   C3536729:Probe [Manufactured Object]
   711 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the ZAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1428222:ZAP [Gene or Genome]
  1000   C1538127:ZAP [Gene or Genome]

Phrase: "Express"

Phrase: "protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.60: Human CYR61, CTGF, and NOV cDNA Fragments for Northern Blots and Library Screening-- We amplified a 1403-bp h-CYR61 cDNA fragment by using cDNA from carbachol-stimulated (1h) HEK 293m1 mAChRs cells. 

Phrase: "Human CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Fragments for Northern Blots"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C1621557:Northern Blots [Research Device]
   770   C0332255:fragment [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C1708096:Fragment [Qualitative Concept]
   770   C1709269:Northern [Spatial Concept]

Phrase: "and"

Phrase: "Library Screening"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0220908:Screening [Health Care Activity]
   861   C0220909:screening [Functional Concept]
   861   C1698960:screening [Intellectual Product]
   861   C1710031:Screening [Diagnostic Procedure]
   861   C1710477:SCREENING [Research Activity]

Phrase: "-"

Phrase: "-"

Phrase: "We"

Phrase: "amplified"

Phrase: "a 1403-bp h-CYR61 cDNA fragment by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cDNA from carbachol-stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: ")"

Phrase: "HEK 293m1 mAChRs cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   793   C1514760:Receptor Cell [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.61: The forward primer EMHF (5'CCAAAACGGGGAAAGTTTCCAGCC3') derived from the partial human sequence A33210 (EMBL accession number Z50168) that showed homology to the 5' end of murine cyr61. 

Phrase: "The forward primer EMHF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953382:Forward primer [Cell]

Phrase: "(5'CCAAAACGGGGAAAGTTTCCAGCC3'"

Phrase: ")"

Phrase: "derived from the partial human sequence A33210"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0086418:Human [Human]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0728938:Partial [Quantitative Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C1519249:Sequence [Functional Concept]
   748   C1550516:partial [Idea or Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "(EMBL accession number Z50168"

Phrase: ")"

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "homology to the 5' end of murine cyr61."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1334043:Homology [Gene or Genome]
   744   C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.62: The reverse primer EMHR (5'TTCCAGTATTACATTTCCCCTCCC3') was homolog to the 3' end of h-CYR61 identified by our differential display experiment. 

Phrase: "The reverse primer EMHR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "(5'TTCCAGTATTACATTTCCCCTCCC3'"

Phrase: ")"

Phrase: "was"

Phrase: "homolog to the 3' end of h-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1334043:Homolog [Gene or Genome]

Phrase: "identified by our differential display experiment."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0205396:Identified [Qualitative Concept]
   753   C0443199:Differential [Qualitative Concept]
   753   C0681814:Experiment [Research Activity]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705242:Differential [Qualitative Concept]
   753   C1705417:Display [Manufactured Object]
   753   C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.63: The PCR products were separated by agarose gel electrophoresis, purified, and cloned into the SmaI restriction site of pBluescript KS (Stratagene). 

Phrase: "The PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by agarose gel electrophoresis,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1382104:Gel [Substance]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "and"

Phrase: "cloned into the SmaI restriction site of pBluescript KS (Stratagene"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C1882940:Restriction Site [Nucleotide Sequence]
   760   C2945843:Site of [Qualitative Concept]
   739   C0009013:cloned [Cell]
   739   C0205145:Site [Spatial Concept]
   739   C0443288:Restriction [Functional Concept]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]
   739   C3541894:ks [Quantitative Concept]
   706 E C1522642:Clone [Tissue]

Phrase: ")."
Processing 00000000.tx.64: The cloned PCR product was sequenced, and a PstI/BamHI restriction fragment that contained 1403bp was used as a probe both for screening a ZAP Express cDNA library and for probing Northern blots. 

Phrase: "The cloned PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "a PstI/BamHI restriction fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332255:fragment [Functional Concept]
   812   C0443288:Restriction [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "that contained 1403bp"

Phrase: "was"

Phrase: "used as a probe"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0182400:Probe [Medical Device]
   770   C1273517:used [Finding]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "both for screening"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C0238767:Both [Spatial Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1706086:Both [Qualitative Concept]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]

Phrase: "a ZAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1428222:ZAP [Gene or Genome]
  1000   C1538127:ZAP [Gene or Genome]

Phrase: "Express"

Phrase: "cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and for probing Northern blots."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0005861:northern blots [Molecular Biology Research Technique]
   806   C1621557:Northern Blots [Research Device]
   760   C0419358:Probing, NOS [Diagnostic Procedure]
   760   C1515981:And [Idea or Concept]
   760   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.65: Human cDNA clones of CTGF (h-CTGF) and NOV (NOVH) were obtained as expressed sequence tag from the Research Center of the German Genome Project at the Max Planck Institute for Molecular Genetics in Berlin, Germany (RZPD) (50). 

Phrase: "Human cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "clones of CTGF (h-CTGF)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0009013:Clone [Cell]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1413791:CTGF [Gene or Genome]
   760   C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "NOV (NOVH"

Phrase: ")"

Phrase: "were"

Phrase: "obtained as expressed sequence tag"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0600510:Expressed Sequence Tag [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0037293:Tag [Neoplastic Process]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0181496:Tag [Manufactured Object]
   760   C1301820:Obtained [Functional Concept]
   760   C1519249:Sequence [Functional Concept]
   760   C1710492:TAG [Gene or Genome]
   726 E C1706701:Obtain [Activity]

Phrase: "from the Research Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683939:research center [Manufactured Object,Organization]
   861   C0205099:Center [Spatial Concept]

Phrase: "of the German Genome Project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709701:Project [Conceptual Entity]

Phrase: "at the Max Planck Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "for Molecular Genetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "in Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "(RZPD"

Phrase: ")"

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.66: A 1678-bp EcoRI/XhoI fragment from human CTGF clone (IMAGp998P101426), and a 1735-bp HindIIIINotI fragment from human NOV clone (IMAGp998J07280) were used to generate radioactive probes for hybridization. 

Phrase: "A 1678-bp EcoRI/XhoI fragment from human CTGF clone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "(IMAGp998P101426"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a 1735-bp HindIIIINotI fragment from human NOV clone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "(IMAGp998J07280"

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "radioactive probes for hybridization."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0182400:Probes [Medical Device]
   737 E C1704681:Probe [Gene or Genome]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]
Processing 00000000.tx.67: Rat CYR61, CTGF, and NOV cDNA Fragments for Northern Blots and Library Screening-- A 1266-bp r-CYR61 cDNA fragment and a 881-bp r-CTGF cDNA fragment were amplified by PCR using fetal rat lung cDNA as template together with the primer combinations rCYR61Ef (5'TCTGAAAGGGATCTGCAGAGCTCA3') and rCYR61Er (5'GGCTTTCACTTGACCCAA CTAATC3') or rCTGF1f (5'TGACTGCCCCTTCCCGAGAAGGGT3') and rCTGF4r (5'CCTTAGTGTGCGTTCTGTCACTGT3'). 

Phrase: "Rat CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Fragments for Northern Blots"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C1621557:Northern Blots [Research Device]
   770   C0332255:fragment [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C1708096:Fragment [Qualitative Concept]
   770   C1709269:Northern [Spatial Concept]

Phrase: "and"

Phrase: "Library Screening"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0220908:Screening [Health Care Activity]
   861   C0220909:screening [Functional Concept]
   861   C1698960:screening [Intellectual Product]
   861   C1710031:Screening [Diagnostic Procedure]
   861   C1710477:SCREENING [Research Activity]

Phrase: "-"

Phrase: "-"

Phrase: "A 1266-bp r-CYR61 cDNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "a 881-bp r-CTGF cDNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fetal rat lung cDNA as template"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "together with the primer combinations rCYR61Ef"

Phrase: "(5'TCTGAAAGGGATCTGCAGAGCTCA3'"

Phrase: ")"

Phrase: "and"

Phrase: "rCYR61Er"

Phrase: "(5'GGCTTTCACTTGACCCAA CTAATC3'"

Phrase: ")"

Phrase: "or"

Phrase: "rCTGF1f"

Phrase: "(5'TGACTGCCCCTTCCCGAGAAGGGT3'"

Phrase: ")"

Phrase: "and"

Phrase: "rCTGF4r"

Phrase: "(5'CCTTAGTGTGCGTTCTGTCACTGT3'"

Phrase: ")."
Processing 00000000.tx.68: A 947-bp NOVR cDNA fragment was amplified by using adult rat brain cDNA as template together with the forward primer NOVM1f (5'TCGATGGGGTCATTTACCGCAACG3') and reverse primer NOVM4r (5'CATATCCTGAGCTTACCTTGATTC3'). 

Phrase: "A 947-bp NOVR cDNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "amplified by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "adult rat brain cDNA as template"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "together with the forward primer NOVM1f"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953382:Forward primer [Cell]

Phrase: "(5'TCGATGGGGTCATTTACCGCAACG3'"

Phrase: ")"

Phrase: "and"

Phrase: "reverse primer NOVM4r"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "(5'CATATCCTGAGCTTACCTTGATTC3'"

Phrase: ")."
Processing 00000000.tx.69: All PCR products were separated by agarose gel electrophoresis, purified, cloned into the pCR-BluntII-TOPO vector (Invitrogen), and sequenced. 

Phrase: "All PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by agarose gel electrophoresis,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1382104:Gel [Substance]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "cloned into the pCR-BluntII-TOPO vector"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0009013:cloned [Cell]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0077229:TOPO [Organophosphorus Compound,Pharmacologic Substance]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0146224:TOPO [Organic Chemical,Pharmacologic Substance]
   748   C0442335:Vector [Spatial Concept]
   748   C0677874:pCR [Finding]
   748   C1705099:Vector [Idea or Concept]
   714 E C1522642:Clone [Tissue]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.70: Rat CYR61 Sequence-- A complete r-CYR61 cDNA sequence was identified by sequence analysis of overlapping cDNAs from different tissues. 

Phrase: "Rat CYR61 Sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "A complete r-CYR61 cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "identified by sequence analysis of overlapping cDNAs"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   748   C0205396:Identified [Qualitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1519249:Sequence [Functional Concept]
   748   C1524024:analysis [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1948020:Overlapping [Conceptual Entity]
   714   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from different tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.71: Rat lung and placenta cDNA libraries (numbers 614and 618) obtained from the Research Center of the German Genome Project at the Max Planck Institute for Molecular Genetics in Berlin (RZPD) (50) were screened with a 1266-bp r-CYR61 cDNA fragment following RZPD instructions. 

Phrase: "Rat lung"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1882727:Rat Lung [Body Part, Organ, or Organ Component]
   861   C0024109:Lung [Body Part, Organ, or Organ Component]
   861   C0819757:LUNG [Tissue]
   861   C1278908:Lung [Body Part, Organ, or Organ Component]
   805 E C2707265:Pulmonary [Clinical Attribute]
   805 E C2709248:Pulmonary [Qualitative Concept]
   768 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "placenta cDNA libraries"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0751608:cDNA Libraries [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
       E   Library
   827   C0023621:Libraries [Manufactured Object,Organization]
   793 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(numbers 614and 618"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: ")"

Phrase: "obtained from the Research Center of the German Genome Project"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0683939:research center [Manufactured Object,Organization]
   757   C0700032:project research [Research Activity]
   739   C0017428:Genome [Gene or Genome]
   739   C0035168:research [Research Activity]
   739   C0205099:Center [Spatial Concept]
   739   C0242481:Research [Research Activity]
   739   C1301820:Obtained [Functional Concept]
   739   C1556085:German [Population Group]
   739   C1709701:Project [Conceptual Entity]
   739   C2338314:Genome [Conceptual Entity]
   706 E C1706701:Obtain [Activity]

Phrase: "at the Max Planck Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "for Molecular Genetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "in Berlin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "(RZPD"

Phrase: ")"

Phrase: "(50"

Phrase: ")"

Phrase: "were"

Phrase: "screened with a 1266-bp r-CYR61 cDNA fragment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0332255:fragment [Functional Concept]
   742   C1413896:CYR61 [Gene or Genome]
   742   C1708096:Fragment [Qualitative Concept]
   708   C0220908:screen [Health Care Activity]
   708   C1305399:screen [Functional Concept]
   708   C1705053:Screen [Medical Device]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "RZPD instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.72: Two lung cDNA clones (p614K0171Q2 and p614O2448Q2) were identified that displayed r-CYR61 5' end (nt 1-534) as well as one placenta cDNA clone p618K0827Q2 corresponding to 3' end (nt 1016-1987). 

Phrase: "Two lung cDNA clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(p614K0171Q2"

Phrase: "and"

Phrase: "p614O2448Q2"

Phrase: ")"

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that displayed r-CYR61 5' end (nt 1-534"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   864   C1514732:Rat-1 [Cell]
   812   C0128167:NT-1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0034693:Rat, NOS [Mammal]
   793   C0034721:Rat [Mammal]
   793   C0332126:NT [Qualitative Concept]
   793   C0444930:End [Spatial Concept]
   793   C0870432:displayed [Functional Concept]
   793   C1413896:CYR61 [Gene or Genome]
   793   C1449832:NT [Diagnostic Procedure]
   793   C2746065:End [Temporal Concept]
   760 E C1705417:Display [Manufactured Object]
   737 E C0205088:Terminal [Temporal Concept]
   737 E C1705314:Terminal [Manufactured Object]
   737 E C1705315:Terminal [Spatial Concept]

Phrase: ")"

Phrase: "as well as"

Phrase: "one placenta cDNA clone p618K0827Q2"

Phrase: "corresponding to 3' end (nt 1016-1987"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332126:NT [Qualitative Concept]
   748   C0444930:End [Spatial Concept]
   748   C1449832:NT [Diagnostic Procedure]
   748   C2746065:End [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.73: PCR products that included the missing region from nt 443-1088 were generated from rat lung, thyroid, and spleen cDNAs of two different animals by using the primers rCYR61Ef (5'TCTGAAAGGGATCTGCAGAGCTCA3') and rCYR61R1 (5'GCATCCTGCATAAGTAAATCGGAC3'). 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the missing region from nt 443-1088"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "were"

Phrase: "generated from rat lung,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1882727:Rat Lung [Body Part, Organ, or Organ Component]
   770   C0024109:Lung [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0819757:LUNG [Tissue]
   770   C1278908:Lung [Body Part, Organ, or Organ Component]
   770   C3146294:Generated [Activity]
   715 E C2707265:Pulmonary [Clinical Attribute]
   715 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "thyroid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spleen cDNAs of two different animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primers rCYR61Ef"

Phrase: "(5'TCTGAAAGGGATCTGCAGAGCTCA3'"

Phrase: ")"

Phrase: "and"

Phrase: "rCYR61R1"

Phrase: "(5'GCATCCTGCATAAGTAAATCGGAC3'"

Phrase: ")."
Processing 00000000.tx.74: In Vivo Experiments-- Adult male Harlan Sprague-Dawley rats were injected intraperitoneally with the mAChR agonist pilocarpine (25mg/kg; Sigma) or with the vehicle PBS as an injection control. 

Phrase: "In Vivo Experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "--"

Phrase: "Adult male Harlan Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034715:Rats, Sprague-Dawley [Mammal]
   827   C2699239:Sprague-Dawley [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally with the mAChR agonist pilocarpine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031923:Pilocarpine [Organic Chemical,Pharmacologic Substance]
   753   C2987634:Agonist [Pharmacologic Substance]

Phrase: "(25mg/kg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "or with the vehicle PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0042444:Vehicle [Biomedical or Dental Material]
   760   C0348005:Vehicle [Manufactured Object]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]

Phrase: "as an injection control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.75: Animal behavior was monitored until the animals were decaptured 75min after drug application. 

Phrase: "Animal behavior"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0004935:Behavior, Animal [Behavior]
   861   C0003062:Animal [Animal]
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "was"

Phrase: "monitored until the animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0003062:Animals [Animal]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "were"

Phrase: "decaptured 75min after drug application."
Processing 00000000.tx.76: Brains were rapidly dissected and frozen on dry ice. 

Phrase: "Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "and"

Phrase: "frozen on dry ice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0013239:Dry Ice [Inorganic Chemical]
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0020746:Ice [Inorganic Chemical]
   770   C0205222:Dry [Qualitative Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C1512080:Dry [Qualitative Concept]
Processing 00000000.tx.77: In Situ Hybridization-- Rat CYR61 (nt 928-1523), r-CTGF (nt 644-1524), or NOVR (nt 224-1280) cDNA fragments were subcloned into pCR-BluntII-TOPO vector (Invitrogen). 

Phrase: "In Situ Hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "--"

Phrase: "Rat CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "(nt 928-1523"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332126:NT [Qualitative Concept]
   827   C1449832:NT [Diagnostic Procedure]

Phrase: ")"

Phrase: ","

Phrase: "r-CTGF (nt 644-1524"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205090:R- [Spatial Concept]
   804   C0332126:NT [Qualitative Concept]
   804   C0684010:R. [Professional or Occupational Group]
   804   C1413791:CTGF [Gene or Genome]
   804   C1449832:NT [Diagnostic Procedure]
   804   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "NOVR"

Phrase: "(nt 224-1280"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332126:NT [Qualitative Concept]
   827   C1449832:NT [Diagnostic Procedure]

Phrase: ")"

Phrase: "cDNA fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "subcloned into pCR-BluntII-TOPO vector"

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.78: Plasmid DNA was digested by restriction enzymes BamHI or XhoI, separated by agarose gel electrophoresis, purified, and subjected to phenol protein extraction and ethanol precipitation. 

Phrase: "Plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "digested by restriction enzymes BamHI"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0443288:Restriction [Functional Concept]
   760   C0868946:digested [Physiologic Function]

Phrase: "or"

Phrase: "XhoI,"

Phrase: "separated by agarose gel electrophoresis,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1382104:Gel [Substance]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "and"

Phrase: "subjected to phenol protein extraction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "ethanol precipitation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]
Processing 00000000.tx.79: Linearized plasmid DNA was used as template to generate radiolabeled sense and antisense cRNA probes by using either T7 or SP6 RNA polymerase (Roche Molecular Biochemicals) together with [-35S]UTP (NEN Life Science Products), GTP, ATP, and CTP, dithiothreitol, and RNase Out (Roche Molecular Biochemicals) for 2h at 37C. 

Phrase: "Linearized plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as template to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "generate"

Phrase: "radiolabeled sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "antisense cRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0056208:cRNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1321571:CRNA [Professional or Occupational Group]

Phrase: "probes by"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0182400:Probe [Medical Device]
   833   C1704681:Probe [Gene or Genome]
   833   C2347609:Probe [Chemical Viewed Functionally]
   833   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either T7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1179691:T7 [Body Location or Region]

Phrase: "or"

Phrase: "SP6 RNA polymerase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0140662:SP6 RNA polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0035681:RNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2984241:RNA polymerase [Functional Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "together with"

Phrase: "[-35S"

Phrase: "]UTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042010:UTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(NEN Life Science Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0332070:Life Science Products [Health Care Related Organization]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "ATP,"

Phrase: "and"

Phrase: "CTP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010734:CTP [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1420150:CTP [Gene or Genome]

Phrase: "dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "RNase Out"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.80: Unincorporated nucleotides were removed by ProbeQuant G50 gel filtration (Amersham Pharmacia Biotech). 

Phrase: "Unincorporated nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "removed by ProbeQuant G50 gel filtration"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0008559:Gel Filtration [Laboratory Procedure]
   753   C0016107:filtration [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0849355:Removed [Qualitative Concept]
   753   C1382104:Gel [Substance]
   719 E C1883720:Remove [Activity]
   719 E C3244314:remove [Functional Concept]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.81: Rat brains were cut on a Leica cryostat microtome in 16-m slices, thawed on glass slides, and stored at 80C before use. 

Phrase: "Rat brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "cut on a Leica cryostat microtome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0181857:MICROTOME, CRYOSTAT [Medical Device]
   753   C0000925:Cut [Injury or Poisoning]
   753   C0180202:Cryostat [Medical Device]
   753   C0181856:microtome [Medical Device]
   753   C0700320:microtome [Laboratory Procedure]
   753   C1883724:CUT [Phenomenon or Process]

Phrase: "in 16-m slices,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1519355:Slice [Substance]

Phrase: "thawed on glass slides,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017596:Glass [Manufactured Object]
   770   C0444330:slides [Research Device]
   770   C1947936:Glass [Medical Device]
   737 E C1705201:Slide [Manufactured Object]
   737   C1710378:Thaw [Laboratory Procedure]

Phrase: "and"

Phrase: "stored at 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "before use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.82: The slices were fixed in 4% paraformaldehyde, acetylated, and prehybridized for 3h at 55C with prehybridization buffer (50% formamide, 5 hybridization salts, 5 Denhardt's, 0.2% SDS, 10mM dithiothreitol, 250g/ml salmon sperm DNA (Stratagene), 250g/ml yeast tRNA (Roche Molecular Biochemicals)) in a humidified chamber. 

Phrase: "The slices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519355:Slice [Substance]

Phrase: "were"

Phrase: "fixed in 4% paraformaldehyde,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "acetylated"

Phrase: ","

Phrase: "and"

Phrase: "prehybridized for 3h"

Phrase: "at 55C"

Phrase: "with prehybridization buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50% formamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016568:formamide [Organic Chemical]

Phrase: "5 hybridization salts,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0036140:Salts [Chemical Viewed Structurally]
   793 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   793 E C0206136:Salt [Food,Inorganic Chemical]
   743 E C1537053:salty [Qualitative Concept]
   721 E C0678584:saltiness [Qualitative Concept]

Phrase: "5 Denhardt's,"

Phrase: "0.2% SDS,"

Phrase: "10mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "250g/ml salmon sperm DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: ","

Phrase: "250g/ml yeast tRNA (Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: ")"

Phrase: "in a humidified chamber."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.83: Hybridization was performed for 18h at 55C with radiolabeled cRNA probes (5000cpm/l) in prehybridization buffer containing 10% dextran sulfate. 

Phrase: "Hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020202:Hybridisation [Genetic Function]
  1000   C1300517:Hybridization [Laboratory Procedure]

Phrase: "was"

Phrase: "performed for 18h"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1442448:18H [Temporal Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at 55C"

Phrase: "with radiolabeled cRNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0206516:cRNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "(5000cpm/l) in prehybridization buffer"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% dextran sulfate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0079224:Dextran Sulfate [Carbohydrate,Pharmacologic Substance]
   827   C0038720:Sulfate [Inorganic Chemical]
   827   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   827   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.84: The slices were dehydrated, washed under non-stringent conditions in 4 SSC at room temperature, followed by RNase A treatment. 

Phrase: "The slices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519355:Slice [Substance]

Phrase: "were"

Phrase: "dehydrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011175:Dehydrated [Disease or Syndrome]

Phrase: ","

Phrase: "washed under non-stringent conditions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C1518422:Non [Functional Concept]
   760   C1548982:Washed [Idea or Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0441648:Wash [Activity]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "in 4 SSC"

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "followed by RNase"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "A treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.85: Two stringent wash steps were performed in 2 SSC for 10min at 55C. 

Phrase: "Two stringent wash steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C1261552:steps [Conceptual Entity]
   779 E C1704379:Step [Functional Concept]
   779 E C1705117:Step [Quantitative Concept]
   779 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "performed in 2 SSC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 10min"

Phrase: "at 55C."
Processing 00000000.tx.86: The slices were dehydrated, and a x-ray film (Kodak Biomax MR) was exposed for 3-14 days. 

Phrase: "The slices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519355:Slice [Substance]

Phrase: "were"

Phrase: "dehydrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011175:Dehydrated [Disease or Syndrome]

Phrase: ","

Phrase: "and"

Phrase: "a x-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0043303:X-Ray Film [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Film [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]
   827   C2314876:ray [Fish]

Phrase: "(Kodak Biomax"

Phrase: "MR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347167:Mr. [Conceptual Entity]

Phrase: "was"

Phrase: "exposed for 3-14 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0332157:Exposed [Clinical Attribute]
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.87: Emulsion dips were prepared with NTB-2 photoemulsion (Kodak), exposed for 1-4 weeks, developed, and fixed. 

Phrase: "Emulsion dips"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0378785:DIPS [Organic Chemical]
   827 E C3539618:DIP [Gene or Genome]

Phrase: "were"

Phrase: "prepared with NTB-2 photoemulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1521827:Prepare [Functional Concept]

Phrase: "(Kodak"

Phrase: ")"

Phrase: ","

Phrase: "exposed for 1-4 weeks,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332157:Exposed [Clinical Attribute]
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "developed"

Phrase: ","

Phrase: "and"

Phrase: "fixed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]
Processing 00000000.tx.88: Sections were counterstained with Mayers Hmalaun (Merck) (51).  

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "counterstained with Mayers Hmalaun"

Phrase: "(Merck"

Phrase: ")"

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.89: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Identification of Human CYR61 by Differential Display-- By using a differential display screen of mRNAs expressed in response to stimulation of m1 mAChR expressing HEK 293cells, we identified two redundant bands of 450and 540bp in length, which were absent in parallel fractions of unstimulated cells (data not shown). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification of Human CYR61"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0242954:Human Identification [Diagnostic Procedure]
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "by Differential Display"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705417:Display [Manufactured Object]

Phrase: "-"

Phrase: "-"

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a differential display screen of mRNAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "expressed in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of m1 mAChR expressing HEK 293cells,"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two redundant bands of 450and 540bp"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0175723:Bands [Medical Device]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "in length,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "which"

Phrase: "were"

Phrase: "absent in parallel fractions of unstimulated cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1264633:Fraction of [Quantitative Concept]
           Fractions
   757   C0805525:Cell fractions [Cell Component]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: Either band contained cDNA corresponding to human CYR61 (h-CYR61), a homolog of the murine growth factor-inducible immediate early gene cyr61 (33). 

Phrase: "Either band contained cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponding to human CYR61 (h-CYR61),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C1413896:CYR61 [Gene or Genome]

Phrase: "a homolog of the murine growth factor-inducible immediate early gene cyr61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C1334043:Gene Homolog [Gene or Genome]
           Homolog

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.91: To verify that mAChRs are coupled to the transcriptional activation of the h-CYR61 gene, we compared RNA from m1 mAChR-expressing cells that were stimulated with carbachol for different incubation times with unstimulated m1 mAChR-expressing cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "coupled to the transcriptional activation of the h-CYR61 gene,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   760   C0162493:Transcriptional Activation [Genetic Function]
   760   C1413896:CYR61 gene [Gene or Genome]
           CYR61
   757   C0017255:Gene Activation [Genetic Function]
   757   C0314604:Human gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   739   C0086418:Human [Human]
   739   C1879547:Activation [Activity]
   739   C1948027:Coupled [Functional Concept]
   706 E C0010222:couple [Family Group]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "RNA from m1 mAChR-expressing cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "were"

Phrase: "stimulated with carbachol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "for different incubation times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "with unstimulated m1 mAChR-expressing cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.92: Northern blot analysis showed no detectable levels of h-CYR61 mRNA in unstimulated cells; 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no detectable levels of h-CYR61 mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in unstimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.93: h-CYR61 signal increased 15min after stimulation, attained a maximum within 50-60 min, and decreased to lower but higher than control levels until 240min after stimulation (Fig. 1A). 

Phrase: "h-CYR61 signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "15min after stimulation,"

Phrase: "attained"

Phrase: "a maximum within 50-60 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0806909:Maximum [Quantitative Concept]
   753   C1552615:maximum [Quantitative Concept]
   753   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "and"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "but"

Phrase: "higher than control levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "until 240min"

Phrase: "after stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.94: An increase of h-CYR61 expression was also detectable in HEK 293m1 cells that were treated with carbachol in the presence of the protein synthesis inhibitor cylcoheximide (Fig. 1B). 

Phrase: "An increase of h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "also detectable in HEK 293m1 cells"

Phrase: "that"

Phrase: "were"

Phrase: "treated with carbachol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the protein synthesis inhibitor cylcoheximide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0033671:Protein Synthesis Inhibitor [Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.95: View larger version (81K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.96: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.97: m1 mAChRs stimulation induced the expression of the immediate early gene h-CYR61. 

Phrase: "m1 mAChRs stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   804   C1948023:Stimulation [Natural Phenomenon or Process]
   717   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the expression of the immediate early gene h-CYR61."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.98: A, m1 mAChR stimulation rapidly increased h-CYR61 expression in a time-dependent manner. 

Phrase: "A,"

Phrase: "m1 mAChR stimulation rapidly increased h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in a time-dependent manner."
Processing 00000000.tx.99: A Northern blot containing total RNA (5g per lane) from carbachol-treated (minutes of stimulation) and untreated m1 mAChR-expressing HEK 293cells was probed with a radiolabeled 1403-bp h-CYR61 cDNA fragment. 

Phrase: "A Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "total RNA (5g per lane"

Phrase: ")"

Phrase: "from carbachol-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "(minutes of stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439232:minute [Temporal Concept]
   790   C0700321:minute [Quantitative Concept]
   790   C0702093:/minute [Temporal Concept]
   790   C1282918:Minute [Quantitative Concept]
   790   C2347166:Minute [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "untreated m1 mAChR-expressing HEK 293cells"

Phrase: "was"

Phrase: "probed with a radiolabeled 1403-bp h-CYR61 cDNA fragment."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0086418:Human [Human]
   739   C0332255:fragment [Functional Concept]
   739   C1413896:CYR61 [Gene or Genome]
   739   C1527121:Radiolabeled [Qualitative Concept]
   739   C1708096:Fragment [Qualitative Concept]
   706   C0182400:Probe [Medical Device]
   706 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.100: B, m1 mAChR stimulation increased h-CYR61 expression in the presence of cycloheximide. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "m1 mAChR stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "h-CYR61 expression in the presence of cycloheximide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.101: A Northern blot containing total RNA (5g per lane) from HEK 293m1 mAChR cells that were treated for 1h with carbachol alone or together with the protein synthesis inhibitor cycloheximide was probed with a radiolabeled 1403-bp h-CYR61 cDNA fragment. 

Phrase: "A Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "total RNA (5g per lane"

Phrase: ")"

Phrase: "from HEK 293m1 mAChR cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "treated for 1h"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1442450:1H [Temporal Concept]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or together with the protein synthesis inhibitor cycloheximide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0033671:Protein Synthesis Inhibitor [Pharmacologic Substance]
   770   C0597295:Protein Synthesis [Molecular Function]
   744   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   744   C1883357:Together [Qualitative Concept]
   744   C1999216:Inhibitor [Qualitative Concept]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "probed with a radiolabeled 1403-bp h-CYR61 cDNA fragment."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0086418:Human [Human]
   739   C0332255:fragment [Functional Concept]
   739   C1413896:CYR61 [Gene or Genome]
   739   C1527121:Radiolabeled [Qualitative Concept]
   739   C1708096:Fragment [Qualitative Concept]
   706   C0182400:Probe [Medical Device]
   706 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.102: Cycloheximide was applied to the cells 15min before carbachol treatment. 

Phrase: "Cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "applied to the cells 15min"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0185125:Applied [Health Care Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1632850:Apply [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1879355:Apply [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "before carbachol treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.103: To control for equal RNA loading, the blots were probed with a specific GAPDH cDNA. ctr, untreated HEK 293m1 mAChR cells; 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for equal RNA loading,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205163:Equal [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1549782:Equal [Idea or Concept]
   760   C1550141:Control [Substance]
   760   C1708715:Loading [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "the blots"

Phrase: "were"

Phrase: "probed with a specific GAPDH cDNA. ctr,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   806   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   806   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   777   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0017854:Glyceraldehyde [Carbohydrate]
   739   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   739   C0031701:phosphate [Organophosphorus Compound]
   739   C0205369:Specific [Qualitative Concept]
   739   C1552740:specific [Intellectual Product]
   739   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]

Phrase: "untreated HEK 293m1 mAChR cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.104: CCh, carbachol; 

Phrase: "CCh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.105: Chx, cycloheximide. 

Phrase: "Chx,"

Phrase: "cycloheximide."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]
Processing 00000000.tx.106: X-ray film exposed to Northern blot: h-CYR61, 48h; 

Phrase: "X-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0043303:X-Ray Film [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Film [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]
   827   C2314876:ray [Fish]

Phrase: "exposed to Northern blot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005861:Northern Blot [Molecular Biology Research Technique]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C1621557:Northern Blot [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: ":"

Phrase: "h-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.107: GAPDH, 1h; 

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.108: kb, kilobase pairs. 

Phrase: "kb,"

Phrase: "kilobase pairs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582520:kilobase pairs [Quantitative Concept]
   861   C0582519:kilobase [Quantitative Concept]
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.109: Human and Rat CYR61 Sequences-- We identified a human CYR61 full-length cDNA clone by screening a ZAP Express cDNA library prepared from carbachol-stimulated m1 mAChR-expressing HEK 293cells. 

Phrase: "Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "Rat CYR61 Sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a human CYR61 full-length cDNA clone by screening"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0525049:clone human [Research Activity]
   742   C0009013:Clone [Cell]
   742   C1522642:Clone [Tissue]

Phrase: "a ZAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1428222:ZAP [Gene or Genome]
  1000   C1538127:ZAP [Gene or Genome]

Phrase: "Express"

Phrase: "cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prepared from carbachol-stimulated m1 mAChR-expressing HEK 293cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   742   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   742   C0812263:HEK [Gene or Genome]
   742   C1704817:HEK [Gene or Genome]
   742   C1948023:Stimulated [Natural Phenomenon or Process]
   708   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.110: By using a 1403-bp h-CYR61 cDNA probe that was obtained by PCR with cDNA from carbachol-stimulated HEK 293m1 mAChR cells, we found that 7out of 40,000clones were human homologues of the murine cyr61 gene. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 1403-bp h-CYR61 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "that"

Phrase: "was"

Phrase: "obtained by PCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from carbachol-stimulated HEK 293m1 mAChR cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that 7out of 40,"

Phrase: "000clones"

Phrase: "were"

Phrase: "human homologues of the murine cyr61 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1334043:Homologue [Gene or Genome]
Processing 00000000.tx.111: The sequence of a 2021-bp human CYR61 clone encoding a complete open reading frame predicted a 381-amino acid protein. 

Phrase: "The sequence of a 2021-bp human CYR61 clone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a complete open reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0079941:Open Reading Frame [Gene or Genome]
   861   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   812   C0034754:Reading [Daily or Recreational Activity]
   812   C0175566:Open [Spatial Concept]
   812   C0180979:Frame [Medical Device]
   812   C1705179:Reading [Finding]
   812   C1705858:Frame [Manufactured Object]
   741 E C0547049:Openness [Spatial Concept]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "a 381-amino acid protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.112: The sequence data of our h-CYR61 full-length clone were submitted to GenBankTM/EBI Data Bank (accession number Y12084), and they confirm the h-CYR61 sequence that was recently published by Jay et al. 

Phrase: "The sequence data of our h-CYR61 full-length clone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0596723:data human [Intellectual Product,Research Activity]
   739   C1511726:Data [Idea or Concept]
   739   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "submitted to GenBankTM/EBI Data Bank"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0242356:Data Bank [Intellectual Product]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1420599:EBI [Gene or Genome]
   753   C1511726:Data [Idea or Concept]
   753   C1515023:Submitted [Functional Concept]
   753   C3245479:data [Medical Device]

Phrase: "(accession number Y12084"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "they"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the h-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "published by Jay et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034037:Published [Occupational Activity]
   760   C0326402:Jay [Bird]
   760   C1704324:Published [Intellectual Product]
Processing 00000000.tx.113: (52). 

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.114: Three different types of cDNA sources were used to identify the complete rat CYR61 (r-CYR61) cDNA sequence (GenBankTM accession number AF218568). 

Phrase: "Three different types of cDNA sources"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332307:Types [Qualitative Concept]
   750   C1547727:Source type [Idea or Concept]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the complete rat CYR61 (r-CYR61) cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "(GenBankTM accession number AF218568"

Phrase: ")."
Processing 00000000.tx.115: By screening a rat lung cDNA library offered by the Research Center of the German Genome Project (50) with a 1266-bp r-CYR61 cDNA probe generated by PCR from fetal rat lung, two lung cDNA clones (p614K0171Q2 and p614O2448Q2) were obtained that contained the 5' end of r-CYR61 (nt 1-534). 

Phrase: "By screening"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]

Phrase: "a rat lung cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   812   C0023621:Library [Manufactured Object,Organization]
   812   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "offered by the Research Center of the German Genome Project"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0683939:research center [Manufactured Object,Organization]
   757   C0700032:project research [Research Activity]
   739   C0017428:Genome [Gene or Genome]
   739   C0035168:research [Research Activity]
   739   C0205099:Center [Spatial Concept]
   739   C0242481:Research [Research Activity]
   739   C1444648:Offered [Finding]
   739   C1556085:German [Population Group]
   739   C1709701:Project [Conceptual Entity]
   739   C2338314:Genome [Conceptual Entity]

Phrase: "(50"

Phrase: ")"

Phrase: "with a 1266-bp r-CYR61 cDNA probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]

Phrase: "generated by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C3146294:Generated [Activity]

Phrase: "from fetal rat lung,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   913   C1517163:Fetal Lung [Embryonic Structure]
   901   C1882727:Rat Lung [Body Part, Organ, or Organ Component]
   867 E C0270151:Fetal pneumonia [Disease or Syndrome]
   827   C0024109:Lung [Body Part, Organ, or Organ Component]
   827   C0819757:LUNG [Tissue]
   827   C1278908:Lung [Body Part, Organ, or Organ Component]
   771 E C2707265:Pulmonary [Clinical Attribute]
   771 E C2709248:Pulmonary [Qualitative Concept]
   734 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "two lung cDNA clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(p614K0171Q2"

Phrase: "and"

Phrase: "p614O2448Q2"

Phrase: ")"

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the 5' end of r-CYR61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "(nt 1-534"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0128167:NT-1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0332126:NT [Qualitative Concept]
   827   C1449832:NT [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.116: PCR products that were generated from rat lung, thyroid, and spleen cDNA corresponded to nt 443-1088. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "generated from rat lung,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1882727:Rat Lung [Body Part, Organ, or Organ Component]
   770   C0024109:Lung [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0819757:LUNG [Tissue]
   770   C1278908:Lung [Body Part, Organ, or Organ Component]
   770   C3146294:Generated [Activity]
   715 E C2707265:Pulmonary [Clinical Attribute]
   715 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "thyroid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spleen cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponded to nt 443-1088."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332126:NT [Qualitative Concept]
   760   C1449832:NT [Diagnostic Procedure]
Processing 00000000.tx.117: Finally, a cDNA clone (p618K0827Q2) corresponding to the 3' end of r-CYR61 (nt 1016-1987) was identified by screening a rat placenta cDNA library from RZPD. 

Phrase: "Finally,"

Phrase: "a cDNA clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(p618K0827Q2"

Phrase: ")"

Phrase: "corresponding to the 3' end of r-CYR61"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0444930:End [Spatial Concept]
   744   C1413896:CYR61 [Gene or Genome]
   744   C2746065:End [Temporal Concept]

Phrase: "(nt 1016-1987"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332126:NT [Qualitative Concept]
   827   C1449832:NT [Diagnostic Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "identified by screening"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0205396:Identified [Qualitative Concept]
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]

Phrase: "a rat placenta cDNA library from RZPD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.118: The consensus sequence of 1987-bp includes one open reading frame encoding a predicted protein of 379amino acids. 

Phrase: "The consensus sequence of 1987-bp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0079160:Consensus Sequence [Nucleotide Sequence]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0376298:Consensus [Social Behavior]
   753   C1519249:Sequence [Functional Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "one open reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0079941:Open Reading Frame [Gene or Genome]
   861   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   812   C0034754:Reading [Daily or Recreational Activity]
   812   C0175566:Open [Spatial Concept]
   812   C0180979:Frame [Medical Device]
   812   C1705179:Reading [Finding]
   812   C1705858:Frame [Manufactured Object]
   741 E C0547049:Openness [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a predicted protein of 379amino acids."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.119: The human and rat CYR61 protein sequences were 93% identical. 

Phrase: "The human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat CYR61 protein sequences"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   923   C1570716:Cyr61 protein, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002518:protein sequences [Amino Acid Sequence]
   861   C2350413:CYR61 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "93% identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.120: Characteristic features of the predicted human and rat CYR61 proteins included N-terminal signal peptides, high content of conserved cysteines, and several domains that are typical for members of the CCN (CYR61/ CEF10, CTGF/FISP-12/, NOV, ELM-1, WISP-3 and COP-1) family (31, 32) as follows: an insulin-like growth factor-binding protein domain, a von Willebrand factor type C motif for possible oligomerization, a thrombospondin-1 domain that can bind both soluble and extracellular matrix molecules, and a C-terminal domain for putative dimerization. 

Phrase: "Characteristic features of the predicted human"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "rat CYR61 proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   988   C1570716:Cyr61 protein, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C2350413:CYR61 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "N-terminal signal peptides,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037081:Signal Peptides [Amino Acid Sequence]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "high content of conserved cysteines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "several domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "typical for members of the CCN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3538928:Typical [Qualitative Concept]

Phrase: "(CYR61/ CEF10,"

Phrase: "CTGF/FISP-12/,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0385569:FISP [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1366521:FISP [Gene or Genome]
   827   C1413791:CTGF [Gene or Genome]
   827   C1705829:FISP [Gene or Genome]

Phrase: "NOV,"

Phrase: "ELM-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330531:Elm [Plant]
   861   C1140703:elm [Pharmacologic Substance]
   861   C2980688:ELM [Organic Chemical,Pharmacologic Substance]

Phrase: "WISP-3"

Phrase: "and"

Phrase: "COP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0110658:Cop 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C0289884:COP-1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C0528008:COP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538830:COP1 [Gene or Genome]
  1000   C2681322:COP1 [Gene or Genome]

Phrase: ")"

Phrase: "family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "an insulin-like growth factor-binding protein domain,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C0162808:Protein Domain [Spatial Concept]
   818   C1514562:Protein Domain [Amino Acid Sequence]
   795   C1880389:Domain [Functional Concept]
   795   C1883221:Domain [Conceptual Entity]
   795   C3541951:Domain [Intellectual Product]
   787   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1149301:insulin-like growth factor binding [Molecular Function]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "a von Willebrand factor type C motif for possible oligomerization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1514562:Motif [Amino Acid Sequence]

Phrase: "a thrombospondin-1 domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
   734   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1336626:THROMBOSPONDIN I [Gene or Genome]

Phrase: "that"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "both soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "extracellular matrix molecules,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "and"

Phrase: "a C-terminal domain for putative dimerization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.121: Expression of CYR61, CTGF, and NOV in Human Brain-- CYR61 and its relatives CTGF and NOV were the first genes that were identified to be members of the CCN gene family (31). 

Phrase: "Expression of CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV in Human Brain"

Phrase: "--"

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "and"

Phrase: "its relatives CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: "were"

Phrase: "the first genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "members of the CCN gene family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: Even though these genes are characterized in peripheral tissues, less is known about their function in brain. 

Phrase: "Even"

Phrase: "though"

Phrase: "these genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "characterized in peripheral tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040300:Tissues [Tissue]
   770   C0205100:Peripheral [Spatial Concept]
   770   C1880022:Characterized [Activity]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "is"

Phrase: "known about their function"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0205309:Known [Qualitative Concept]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "in brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.123: In order to demonstrate the expression of CYR61, CTGF, and NOV in human brain, we probed Northern blots of poly(A+) RNA from several regions of adult human brains with cDNA probes of these three family members and found all of them to be expressed throughout human brain (Fig. 2). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the expression of CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV in human brain,"

Phrase: "we"

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "Northern blots of poly(A+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0005861:northern blots [Molecular Biology Research Technique]
   806   C1621557:Northern Blots [Research Device]
   760   C1709269:Northern [Spatial Concept]

Phrase: ")"

Phrase: "RNA from several regions of adult human brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "probes of these three family members"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0086282:Family Members [Family Group]
   756 E C1611821:Family Member [Intellectual Product]
   753   C0015576:Family [Family Group]
   753   C0182400:Probe [Medical Device]
   753   C0205449:Three [Quantitative Concept]
   753   C0680022:members [Population Group]
   753   C1704681:Probe [Gene or Genome]
   753   C1704727:Family [Conceptual Entity]
   753   C2347609:Probe [Chemical Viewed Functionally]
   753   C3536729:Probe [Manufactured Object]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "all of them to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "be"

Phrase: "expressed throughout human brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0086418:Human [Human]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.124: The strongest expression of h-CYR61 occurred in spinal cord, frontal, temporal, and occipital cortices, as well as in the hippocampus and caudate nucleus. 

Phrase: "The strongest expression of h-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "occurred in spinal cord,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   833   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   770   C0521329:Spinal [Spatial Concept]
   770   C1550235:Cord [Body Part, Organ, or Organ Component]
   770   C1552938:cord [Quantitative Concept]
   770   C1706500:Cord [Manufactured Object]
   770   C1709305:Occurred [Activity]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "frontal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205123:Frontal [Spatial Concept]

Phrase: "temporal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442043:Temporal [Spatial Concept]
  1000   C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "occipital cortices,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0028785:Occipital cortex [Body Part, Organ, or Organ Component]
   861   C1184145:Occipital [Body Location or Region]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "as well as in the hippocampus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "caudate nucleus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007461:Caudate Nucleus [Body Part, Organ, or Organ Component]
  1000   C1269580:Caudate nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.125: In addition to the expected message of 2.4kilobase pairs we detected a 3.8-kilobase pair message that may represent a splice variant of h-CYR61 mRNA. 

Phrase: "In addition to the expected message"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470166:Message [Intellectual Product]

Phrase: "of 2.4kilobase"

Phrase: "pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a 3.8-kilobase pair message"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0470166:Message [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a splice variant of h-CYR61 mRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.126: The expression pattern of h-CTGF was similar to that of h-CYR61 except that tissue levels of h-CTGF transcripts were lower in hippocampus, caudate nucleus, and corpus callosum (Fig. 2). 

Phrase: "The expression pattern of h-CTGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "similar to that of h-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that tissue levels of h-CTGF transcripts"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0040300:Tissue [Tissue]
   748   C0441889:Levels [Qualitative Concept]
   748   C1547928:Tissue [Intellectual Product]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "lower in hippocampus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "caudate nucleus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007461:Caudate Nucleus [Body Part, Organ, or Organ Component]
  1000   C1269580:Caudate nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "corpus callosum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010090:Corpus Callosum [Body Part, Organ, or Organ Component]
   861   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.127: NOVH was expressed at high levels in amygdala and spinal cord, as well as in brain cortex and hippocampus (Fig. 2). 

Phrase: "NOVH"

Phrase: "was"

Phrase: "expressed at high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in amygdala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "as well as in brain cortex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0007776:Cortex [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C2700441:Cortex [Plant]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.128: View larger version (84K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(84K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.130: Expression of CCN genes in human brain. 

Phrase: "Expression of CCN genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in human brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.131: The CCN gene family members CYR61, CTGF, and NOV were expressed in adult human brain regions. 

Phrase: "The CCN gene family members CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1413896:CYR61 [Gene or Genome]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: "were"

Phrase: "expressed in adult human brain regions."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0001675:Human, Adult [Age Group]
           Adult
   790   C1273723:brain regions [Body Location or Region]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1706450:Adult [Human]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]
Processing 00000000.tx.132: Human brain Northern blots loaded with poly(A+) RNA (CLONTECH) were hybridized with a radiolabeled 1403-bp h-CYR61 cDNA probe, a 1678-bp h-CTGF cDNA probe, and a 1735-bp NOVH cDNA probe. 

Phrase: "Human brain Northern blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005861:northern blots [Molecular Biology Research Technique]
   861   C1621557:Northern Blots [Research Device]
   812   C1709269:Northern [Spatial Concept]

Phrase: "loaded with poly(A+"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   770   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0747726:POLY [Conceptual Entity]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: ")"

Phrase: "RNA (CLONTECH"

Phrase: ")"

Phrase: "were"

Phrase: "hybridized with a radiolabeled 1403-bp h-CYR61 cDNA probe,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0086418:Human [Human]
   739   C0182400:Probe [Medical Device]
   739   C1413896:CYR61 [Gene or Genome]
   739   C1527121:Radiolabeled [Qualitative Concept]
   739   C1704681:Probe [Gene or Genome]
   739   C2347609:Probe [Chemical Viewed Functionally]
   739   C3536729:Probe [Manufactured Object]
   706 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "a 1678-bp h-CTGF cDNA probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "a 1735-bp NOVH cDNA probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.133: The h-CTGF and NOVH probes were derived from human expressed sequence tags obtained from the Resource Center of the German Human Genome Project at the Max-Planck-Institute for Molecular Genetics, Berlin (50). 

Phrase: "The h-CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVH probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "derived from human expressed sequence tags"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0600510:Expressed Sequence Tags [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0086418:Human [Human]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1139855:tags [Medical Device]
   753   C1441547:Derived [Qualitative Concept]
   753   C1519249:Sequence [Functional Concept]
   753   C3245521:derived [Idea or Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "obtained from the Resource Center of the German Human Genome Project"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   775   C0020125:Human Genome Project [Research Activity]
   756   C0017429:Genome, Human [Gene or Genome]
   754   C0220852:human resource [Quantitative Concept]
   738   C0017428:Genome [Gene or Genome]
   738   C0035201:Resource [Idea or Concept]
   738   C0086418:Human [Human]
   738   C0205099:Center [Spatial Concept]
   738   C1301820:Obtained [Functional Concept]
   738   C1556085:German [Population Group]
   738   C1709701:Project [Conceptual Entity]
   738   C2338314:Genome [Conceptual Entity]
   704 E C1706701:Obtain [Activity]

Phrase: "at the Max-Planck-Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "for Molecular Genetics,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "Berlin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.134: As a loading control, both blots were probed with a human -Actin cDNA fragment (CLONTECH). 

Phrase: "As a loading control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "both blots"

Phrase: "were"

Phrase: "probed with a human -Actin cDNA fragment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086418:Human [Human]
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: "(CLONTECH"

Phrase: ")."
Processing 00000000.tx.135: X-ray films exposed to Northern blots: h-CYR61, 48h; 

Phrase: "X-ray films"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0043303:X-Ray Films [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Films [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C2314876:ray [Fish]
   793 E C1561571:film [Biomedical or Dental Material]
   793 E C1561572:film [Substance]

Phrase: "exposed to Northern blots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C1621557:Northern Blots [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: ":"

Phrase: "h-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.136: NOVH, 24h; 

Phrase: "NOVH,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.137: h-CTGF, 72h; 

Phrase: "h-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "72h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292423:72H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.138: -Actin, 1h. 

Phrase: "-Actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.139: kb, kilobase pairs. 

Phrase: "kb,"

Phrase: "kilobase pairs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582520:kilobase pairs [Quantitative Concept]
   861   C0582519:kilobase [Quantitative Concept]
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.140: Muscarinic AChRs Induce the Expression of r-CYR61 in Primary Neurons-- To investigate r-CYR61, r-CTGF, and NOVR expression in neuronal cells that endogenously express mAChRs, we stimulated a mixed culture of primary cortical and hippocampal neurons from embryonic (E18) rat brains with carbachol for 1or 3h (Fig. 3A). 

Phrase: "Muscarinic AChRs"

Phrase: "Induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the Expression of r-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Primary Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "r-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR expression in neuronal cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that endogenously"

Phrase: "express"

Phrase: "mAChRs,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "we"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "a mixed culture of primary cortical"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0010453:Culture [Idea or Concept]
   753   C0205430:Mixed [Functional Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3160715:Mixed [Finding]
   719 E C1421951:MIX [Gene or Genome]
   719 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "hippocampal neurons from embryonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "(E18"

Phrase: ")"

Phrase: "rat brains with carbachol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   816   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "for 1or 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.141: We found all three genes to be constitutively expressed. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "all three genes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "be"

Phrase: "constitutively"

Phrase: "expressed."
Processing 00000000.tx.142: The stimulation with carbachol for 1h increased basal r-CYR61 mRNA levels 3.5-fold, and this increase was blocked by atropine (Fig. 3, A and B). 

Phrase: "The stimulation with carbachol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "basal r-CYR61 mRNA levels 3.5-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332462:Fold [Spatial Concept]
   793   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "blocked by atropine"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C1161352:atropine [Pharmacologic Substance]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.143: After 3h of carbachol treatment r-CYR61 expression decreased to basal levels. 

Phrase: "After 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "of carbachol treatment r-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "decreased to basal levels."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0205112:Basal [Spatial Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.144: In contrast, r-CTGF and NOVR expression was not influenced by mAChR stimulation, nor after 1or 3h of carbachol treatment (Fig. 3, A and B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "r-CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influenced by mAChR stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "nor after 1or 3h of carbachol treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   748   C0028423:NOR [Geographic Area]
   748   C0028609:NOR [Cell Component]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1442460:3H [Temporal Concept]
   748   C1513854:NOR [Mammal]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.145: The inhibition of m2 mAChRs with the m2-antagonist gallamine together with carbachol failed to block the carbachol-induced r-CYR61 expression (data not shown). 

Phrase: "The inhibition of m2 mAChRs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1514761:Receptor Inhibition [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "with the m2-antagonist gallamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016971:Gallamine [Organic Chemical,Pharmacologic Substance]

Phrase: "together with carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the carbachol-induced r-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.148: Muscarinic mAChRs induce CYR61 expression in rat primary neurons. 

Phrase: "Muscarinic mAChRs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "CYR61 expression in rat primary neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: Rat CYR61, r-CTGF, and NOVR expression in a mixed culture of primary cortical and hippocampal neurons after carbachol treatment are shown. 

Phrase: "Rat CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR expression in a mixed culture of primary cortical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "hippocampal neurons after carbachol treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.150: A, Northern blots with 10g of total RNA from rat primary neurons treated with mAChR agonist carbachol (CCh) for 1or 3h alone or together with mAChR antagonist atropine (Atr) were hybridized with a r-CYR61, r-CTGF, and NOVR probe. 

Phrase: "A,"

Phrase: "Northern blots with 10g of total RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005861:northern blots [Molecular Biology Research Technique]
   778   C1621557:Northern Blots [Research Device]
   748   C1709269:Northern [Spatial Concept]

Phrase: "from rat primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "treated with mAChR agonist carbachol (CCh)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   760   C2987634:Agonist [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 1or 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or together with mAChR antagonist atropine (Atr)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
   753   C0231491:Antagonist [Organ or Tissue Function]
   753   C1161352:atropine [Pharmacologic Substance]
   753   C1883357:Together [Qualitative Concept]

Phrase: "were"

Phrase: "hybridized with a r-CYR61,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1413896:CYR61 [Gene or Genome]

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.151: Atropine was applied to the cells 10min before carbachol treatment. 

Phrase: "Atropine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
  1000   C1161352:atropine [Pharmacologic Substance]

Phrase: "was"

Phrase: "applied to the cells 10min"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0185125:Applied [Health Care Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1632850:Apply [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1879355:Apply [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "before carbachol treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.152: GAPDH was used as a loading control. 

Phrase: "GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used as a loading control."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1550141:Control [Substance]
   760   C1708715:Loading [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.153: X-ray film exposed to Northern blots: r-CYR61, 48h; 

Phrase: "X-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0043303:X-Ray Film [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Film [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]
   827   C2314876:ray [Fish]

Phrase: "exposed to Northern blots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C1621557:Northern Blots [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: ":"

Phrase: "r-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.154: r-CTGF, 24h; 

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.155: NOVR, 12h; 

Phrase: "NOVR,"

Phrase: "12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.156: GAPDH, 1h. 

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.157: B, densitometric analyses and quantification of r-CYR61, r-CTGF, and NOVR mRNA expression in primary neurons normalized to cellular levels of GAPDH mRNA. kb, kilobase pairs. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "densitometric analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "quantification of r-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR mRNA expression in primary neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "normalized to cellular levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1882115:Normalized [Research Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "of GAPDH mRNA. kb,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   734   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   700   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]

Phrase: "kilobase pairs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582520:kilobase pairs [Quantitative Concept]
   861   C0582519:kilobase [Quantitative Concept]
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.158: mAChR-dependent Regulation of CYR61 in the Mammalian Brain-- In the mammalian brain, neuronal cells in the cortex, the hippocampus, and some thalamic nuclei receive cholinergic input from the basal forebrain (2, 3). 

Phrase: "mAChR-dependent Regulation of CYR61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in the Mammalian Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "-"

Phrase: "-"

Phrase: "In the mammalian brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "neuronal cells in the cortex,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C1166657:cell cortex [Cell Component]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "some thalamic nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "cholinergic input from the basal forebrain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708517:Input [Conceptual Entity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.159: To investigate whether mAChR regulate CYR61 expression in vivo, the mAChR agonist pilocarpine was administered to adult rats and brains were prepared 75min later. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "mAChR"

Phrase: "regulate"

Phrase: "CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the mAChR agonist pilocarpine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031923:Pilocarpine [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "administered to adult rats"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0001675:Adult [Age Group]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C1521801:Administered [Functional Concept]
   770   C1706450:Adult [Human]
   737 E C1621583:Administer [Functional Concept]

Phrase: "and"

Phrase: "brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "75min later."
Processing 00000000.tx.160: Brains of non-injected and PBS-injected animals were used as controls. 

Phrase: "Brains of non-injected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0196008:Injection of brain [Therapeutic or Preventive Procedure]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "PBS-injected animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.161: In situ hybridization analyses of cryostat slices of forebrain tissue from control and pilocarpine-treated animals demonstrated that expression of r-CYR61, but not r-CTGF or NOVR readily increased in response to mAChR stimulation (Fig. 4A). 

Phrase: "In situ hybridization analyses of cryostat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "slices of forebrain tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0040300:Tissue [Tissue]
   770   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   770   C1519355:Slice [Substance]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "pilocarpine-treated animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "demonstrated"

Phrase: "that expression of r-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not r-CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1413791:CTGF [Gene or Genome]

Phrase: "or"

Phrase: "NOVR readily"

Phrase: "increased in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to mAChR stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.162: In both non-injected and PBS-injected control animals, we detected a very low basal expression of r-CYR61 that increased after pilocarpine treatment in cortical layer VI as well as in some cells of cortical layer V and in thalamic nuclei (Fig. 4, A and B). 

Phrase: "In both non-injected"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C1518422:Non [Functional Concept]
   827   C1720154:Inject [Functional Concept]
   789 E C0021485:injection [Therapeutic or Preventive Procedure]
   789 E C1272883:Injection [Biomedical or Dental Material]
   789 E C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   789 E C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "PBS-injected control animals,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1511501:Control Animal [Animal]
   812   C0003062:Animals [Animal]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a very low basal expression of r-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "increased after pilocarpine treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0031923:Pilocarpine [Organic Chemical,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "in cortical layer VI"

Phrase: "as well as in some cells of cortical layer V"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C1511526:Cortical Cell Layer [Tissue]
   757   C2347578:Cells/well [Quantitative Concept]
   739   C0001613:Cortical [Body Part, Organ, or Organ Component]
   739   C0007634:Cells [Cell]
   739   C0007776:Cortical [Body Part, Organ, or Organ Component]
   739   C0022655:Cortical [Body Part, Organ, or Organ Component]
   739   C0205170:Well [Qualitative Concept]
   739   C0934502:Layer [Body Part, Organ, or Organ Component]
   739   C1522408:Layer [Qualitative Concept]
   739   C1561599:Layer [Intellectual Product]
   739   C3146287:Well [Manufactured Object]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "and in thalamic nuclei"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   770   C0039729:Thalamic [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   737   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.163: Rat CTGF mRNA was predominantly expressed in cortical layer VI in both control and pilocarpine-treated rats (Fig. 4A). 

Phrase: "Rat CTGF mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "predominantly"

Phrase: "expressed in cortical layer VI"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "in both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "pilocarpine-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.164: Comparable to r-CTGF, NOVR expression was not altered by mAChR stimulation. 

Phrase: "Comparable to r-CTGF,"

Phrase: "NOVR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by mAChR stimulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Altered [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.165: NOVR mRNA was detected in cortical layers II/III, V, and VI, the pyramidal cell CA1-CA3 hippocampal regions, and the amygdala (Fig. 4A). 

Phrase: "NOVR mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "detected in cortical layers II/III,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0439070:III [Intellectual Product]
   753   C0442726:Detected [Finding]
   753   C0934502:layers [Body Part, Organ, or Organ Component]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1705160:III [Qualitative Concept]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]

Phrase: "V,"

Phrase: "and"

Phrase: "VI,"

Phrase: "the pyramidal cell CA1-CA3 hippocampal regions,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   859   C1268228:Cell region [Cell Component]
   810   C3496509:hippocampal region [Body Location or Region]
   766   C0017446:Region [Geographic Area]
   766   C0205147:Region [Spatial Concept]
   716 E C0205276:Regional [Spatial Concept]
   716 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the amygdala"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.166: View larger version (90K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(90K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334335:90K [Gene or Genome]
  1000   C1705384:90K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 4.  

Phrase: "4."
Processing 00000000.tx.168: Muscarinic mAChRs induce the expression of r-CYR61 in rat brain. 

Phrase: "Muscarinic mAChRs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of r-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.169: In situ hybridization experiments with rat brains were performed with rats that were injected intraperitoneally with the mAChR agonist pilocarpine (25mg/kg). 

Phrase: "In situ hybridization experiments with rat brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "performed with rats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally with the mAChR agonist pilocarpine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031923:Pilocarpine [Organic Chemical,Pharmacologic Substance]
   753   C2987634:Agonist [Pharmacologic Substance]

Phrase: "(25mg/kg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.170: A, frontal sections of control and rat brains stimulated for 75min were hybridized with r-CYR61, r-CTGF, or NOVR antisense riboprobes. 

Phrase: "A,"

Phrase: "frontal sections of control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205123:Frontal [Spatial Concept]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "rat brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "stimulated for 75min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "hybridized with r-CYR61,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1413896:CYR61 [Gene or Genome]

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "or"

Phrase: "NOVR antisense riboprobes."
Processing 00000000.tx.171: Rat CYR61 revealed low basal expression in control animals but was strongly induced in cortical layers V, VI, and thalamic nuclei (thal) in pilocarpine-treated rats. 

Phrase: "Rat CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "low basal expression in control animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "was"

Phrase: "strongly"

Phrase: "induced in cortical layers V,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0205263:Induced [Functional Concept]
   760   C0934502:layers [Body Part, Organ, or Organ Component]
   726 E C1522408:Layer [Qualitative Concept]
   726 E C1561599:Layer [Intellectual Product]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "VI,"

Phrase: "and"

Phrase: "thalamic nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "(thal) in pilocarpine-treated rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.172: Rat CTGF and NOVR expression was not altered by mAChR stimulation as their mRNA distribution did not differ in control and pilocarpine-treated rat brain. 

Phrase: "Rat CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by mAChR stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Altered [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "as their mRNA distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "pilocarpine-treated rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.173: R-CTGF was predominantly expressed in cortical layer VI. 

Phrase: "R-CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "was"

Phrase: "predominantly"

Phrase: "expressed in cortical layer VI."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]
Processing 00000000.tx.174: NOVR mRNA was detected in cortical layers II/III, V, VI, the hippocampal CA1-3 region, and the amygdala (ad). 

Phrase: "NOVR mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "detected in cortical layers II/III,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0439070:III [Intellectual Product]
   753   C0442726:Detected [Finding]
   753   C0934502:layers [Body Part, Organ, or Organ Component]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1705160:III [Qualitative Concept]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]

Phrase: "V,"

Phrase: "VI,"

Phrase: "the hippocampal CA1-3 region,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   923   C0694598:CA1 Region, Hippocampal [Body Location or Region]
   902   C3496509:hippocampal region [Body Location or Region]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the amygdala (ad)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]
Processing 00000000.tx.175: X-ray films exposed to brain slices: r-CYR61, 14days; 

Phrase: "X-ray films"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0043303:X-Ray Films [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Films [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C2314876:ray [Fish]
   793 E C1561571:film [Biomedical or Dental Material]
   793 E C1561572:film [Substance]

Phrase: "exposed to brain slices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C1519355:Slice [Substance]

Phrase: ":"

Phrase: "r-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "14days"

Phrase: ";"
Processing 00000000.tx.176: r-CTGF, 14days; 

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "14days"

Phrase: ";"
Processing 00000000.tx.177: NOVR, 3days. 

Phrase: "NOVR,"

Phrase: "3days."
Processing 00000000.tx.178: B, rat CYR61 in cortical layer VI of pilocarpine-treated animals compared with corresponding region of control rats. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "rat CYR61 in cortical layer VI of pilocarpine-treated animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1413896:CYR61 [Gene or Genome]

Phrase: "compared with corresponding region of control rats."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0017446:Region [Geographic Area]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0205147:Region [Spatial Concept]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1707455:Compared [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.179: VI, cortical layer VI; 

Phrase: "VI,"

Phrase: "cortical layer VI"

Phrase: ";"
Processing 00000000.tx.180: CC, corpus callosum; 

Phrase: "CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538933:CC [Cell Component]

Phrase: "corpus callosum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010090:Corpus Callosum [Body Part, Organ, or Organ Component]
   861   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.181: arrows indicate r-CYR61 positive grains. 

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "r-CYR61 positive grains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0007757:Grains [Food]
   812   C0086369:Grains [Plant]
   779 E C1552950:Grain [Quantitative Concept]
Processing 00000000.tx.182: Muscarinic AChR Subtypes m1-m4 Induced Transcription of Human CYR61-- To determine which mAChR subtype can couple to h-CYR61 expression, we analyzed Northern blots of RNA obtained from carbachol-treated HEK 293cells stably expressing m1, m2, m3, or m4 mAChRs as well as untransfected wild type cells. h-CYR61 expression was differently affected by these receptor subtypes (Fig. 5A). 

Phrase: "Muscarinic AChR Subtypes m1-m4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C1561479:M4 [Intellectual Product]

Phrase: "Induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "Transcription of Human CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which mAChR subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:Subtype [Classification]

Phrase: "can"

Phrase: "couple to h-CYR61 expression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0010222:couple [Family Group]
   760   C0086418:Human [Human]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1413896:CYR61 [Gene or Genome]
   760   C1948027:Couple [Functional Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "Northern blots of RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C1621557:Northern Blots [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: "obtained from carbachol-treated HEK 293cells stably"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   748   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   748   C0332293:treated [Therapeutic or Preventive Procedure]
   748   C0812263:HEK [Gene or Genome]
   748   C1301820:Obtained [Functional Concept]
   748   C1522326:Treated [Functional Concept]
   748   C1704817:HEK [Gene or Genome]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "expressing"

Phrase: "m1, m2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "m3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "or"

Phrase: "m4 mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0026815:muscarinic [Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "as well as"

Phrase: "untransfected wild type cells. h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "differently"

Phrase: "affected by these receptor subtypes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0392760:Affected [Functional Concept]
   760   C0449560:subtypes [Classification]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.183: m1 and m3 mAChRs increased cellular levels of h-CYR61 mRNA 5-10 times as compared with unstimulated control cells (Fig. 5B). 

Phrase: "m1"

Phrase: "and"

Phrase: "m3 mAChRs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   886   C0289799:M3 receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0026815:muscarinic [Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cellular levels of h-CYR61 mRNA 5-10 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0456951:Level 5 [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "compared with unstimulated control cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C0439819:Unstimulated [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.184: In contrast, m2 and m4 mAChRs-expressing cells stimulated h-CYR61 expression only weakly. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "m4 mAChRs-expressing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "h-CYR61 expression only weakly."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0086418:Human [Human]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0205171:Only [Quantitative Concept]
   804   C1413896:CYR61 [Gene or Genome]
   804   C1720467:Only [Intellectual Product]
Processing 00000000.tx.185: In carbachol-stimulated as well as in unstimulated wild type HEK 293cells minimal h-CYR61 signals were detected on Northern blots. 

Phrase: "In carbachol-stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "as well as in unstimulated wild type HEK 293cells minimal h-CYR61 signals"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   750   C1883559:Wild Type [Organism Attribute]
   735   C0086418:Human [Human]
   735   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   735   C0205170:Well [Qualitative Concept]
   735   C0332307:Type [Qualitative Concept]
   735   C0439819:Unstimulated [Qualitative Concept]
   735   C0445392:Wild [Intellectual Product]
   735   C0547040:Minimal [Qualitative Concept]
   735   C0812263:HEK [Gene or Genome]
   735   C1413896:CYR61 [Gene or Genome]
   735   C1524031:MINIMAL [Qualitative Concept]
   735   C1547052:*Type [Quantitative Concept]
   735   C1704817:HEK [Gene or Genome]
   735   C2945599:Minimal [Qualitative Concept]
   735   C3146287:Well [Manufactured Object]
   702   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "detected on Northern blots."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C1621557:Northern Blots [Research Device]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.186: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.187: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.188: Muscarinic receptor subtypes differently induce h-CYR61 expression. 

Phrase: "Muscarinic receptor subtypes differently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449560:subtypes [Classification]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "h-CYR61 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.189: HEK 293wild type (wt) cells or cells either transfected with m1, m2, m3, or m4 mAChRs were treated with or without 1mM carbachol (CCh) for 1h. 

Phrase: "HEK 293wild type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(wt) cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells either"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with m1, m2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0457242:m2 [Quantitative Concept]

Phrase: "m3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "or"

Phrase: "m4 mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0026815:muscarinic [Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without 1mM carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "(CCh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.190: A, Northern blot containing total RNA (5g per lane) was hybridized with a 1403-bp h-CYR61 cDNA probe. 

Phrase: "A,"

Phrase: "Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "total RNA (5g per lane"

Phrase: ")"

Phrase: "was"

Phrase: "hybridized with a 1403-bp h-CYR61 cDNA probe."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086418:Human [Human]
   742   C0182400:Probe [Medical Device]
   742   C1413896:CYR61 [Gene or Genome]
   742   C1704681:Probe [Gene or Genome]
   742   C2347609:Probe [Chemical Viewed Functionally]
   742   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.191: GAPDH probe was used as a loading control. 

Phrase: "GAPDH probe"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]
   771   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   771   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   717   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]

Phrase: "was"

Phrase: "used as a loading control."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1550141:Control [Substance]
   760   C1708715:Loading [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.192: X-ray film exposed to Northern blot: h-CYR61, 48h; 

Phrase: "X-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0043303:X-Ray Film [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Film [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]
   827   C2314876:ray [Fish]

Phrase: "exposed to Northern blot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005861:Northern Blot [Molecular Biology Research Technique]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C1621557:Northern Blot [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: ":"

Phrase: "h-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.193: GAPDH, 1h. 

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.194: B, quantification of h-CYR61 expression normalized to GAPDH control. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantification of h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to GAPDH control."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   734   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   734   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   700   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
Processing 00000000.tx.195: Bars represent means derived from two representative independent stimulation and hybridization experiments. kb, kilobase pairs. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "derived from two representative independent stimulation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0085862:Independent [Idea or Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1299583:Independent [Finding]
   753   C1441547:Derived [Qualitative Concept]
   753   C1882932:Representative [Activity]
   753   C1948023:Stimulation [Natural Phenomenon or Process]
   753   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "hybridization experiments. kb,"

Phrase: "kilobase pairs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582520:kilobase pairs [Quantitative Concept]
   861   C0582519:kilobase [Quantitative Concept]
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.196: Multiple Internal and External Signals Coupled CYR61 Expression to mAChRs in HEK 293Cells-- To determine the signal transduction pathways that couple CYR61 induction to mAChRs, we treated HEK 293m1 mAChRs cells with activators or inhibitors of known signaling cascades. 

Phrase: "Multiple Internal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205102:Internal [Spatial Concept]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]

Phrase: "and"

Phrase: "External Signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "Coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "CYR61 Expression to mAChRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HEK 293Cells"

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0086982:Signal Transduction Pathways [Molecular Function]
   913   C0037080:Signal Pathways [Molecular Function]
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "CYR61 induction to mAChRs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "HEK 293m1 mAChRs cells with activators"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   737   C1514760:Receptor Cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "inhibitors of known signaling cascades."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.197: Alternatively, cells were treated with the mAChR agonist carbachol together with pharmacological inhibitors. 

Phrase: "Alternatively,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with the mAChR agonist carbachol"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   753   C2987634:Agonist [Pharmacologic Substance]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "together with pharmacological inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.198: Northern blots of RNA derived from these cells were hybridized with a h-CYR61 cDNA probe (Fig. 6A). 

Phrase: "Northern blots of RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C1621557:Northern Blots [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: "derived from these cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "hybridized with a h-CYR61 cDNA probe"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086418:Human [Human]
   748   C0182400:Probe [Medical Device]
   748   C1413896:CYR61 [Gene or Genome]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.199: The muscarinic antagonist atropine blocked the carbachol-induced increase in cellular levels of h-CYR61 mRNA in HEK 293m1 cells. 

Phrase: "The muscarinic antagonist atropine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
   827   C1161352:atropine [Pharmacologic Substance]
   734   C0003385:Muscarinic Antagonist [Pharmacologic Substance]
   734   C3536931:Muscarinic Antagonist [Pharmacologic Substance]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the carbachol-induced increase in cellular levels of h-CYR61 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "in HEK 293m1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.200: Stimulation of PKC with the phorbol ester phorbol myristate acetate increased h-CYR61 expression 3.0-fold (Fig. 6B), and this increase was blocked by the PKC inhibitor GF109203X. 

Phrase: "Stimulation of PKC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with the phorbol ester phorbol myristate acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   804   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "h-CYR61 expression 3.0-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332462:Fold [Spatial Concept]
   799   C1880834:FOLD [Phenomenon or Process]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "blocked by the PKC inhibitor GF109203X."
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
   833   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   800   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   793   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C3537023:kinase inhibitor [Molecular Function]
   767   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0028778:Blocked [Pathologic Function]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]
   744   C0332206:Blocked [Functional Concept]
   744   C1999216:Inhibitor [Qualitative Concept]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.201: Inhibition of PKC with GF109203X along with carbachol stimulation, however, still led to transcriptional activation of h-CYR61 but to lower magnitudes as compared with carbachol alone. 

Phrase: "Inhibition of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "with GF109203X"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]

Phrase: "along with carbachol stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "however,"

Phrase: "still"

Phrase: "led to transcriptional activation of h-CYR61"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   778   C0162493:Transcriptional Activation [Genetic Function]
   748   C0040649:Transcriptional [Genetic Function]
   748   C0086418:Human [Human]
   748   C1413896:CYR61 [Gene or Genome]
   748   C1708698:LED [Manufactured Object]
   748   C1879547:Activation [Activity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "magnitudes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704240:Magnitudes [Quantitative Concept]
   966 E C0449286:magnitude [Quantitative Concept]

Phrase: "as"

Phrase: "compared with carbachol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]
   790   C1707455:Compared [Activity]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.202: These results demonstrate that stimulation of PKC is sufficient but not necessary to induce h-CYR61 expression. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that stimulation of PKC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "sufficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205410:Sufficient [Qualitative Concept]

Phrase: "but"

Phrase: "not necessary to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "h-CYR61 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.203: In contrast, the activation of protein kinase A (PKA) by 8-bromo-cAMP failed to induce h-CYR61 transcription, and the PKA inhibitor H7 failed to block the carbachol-induced increase in CYR61 message. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the activation of protein kinase A (PKA)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C2247782:protein kinase A activation [Cell Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "by 8-bromo-cAMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000661:8-Bromo-cAMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "h-CYR61 transcription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "the PKA inhibitor H7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the carbachol-induced increase in CYR61 message."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]
Processing 00000000.tx.204: Moreover, activation of phospholipase A2 by mellitin increased h-CYR61 expression, and this effect was slightly decreased by the phospholipase A2 inhibitor DEDA, but DEDA failed to block the carbachol-induced increase. 

Phrase: "Moreover,"

Phrase: "activation of phospholipase A2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C2245662:phospholipase A2 activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "by mellitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "h-CYR61 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "decreased by the phospholipase A2 inhibitor DEDA,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C0893636:phospholipase A2 inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C0031667:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1744635:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C3539768:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   748   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1999216:Inhibitor [Qualitative Concept]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "DEDA"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the carbachol-induced increase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]
Processing 00000000.tx.205: Both the increase of intracellular Ca2+ levels by ionomycin as well as serum induced h-CYR61 expression. 

Phrase: "Both"

Phrase: "the increase of intracellular Ca2+ levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "by ionomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022020:Ionomycin [Lipid,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "h-CYR61 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.206: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.207: 6.  

Phrase: "6."
Processing 00000000.tx.208: Redundant internal signaling pathways induce h-CYR61 expression. 

Phrase: "Redundant internal signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "h-CYR61 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.209: HEK 293m1 cells were treated with activators or inhibitors of enzymes involved in mAChR signaling. 

Phrase: "HEK 293m1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with activators"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "inhibitors of enzymes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0014432:enzymes inhibitors [Pharmacologic Substance]
   858   C1152555:enzymes inhibitors [Molecular Function]
   841 E C2756995:Enzyme Inhibitors [Molecular Function]
   824 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "involved in mAChR signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037083:Signaling [Cell Function]
   770   C1314939:Involved [Functional Concept]
   770   C3537152:signaling [Biologic Function]
Processing 00000000.tx.210: A, Northern blots containing 5g of RNA were hybridized with a h-CYR61 1403-bp cDNA probe. 

Phrase: "A,"

Phrase: "Northern blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:northern blots [Molecular Biology Research Technique]
  1000   C1621557:Northern Blots [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5g of RNA"

Phrase: "were"

Phrase: "hybridized with a h-CYR61 1403-bp cDNA probe."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086418:Human [Human]
   742   C0182400:Probe [Medical Device]
   742   C1413896:CYR61 [Gene or Genome]
   742   C1704681:Probe [Gene or Genome]
   742   C2347609:Probe [Chemical Viewed Functionally]
   742   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.211: GAPDH was used as a loading control. 

Phrase: "GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used as a loading control."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1550141:Control [Substance]
   760   C1708715:Loading [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.212: X-ray film exposed to Northern blot: h-CYR61, 48h; 

Phrase: "X-ray film"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0043303:X-Ray Film [Medical Device]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086296:Film [Manufactured Object]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]
   827   C2314876:ray [Fish]

Phrase: "exposed to Northern blot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005861:Northern Blot [Molecular Biology Research Technique]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C1621557:Northern Blot [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: ":"

Phrase: "h-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.213: GAPDH, 1h. 

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.214: B, densitometric analyses and quantification of h-CYR61 expression normalized to cellular levels of GAPDH. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "densitometric analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "quantification of h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "normalized to cellular levels of GAPDH."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   818   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   818   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   784   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   762   C0428304:levels phosphate [Laboratory or Test Result]
   745   C0456949:Level 3 [Intellectual Product]
   742   C0007634:Cellular [Cell]
   742   C0017854:Glyceraldehyde [Carbohydrate]
   742   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C0178539:Cellular [Functional Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   742   C1882115:Normalized [Research Activity]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.215: CCh, carbachol; 

Phrase: "CCh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.216: PMA, phorbol myristate acetate; 

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "phorbol myristate acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.217: GF, GF109203X; 

Phrase: "GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016703:GF [Geographic Area]
  1000   C1551081:gf [Quantitative Concept]

Phrase: "GF109203X"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.218: cAMP, 8-bromo-cAMP; 

Phrase: "cAMP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "8-bromo-cAMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000661:8-Bromo-cAMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.219: Mell, mellitin; 

Phrase: "Mell,"

Phrase: "mellitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: ";"
Processing 00000000.tx.220: Ca, Ca2+; 

Phrase: "Ca,"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.221: S, fetal calf serum; 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.222: PLA2, phospholipase A2; 

Phrase: "PLA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540622:PLA2 [Gene or Genome]

Phrase: "phospholipase A2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031667:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1744635:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539768:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.223: Atr, atropine; 

Phrase: "Atr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
  1000   C1161352:atropine [Pharmacologic Substance]

Phrase: "atropine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
  1000   C1161352:atropine [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.224: kb, kilobase pairs.  

Phrase: "kb,"

Phrase: "kilobase pairs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582520:kilobase pairs [Quantitative Concept]
   861   C0582519:kilobase [Quantitative Concept]
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.225: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In brain, mAChR are associated with long term memory formation that depends on changes in synaptic plasticity, including modifications of preexisting synapses and the generation of new neuronal connections. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES In brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]

Phrase: "mAChR"

Phrase: "are"

Phrase: "associated with long term memory formation"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   833   C0423909:Memory, Long-Term [Mental Process]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0443252:Long-term [Temporal Concept]
   753   C0025260:Memory [Mental Process]
   753   C0205166:Long [Qualitative Concept]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C0700327:memory [Finding]
   753   C1515273:Term [Temporal Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C1706377:Memory [Manufactured Object]
   753   C2826302:TERM [Intellectual Product]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "depends on changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0725813:depend [Medical Device]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in synaptic plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "modifications of preexisting synapses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "the generation of new neuronal connections."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1820186:generation of neurons [Organism Function]
           neuron generation
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]
Processing 00000000.tx.226: These synaptic modifications are mediated by alterations in the expression of activity-dependent genes. 

Phrase: "These synaptic modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "are"

Phrase: "mediated by alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   756   C1515926:Alteration [Idea or Concept]

Phrase: "in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of activity-dependent genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.227: Muscarinic AChR induce the expression of immediate early gene transcription factors c-fos, jun-B, Egr-1/Krox20, and Egr-2/Krox24 (53), and a variety of activity-dependent genes are known that proteins directly influence synaptic plasticity, like growth factors (-activin, Ref. 54) and intracellular signaling molecules (Rheb; Ref. 55), as well as cytoskeletal-associated (Arc; Ref. 56), and secreted proteins that modify the extracellular matrix (tPA; Ref. 57) or promote neurite outgrowth (Neuritin; Ref. 58). 

Phrase: "Muscarinic AChR"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of immediate early gene transcription factors c-fos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "jun-B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Egr-1/Krox20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1414315:KROX20 [Gene or Genome]
   734   C1566493:EGR-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Egr-2/Krox24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1414314:KROX24 [Gene or Genome]

Phrase: "(53"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a variety of activity-dependent genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that proteins directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "influence"

Phrase: "synaptic plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "like growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(-activin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
  1000   C1149454:activin [Molecular Function]
  1000   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Ref. 54"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "intracellular signaling molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1519315:Signaling Molecule [Biologically Active Substance]
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "(Rheb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419383:RHEB [Gene or Genome]
  1000   C1419384:RHEB [Gene or Genome]

Phrase: "; Ref. 55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450382:55 [Intellectual Product]
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "cytoskeletal-associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0332281:Associated [Qualitative Concept]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Arc"

Phrase: "; Ref. 56"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "secreted proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the extracellular matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015350:Extracellular Matrix [Tissue]
   861   C0521119:Extracellular [Cell Component]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "(tPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032143:T-PA [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "; Ref. 57"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "(Neuritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425210:NEURITIN [Gene or Genome]

Phrase: "; Ref. 58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.228: The members of the CCN family CYR61, CTGF, and NOV are secreted extracellular signaling molecules with different functions in cellular growth, adhesion, migration, and survival in peripheral tissues (32), but their function in brain is still unknown. 

Phrase: "The members of the CCN family CYR61,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C0086282:Family Members [Family Group]
   757 E C1611821:Family Member [Intellectual Product]
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: "are"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "extracellular signaling molecules with different functions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1519315:Signaling Molecule [Biologically Active Substance]
   753   C0567416:molecules [Substance]
   725   C1148560:molecular function [Molecular Function]

Phrase: "in cellular growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cellular Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "migration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "survival in peripheral tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0040297:Tissue Survival [Organ or Tissue Function]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "their function in brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0678908:brain function [Organ or Tissue Function]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "still unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.229: The results of this study show that CYR61, CTGF, and NOV were expressed throughout the human central nervous system. 

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: "were"

Phrase: "expressed throughout the human central nervous system."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0927232:Central Nervous System [Body System]
   814   C1269563:Central nervous system [Body System]
   778   C0027763:Nervous System [Body System]
   778   C0422837:NERVOUS SYSTEM [Finding]
   778   C1269560:Nervous system [Body System]
   748   C0027769:Nervous [Sign or Symptom]
   748   C0086418:Human [Human]
   748   C0205099:Central [Spatial Concept]
   748   C0449913:System [Functional Concept]
   748   C0599851:Nervous [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1879652:Central - [Laboratory Procedure]
   723 E C0205494:Neurologic [Qualitative Concept]
Processing 00000000.tx.230: Among these three family members, the immediate early gene CYR61 was unique in that its expression was regulated by mAChR activity, both in primary cortical neurons and in adult rat brain. 

Phrase: "Among these three family members,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "the immediate early gene CYR61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1413896:CYR61 [Gene or Genome]
   756   C0206256:Immediate-Early Gene [Gene or Genome]

Phrase: "was"

Phrase: "unique in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1710548:Unique [Qualitative Concept]

Phrase: "that"

Phrase: "its expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "regulated by mAChR activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "both in primary cortical neurons"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   760   C0205225:Primary [Qualitative Concept]
   760   C0238767:Both [Spatial Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1706086:Both [Qualitative Concept]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "and in adult rat brain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   760   C0001675:Adult [Age Group]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C1706450:Adult [Human]
Processing 00000000.tx.231: In order to identify genes that expression is regulated in response to mAChR stimulation, we established a differential display screen by comparing gene expression of unstimulated and carbachol-stimulated HEK 293cells that stably overexpress the m1 mAChR subtype (49). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "identify"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to mAChR stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a differential display screen by comparing gene expression of unstimulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220908:screen [Health Care Activity]
   739   C1305399:screen [Functional Concept]
   739   C1705053:Screen [Medical Device]

Phrase: "and"

Phrase: "carbachol-stimulated HEK 293cells"

Phrase: "that stably"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "the m1 mAChR subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449560:Subtype [Classification]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.232: HEK 293cells are human embryonic kidney cells that do not express mAChRs endogenously. 

Phrase: "HEK 293cells"

Phrase: "are"

Phrase: "human embryonic kidney cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "mAChRs endogenously."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0026815:muscarinic [Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.233: It has been shown that recombinant expressed mAChR subtypes in HEK 293cells are coupled to the same signal transduction pathways as in neuronal cells and mediate mAChR-related processing of the amyloid precursor protein in the same manner as in central nervous system (13, 14, 46, 59). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that recombinant expressed mAChR subtypes in HEK 293cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "coupled to the same signal transduction pathways"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0086982:Signal Transduction Pathways [Molecular Function]
   778   C0037083:Signal Transduction [Cell Function]
   774   C0037080:Signal Pathways [Molecular Function]
   748   C0445247:Same [Qualitative Concept]
   748   C1160185:transduction [Organism Function]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
   748   C1710082:Signal [Phenomenon or Process]
   748   C1948027:Coupled [Functional Concept]
   714 E C0010222:couple [Family Group]

Phrase: "as in neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "mAChR-related processing of the amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0033666:protein processing [Molecular Function]
   744   C1709694:Processing [Activity]

Phrase: "in the same manner"

Phrase: "as in central nervous system"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C0927232:Central Nervous System [Body System]
   862   C1269563:Central nervous system [Body System]
   806   C0027763:Nervous System [Body System]
   806   C0422837:NERVOUS SYSTEM [Finding]
   806   C1269560:Nervous system [Body System]
   760   C0027769:Nervous [Sign or Symptom]
   760   C0205099:Central [Spatial Concept]
   760   C0449913:System [Functional Concept]
   760   C0599851:Nervous [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   760   C1879652:Central - [Laboratory Procedure]
   751 E C0205494:Neurologic [Qualitative Concept]
   714 E C0027855:Neurology [Biomedical Occupation or Discipline]

Phrase: "(13,"

Phrase: "14,"

Phrase: "46,"

Phrase: "59"

Phrase: ")."
Processing 00000000.tx.234: In addition to that the expression of the immediate early transcription factor genes Egr-1/Krox24 and Egr-2/Krox20 is induced by mAChR stimulation in HEK 293m1 cells as well as in brains from rats that were treated with the mAChR agonist pilocarpine (29, 30, 53). 

Phrase: "In addition to"

Phrase: "that"

Phrase: "the expression of the immediate early transcription factor genes Egr-1/Krox24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "and"

Phrase: "Egr-2/Krox20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1414315:KROX20 [Gene or Genome]

Phrase: "is"

Phrase: "induced by mAChR stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205263:Induced [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in HEK 293m1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "as well as in brains"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "treated with the mAChR agonist pilocarpine"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0031923:Pilocarpine [Organic Chemical,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   753   C2987634:Agonist [Pharmacologic Substance]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(29,"

Phrase: "30,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.235: In unstimulated HEK 293m1 mAChRs cells, the acetylcholine analog carbachol rapidly induced h-CYR61 expression within 15min of stimulation. h-CYR61 expression reached a maximum 50-60 min after stimulation and attained lower but clearly detectable levels up to 4h after stimulation. 

Phrase: "In unstimulated HEK 293m1 mAChRs cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   785   C1514760:Receptor Cell [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "the acetylcholine analog carbachol rapidly induced h-CYR61 expression within 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of stimulation. h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a maximum 50-60 min after stimulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "attained"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "but"

Phrase: "clearly detectable levels up to 4h"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "after stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.236: This time course was consistent with the kinetics of serum induction of murine cyr61 expression in fibroblasts (33, 60). 

Phrase: "This time course"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "consistent with the kinetics of serum induction of murine cyr61 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "(33,"

Phrase: "60"

Phrase: ")."
Processing 00000000.tx.237: In addition carbachol-mediated h-CYR61 expression increased in the presence of the protein synthesis inhibitor cycloheximide, proving CYR61 to be an immediate early gene that expression is independent of de novo protein synthesis in response to mAChR-related signaling. 

Phrase: "In addition carbachol-mediated h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increased in the presence of the protein synthesis inhibitor cycloheximide,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   782   C0033671:Protein Synthesis Inhibitor [Pharmacologic Substance]
   777   C1372531:Increased Protein Synthesis [Molecular Function]
   760   C0597295:Protein Synthesis [Molecular Function]
   739   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205217:Increased [Quantitative Concept]
   739   C0220781:synthesis [Biologic Function]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0442805:Increased [Functional Concept]
   739   C1883254:Synthesis [Activity]
   739   C1999216:Inhibitor [Qualitative Concept]
   722 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "proving"

Phrase: "CYR61 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "be"

Phrase: "an immediate early gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206256:Immediate-Early Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0205253:Immediate [Temporal Concept]
   827   C0205548:Immediate [Temporal Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "that expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is independent of de novo protein synthesis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0332291:Independent of [Functional Concept]
   778   C0597295:Protein Synthesis [Molecular Function]
   778   C1515568:de novo [Idea or Concept]
   748   C0011198:DE [Geographic Area]
   748   C0017480:DE [Geographic Area]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085862:Independent [Idea or Concept]
   748   C0220781:synthesis [Biologic Function]
   748   C1299583:Independent [Finding]
   748   C1883254:Synthesis [Activity]
   748   C3541240:DE [Idea or Concept]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to mAChR-related signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
Processing 00000000.tx.238: Consistent with the fact that CYR61, CTGF, and NOV are expressed during development of the central nervous system (40, 45), we found basal levels of message for these three genes in primary cortical neurons prepared from E18 embryonic brains. 

Phrase: "Consistent with the fact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOV"

Phrase: "are"

Phrase: "expressed during development of the central nervous system"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   822   C1160339:central nervous system development [Organ or Tissue Function]
   800   C0927232:Central Nervous System [Body System]
   800   C1269563:Central nervous system [Body System]
   793   C0598282:Nervous System Development [Organ or Tissue Function]
   770   C0027763:Nervous System [Body System]
   770   C0422837:NERVOUS SYSTEM [Finding]
   770   C1269560:Nervous system [Body System]
   767   C1744604:system development [Biologic Function]
   744   C0027769:Nervous [Sign or Symptom]
   744   C0205099:Central [Spatial Concept]
   744   C0243107:development [Physiologic Function]
   744   C0449913:System [Functional Concept]
   744   C0599851:Nervous [Functional Concept]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1879652:Central - [Laboratory Procedure]
   715 E C0205494:Neurologic [Qualitative Concept]
   709   C1818230:nerve development [Organ or Tissue Function]
   706 E C0814002:Neural Development [Cell Function,Organism Function]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "basal levels of message"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "for these three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "in primary cortical neurons"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   827   C0001613:Cortical [Body Part, Organ, or Organ Component]
   827   C0007776:Cortical [Body Part, Organ, or Organ Component]
   827   C0022655:Cortical [Body Part, Organ, or Organ Component]
   827   C0027882:Neurons [Cell]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   771 E C0234875:bark [Organism Attribute]
   771 E C2700441:Bark [Plant]
   743 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   743 E C0521390:Neuronal [Immunologic Factor]
   743 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "prepared from E18 embryonic brains."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0013935:Embryonic [Embryonic Structure]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.239: Carbachol-induced stimulation of r-CYR61 of endogenously expressed mAChRs in primary cortical neurons was atropine-sensitive, indicating that muscarinic receptors mediated the activation of r-CYR61 expression. 

Phrase: "Carbachol-induced stimulation of r-CYR61 of endogenously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "expressed"

Phrase: "mAChRs in primary cortical neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   778   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   748   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C0026815:muscarinic [Pharmacologic Substance]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   716   C2325760:Neuronal receptor [Cell Component]

Phrase: "was"

Phrase: "atropine-sensitive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "indicating"

Phrase: "that muscarinic receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034826:Receptors, Muscarinic [Amino Acid, Peptide, or Protein,Receptor]
   861   C0026815:muscarinic [Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "the activation of r-CYR61 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]
Processing 00000000.tx.240: The failure of the m2-antagonist gallamine to block this response indicated that it was primarily mediated by m1, and possibly by m3 mAChRs. 

Phrase: "The failure of the m2-antagonist gallamine to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0231174:Failure [Functional Concept]
   744   C0680095:failure [Individual Behavior]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "this response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "it"

Phrase: "was"

Phrase: "primarily"

Phrase: "mediated by m1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "possibly by m3 mAChRs."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   847   C1334832:Muscarinic Acetylcholine Receptor M3 [Amino Acid, Peptide, or Protein,Receptor]
   833   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   814   C0289799:Muscarinic Receptors M3 [Amino Acid, Peptide, or Protein,Receptor]
           M3 receptor
   790   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   753   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0026815:muscarinic [Pharmacologic Substance]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C1300554:m3 [Quantitative Concept]
   753   C2362652:Possibly [Qualitative Concept]
   753   C3484373:M3 [Intellectual Product]
Processing 00000000.tx.241: Receptor subtype analyses in HEK 293cells underscored that finding in that m1 and m3 rather than m2, and m4 mAChR-mediated signaling induced the expression of CYR61. 

Phrase: "Receptor subtype analyses in HEK 293cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "underscored"

Phrase: "that finding in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0037088:Finding [Sign or Symptom]
   790   C0243095:Finding [Finding]
   790   C2825141:Finding [Finding]

Phrase: "that m1"

Phrase: "and"

Phrase: "m3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "rather than"

Phrase: "m2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "m4 mAChR-mediated signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the expression of CYR61."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.242: The Gq/G11-coupled m1 and m3 receptors strongly induced h-CYR61 expression. 

Phrase: "The Gq/G11-coupled m1"

Phrase: "and"

Phrase: "m3 receptors strongly induced h-CYR61 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   860   C0597360:receptor expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.243: In contrast, the Gi/Go-coupled m2 and m4 mAChRs only lead to a very subtle induction of h-CYR61 that was still higher, however, than the absent response in untransfected control cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the Gi/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "coupled m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "m4 mAChRs only"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   840   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   804   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   804   C0026815:muscarinic [Pharmacologic Substance]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "lead to a very subtle induction of h-CYR61"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0086418:Human [Human]
   742   C0205263:Induction [Functional Concept]
   742   C0442824:Very [Qualitative Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]
   742   C1413896:CYR61 [Gene or Genome]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "was"

Phrase: "still higher, however,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0205250:High [Qualitative Concept]
   793   C1299351:High [Qualitative Concept]
   793   C2700149:HIGH [Intellectual Product]
   743 E C0489786:Height [Organism Attribute]

Phrase: "than the absent response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "in untransfected control cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.244: This subtle increase may be related to the weak stimulation of PKC coupled to m2 and m4 mAChRs (14, 20). 

Phrase: "This subtle increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "related to the weak stimulation of PKC"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   790   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   784 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   781   C0027120:Kinase-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   781   C1833135:KINASE-RELATED PROTEIN [Gene or Genome]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0004093:Weak [Sign or Symptom]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1762617:Weak [Qualitative Concept]
   742   C1948023:Stimulation [Natural Phenomenon or Process]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "coupled to m2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0457242:m2 [Quantitative Concept]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "m4 mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   861   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0026815:muscarinic [Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(14,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.245: Consistent with our finding that mainly m1 and m3 mAChR subtypes induce CYR61 expression in receptor-transfected cells, we found two principal signaling mechanisms that may couple h-CYR61 expression to mAChR activation, PKC and Ca2+. 

Phrase: "Consistent with our"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that mainly m1"

Phrase: "and"

Phrase: "m3 mAChR subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449560:subtypes [Classification]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "CYR61 expression in receptor-transfected cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0597360:receptor expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "two principal signaling mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "h-CYR61 expression to mAChR activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.246: These signal transduction mediators independently increased cellular levels of h-CYR61 mRNA, but our data do not exclude the possibility of cross-talk among them. 

Phrase: "These signal transduction mediators independently"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   779 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cellular levels of h-CYR61 mRNA,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility of cross-talk"

Phrase: "among them."
Processing 00000000.tx.247: Recent studies show that the expression of CYR61 is activated during the basic fibroblast growth factor-induced differentiation process in the embryonic hippocampal neuronal cell line H19-7 in a MAP kinase-dependent and -independent manner (61). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "activated during the basic fibroblast growth factor-induced differentiation process"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   806   C0380603:Fibroblast Growth Factor, Basic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0919506:FIBROBLAST GROWTH FACTOR, BASIC [Gene or Genome]
   806   C1522505:Basic Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0007589:Differentiation [Cell Function]
   739   C0016030:Fibroblast [Cell]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0205263:Induced [Functional Concept]
   739   C0220844:growth [Physiologic Function]
   739   C1184743:Process [Body Part, Organ, or Organ Component]
   739   C1511938:Differentiation [Clinical Attribute]
   739   C1521761:Factor [Functional Concept]
   739   C1522240:Process [Phenomenon or Process]
   739   C1527178:Basic [Functional Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1879547:Activated [Activity]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C2945687:Differentiation [Functional Concept]
   706 E C1515877:Activate [Functional Concept]

Phrase: "in the embryonic hippocampal neuronal cell line H19-7"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   845   C1947950:Embryonic Cell [Embryonic Structure]
   818   C0007600:Cell Line [Cell]
   795   C0007634:Cell [Cell]
   795   C0013935:Embryonic [Embryonic Structure]
   795   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   795   C0205132:Line [Spatial Concept]
   795   C0521390:Neuronal [Immunologic Factor]
   795   C1269647:Cell [Cell]
   795   C1333887:H19 [Gene or Genome]
   795   C1333888:H19 [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   724 E C0027882:Neuron [Cell]

Phrase: "in a MAP kinase-dependent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]
   734   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "independent manner"

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.248: In addition to PKC and Ca2+, muscarinic m1 receptors are known to activate MAP kinase signaling (62, 63) strongly suggesting that MAP kinase signaling may couple muscarinic receptor stimulation to CYR61 expression. 

Phrase: "In addition to PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "muscarinic m1 receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0531859:Receptors, Muscarinic M1 [Amino Acid, Peptide, or Protein,Receptor]
           M1 receptor
   913   C0034826:Receptors, Muscarinic [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MAP kinase signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
   734   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(62,"

Phrase: "63"

Phrase: ")"

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that MAP kinase signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
   734   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "muscarinic receptor stimulation to CYR61 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.249: To exclude that mAChR-dependent increases in cAMP or PKA regulate h-CYR61 expression, we treated cells with 8-bromo-cAMP, and we found that it failed to change basal levels of h-CYR61 mRNA. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "that mAChR-dependent increases in cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "or"

Phrase: "PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulate"

Phrase: "h-CYR61 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "cells with 8-bromo-cAMP,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "it"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "basal levels of h-CYR61 mRNA."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.250: Likewise, inhibition of PKA with H7 failed to block the carbachol-induced stimulation of h-CYR61 expression. 

Phrase: "Likewise,"

Phrase: "inhibition of PKA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "with H7"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the carbachol-induced stimulation of h-CYR61 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.251: These data argue against a significant role of cAMP-PKA-CREB1 signaling in coupling h-CYR61 expression to mAChR in HEK 293cells. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "argue against a significant role of cAMP-PKA-CREB1 signaling"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   751   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   751   C1155589:cAMP signaling [Molecular Function]
   751   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0035820:Role [Social Behavior]
   736   C0037083:Signaling [Cell Function]
   736   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   736   C0237881:significant [Quantitative Concept]
   736   C0750502:Significant [Idea or Concept]
   736   C1546944:Significant [Qualitative Concept]
   736   C1705810:Role [Conceptual Entity]
   736   C3537152:signaling [Biologic Function]

Phrase: "in coupling h-CYR61 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "to mAChR"

Phrase: "in HEK 293cells."
Processing 00000000.tx.252: Taken together our data are compatible with the concept that mAChRs induce h-CYR61 expression via PKC, MAP kinase, and Ca2+ signaling. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "compatible with the concept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:compatible [Idea or Concept]
   770   C1524057:Compatible [Qualitative Concept]

Phrase: "that mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "h-CYR61 expression via PKC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "MAP kinase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0024779:Map [Manufactured Object]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "Ca2+ signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.253: CYR61 and CTGF are both immediate early genes, but the expression of r-CTGF was unchanged in response to mAChR stimulation in primary neurons. 

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "and"

Phrase: "CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "are"

Phrase: "both immediate early genes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206256:Genes, Immediate-Early [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
   827   C0205253:Immediate [Temporal Concept]
   827   C0205548:Immediate [Temporal Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "but"

Phrase: "the expression of r-CTGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "unchanged in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]

Phrase: "to mAChR stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in primary neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.254: The CTGF promoter contains consensus sequences that are characteristic for growth factor-inducible genes as well as a TGF- response element, but different promoters have been postulated for CTGF in different tissues (34, 64). 

Phrase: "The CTGF promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "consensus sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0079160:Sequences, Consensus [Nucleotide Sequence]
   861   C0162326:Sequences [Nucleotide Sequence]
   861   C0376298:Consensus [Social Behavior]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "characteristic for growth factor-inducible genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristic [Qualitative Concept]

Phrase: "as well as"

Phrase: "a TGF- response element,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "but"

Phrase: "different promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "have"

Phrase: "been"

Phrase: "postulated for CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1413791:CTGF [Gene or Genome]

Phrase: "in different tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(34,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.255: Our data indicate that mAChR-related signaling do not regulate r-CTGF expression. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that mAChR-related signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "regulate"

Phrase: "r-CTGF expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.256: NOV is expressed in quiescent cells and known to be down-regulated after serum stimulation in chicken embryo fibroblasts (36). 

Phrase: "NOV"

Phrase: "is"

Phrase: "expressed in quiescent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "down-regulated after serum stimulation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0229671:Serum [Body Substance]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "in chicken embryo fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.257: Even though this appears in a PKC-dependent manner, we could not detect any down-regulation of NOVR after either 1or 3h of mAChR stimulation. 

Phrase: "Even"

Phrase: "though"

Phrase: "this"

Phrase: "appears in a PKC-dependent manner,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   800   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0700364:APPEAR [Qualitative Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any down-regulation of NOVR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "after either 1or 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "of mAChR stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.258: To determine whether mAChRs stimulate the expression of r-CYR61, r-CTGF, and NOVR in vivo, we analyzed forebrain regions of pilocarpine- and vehicle-treated rats and found that our data from primary neurons were confirmed by the in vivo situation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "stimulate"

Phrase: "the expression of r-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "forebrain regions of pilocarpine-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "vehicle-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "our data from primary neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2827398:Primary Data [Idea or Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "confirmed by the in vivo situation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C0750484:Confirmed [Idea or Concept]
   719 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.259: Whereas r-CYR61 was rarely detectable in unstimulated rat brain, the stimulation of mAChRs strongly increased r-CYR61 mRNA levels in cortical layers V, VI, and in thalamic nuclei. 

Phrase: "Whereas"

Phrase: "r-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "was"

Phrase: "rarely detectable in unstimulated rat brain,"

Phrase: "the stimulation of mAChRs strongly increased r-CYR61 mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   736   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in cortical layers V,"

Phrase: "VI,"

Phrase: "and in thalamic nuclei."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   770   C0039729:Thalamic [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   737   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.260: This special pattern is consistent with the innervation of the cortex by cholinergic neurons from the basal forebrain and with the known expression pattern of m1 and m3 mAChRs throughout the cortex, predominantly in cortical layer VI (2, 3, 65, 66). 

Phrase: "This special pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "is"

Phrase: "consistent with the innervation of the cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from the basal forebrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2331620:Basal forebrain [Body Part, Organ, or Organ Component]
   861   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]

Phrase: "and with the known expression pattern of m1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205309:Known [Qualitative Concept]
   744   C0449774:Pattern [Spatial Concept]
   744   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "m3 mAChRs throughout the cortex,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   823   C1334832:Muscarinic Acetylcholine Receptor M3 [Amino Acid, Peptide, or Protein,Receptor]
   814   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   800   C0289799:Muscarinic Receptors M3 [Amino Acid, Peptide, or Protein,Receptor]
           M3 receptor
   778   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   748   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C0026815:muscarinic [Pharmacologic Substance]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "predominantly in cortical layer VI (2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")."
Processing 00000000.tx.261: Moreover, some thalamic nuclei are innervated by cholinergic neurons from the midbrain and nucleus basalis Meynert (2). 

Phrase: "Moreover,"

Phrase: "some thalamic nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "are"

Phrase: "innervated by cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2333949:Cholinergic Neurons [Cell]
   770   C0027882:Neurons [Cell]
   770   C0599668:cholinergic [Functional Concept]

Phrase: "from the midbrain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
  1000   C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "nucleus basalis Meynert"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0004788:Nucleus basalis [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.262: In rat brain, mAChRs induce the expression of the immediate early genes c-fos, jun-B, and Egr-1/Krox24 in cortical layers IV, VI, and the hippocampus (53). 

Phrase: "In rat brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of the immediate early genes c-fos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "jun-B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Egr-1/Krox24 in cortical layers IV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1414314:KROX24 [Gene or Genome]

Phrase: "VI,"

Phrase: "and"

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.263: Even though r-CYR61 revealed basal expression in hippocampus, the expression was not altered in response to mAChR stimulation in this brain region. 

Phrase: "Even"

Phrase: "though"

Phrase: "r-CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "basal expression in hippocampus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0392747:Altered [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to mAChR stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in this brain region."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:Brain region [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.264: In contrast, r-CTGF message was predominantly present in the cortical layer VI, in both control and stimulated animals. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "r-CTGF message"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0470166:Message [Intellectual Product]

Phrase: "was"

Phrase: "predominantly"

Phrase: "present in the cortical layer VI,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "in both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "stimulated animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.265: Throughout the central nervous system, CTGF protein is found in astrocytes, as well as in neuronal cells of the cortex, where it supposedly mediates TGF--related functions in cell growth, development, and tissue remodeling following injury (67, 68). 

Phrase: "Throughout the central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "CTGF protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "found in astrocytes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "as well as in neuronal cells of the cortex,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   762   C2347578:Cells/well [Quantitative Concept]
   745   C1166657:cell cortex [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0007776:Cortex [Body Part, Organ, or Organ Component]
   742   C0205170:Well [Qualitative Concept]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C1176472:Cortex [Body Part, Organ, or Organ Component]
   742   C2700441:Cortex [Plant]
   742   C3146287:Well [Manufactured Object]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "where"

Phrase: "it supposedly"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "TGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "related functions in cell growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0007595:Cell Growth [Cell Function]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "tissue remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1820201:tissue remodeling [Biologic Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "(67,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.266: NOVR was expressed in cortical layers II/III, V, and VI, in the CA1-CA3 hippocampus region and the amygdala, which are major parts of the basal forebrain cholinergic system, but its expression did not change in response to mAChR stimulation. 

Phrase: "NOVR"

Phrase: "was"

Phrase: "expressed in cortical layers II/III,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0439070:III [Intellectual Product]
   753   C0934502:layers [Body Part, Organ, or Organ Component]
   753   C1705160:III [Qualitative Concept]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]

Phrase: "V,"

Phrase: "and"

Phrase: "VI,"

Phrase: "in the CA1-CA3 hippocampus region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the amygdala,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "are"

Phrase: "major parts of the basal forebrain cholinergic system,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1292711:Part of [Spatial Concept]
   744   C0449719:parts [Spatial Concept]
   744   C1709471:PARTS [Quantitative Concept]

Phrase: "but"

Phrase: "its expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1705241:Change [Quantitative Concept]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to mAChR stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.267: NOV is expressed during development of the central nervous system, and its protein is supposed to have important functions in the maintenance of differentiated neurons (40, 69). 

Phrase: "NOV"

Phrase: "is"

Phrase: "expressed during development of the central nervous system,"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   822   C1160339:central nervous system development [Organ or Tissue Function]
   800   C0927232:Central Nervous System [Body System]
   800   C1269563:Central nervous system [Body System]
   793   C0598282:Nervous System Development [Organ or Tissue Function]
   770   C0027763:Nervous System [Body System]
   770   C0422837:NERVOUS SYSTEM [Finding]
   770   C1269560:Nervous system [Body System]
   767   C1744604:system development [Biologic Function]
   744   C0027769:Nervous [Sign or Symptom]
   744   C0205099:Central [Spatial Concept]
   744   C0243107:development [Physiologic Function]
   744   C0449913:System [Functional Concept]
   744   C0599851:Nervous [Functional Concept]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1879652:Central - [Laboratory Procedure]
   715 E C0205494:Neurologic [Qualitative Concept]
   709   C1818230:nerve development [Organ or Tissue Function]
   706 E C0814002:Neural Development [Cell Function,Organism Function]

Phrase: "and"

Phrase: "its protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "supposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "important functions in the maintenance of differentiated neurons"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0542341:Functions [Functional Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.268: Interestingly, we found r-CYR61, r-CTGF, and NOVR to be expressed in cells of cortical layer VI near corpus callosum. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "r-CYR61,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413896:CYR61 [Gene or Genome]

Phrase: "r-CTGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413791:CTGF [Gene or Genome]

Phrase: "and"

Phrase: "NOVR to"

Phrase: "be"

Phrase: "expressed in cells of cortical layer VI"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   789   C1511526:Cortical Cell Layer [Tissue]
   748   C0001613:Cortical [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0007776:Cortical [Body Part, Organ, or Organ Component]
   748   C0022655:Cortical [Body Part, Organ, or Organ Component]
   748   C0934502:Layer [Body Part, Organ, or Organ Component]
   748   C1522408:Layer [Qualitative Concept]
   748   C1561599:Layer [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "near corpus callosum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010090:Corpus Callosum [Body Part, Organ, or Organ Component]
   861   C0227813:Corpus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.269: Kondo et al. 

Phrase: "Kondo et al."
Processing 00000000.tx.270: (67) detected CTGF protein in rat brain in cortical layers III and V, and Su et al. 

Phrase: "(67"

Phrase: ")"

Phrase: "detected CTGF protein in rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2002820:Ctgf protein, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cortical layers III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "V,"

Phrase: "and"

Phrase: "Su et al."
Processing 00000000.tx.271: (40) localized NOV mRNA in cortical layers V and VI of 38-week human embryos. 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "localized NOV mRNA in cortical layers V"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "VI of 38-week human embryos."
Processing 00000000.tx.272: Efferents and afferents of neurons in cortical layer VI project to other cortical layers. 

Phrase: "Efferents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205116:Efferent [Spatial Concept]

Phrase: "and"

Phrase: "afferents of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0027883:Neurons, Afferent [Cell]
   756   C0205115:Afferent [Spatial Concept]

Phrase: "in cortical layer VI project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709701:Project [Conceptual Entity]

Phrase: "to other cortical layers."
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   861   C0001613:Cortical [Body Part, Organ, or Organ Component]
   861   C0007776:Cortical [Body Part, Organ, or Organ Component]
   861   C0022655:Cortical [Body Part, Organ, or Organ Component]
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]
   805 E C0234875:bark [Organism Attribute]
   805 E C2700441:Bark [Plant]
   777 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   777 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.273: Therefore, differences between mRNA and protein localization especially of CTGF may be related to neuronal protein transport rather than diffusion of the secreted proteins. 

Phrase: "Therefore,"

Phrase: "differences between mRNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "protein localization especially of CTGF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0597704:protein localisation [Cell Function]
   806   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "may"

Phrase: "be"

Phrase: "related to neuronal protein transport"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0599895:protein transport [Cell Function]
   806   C1159772:Protein Transport [Cell Function]
   797 E C0007292:Transport protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0178766:neuronal transport [Cell Function]
   797   C1550030:Transport To [Idea or Concept]
   760   C0005528:Transport, NOS [Cell Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "rather than"

Phrase: "diffusion of the secreted proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012222:Diffusion [Natural Phenomenon or Process]
   760   C1696141:Diffusion [Functional Concept]
Processing 00000000.tx.274: In addition to that afferents from pyramidal cells in cortical layer VI innervate the thalamus (70). 

Phrase: "In addition to that afferents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205115:Afferent [Spatial Concept]

Phrase: "from pyramidal cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0206441:Pyramidal Cells [Cell]
   966 E C2334588:Pyramidal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in cortical layer VI"

Phrase: "innervate"

Phrase: "the thalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039729:Thalamus [Body Part, Organ, or Organ Component]
  1000   C1269896:Thalamus [Body Part, Organ, or Organ Component]

Phrase: "(70"

Phrase: ")."
Processing 00000000.tx.275: Our data suggest that CYR61 protein has a role in mediating mAChR-related alterations in synaptic plasticity. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that CYR61 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2350413:CYR61 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "a role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "mAChR-related alterations in synaptic plasticity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.276: CYR61 encodes a secretory protein with functions in extracellular signaling; 

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a secretory protein with functions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   781   C0815043:function protein [Amino Acid, Peptide, or Protein]
   781   C1527118:Protein Function [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in extracellular signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: ";"
Processing 00000000.tx.277: it binds to integrin v3 and IIb3 at the cell surface, as well as to heparin-containing components of the extracellular matrix (71-73). 

Phrase: "it"

Phrase: "binds to integrin v3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   770   C0507236:V3 [Body Part, Organ, or Organ Component]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "IIb3 at the cell surface,"

Phrase: "as well as to heparin-containing components of the extracellular matrix"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   756   C0015350:Extracellular Matrix [Tissue]
   738   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0205170:Well [Qualitative Concept]
   738   C0332256:Containing [Functional Concept]
   738   C0449432:Components [Manufactured Object]
   738   C0521119:Extracellular [Cell Component]
   738   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C1704640:Matrix [Spatial Concept]
   738   C1706515:Matrix [Body Substance]
   738   C2700400:Containing [Activity]
   738   C3146287:Well [Manufactured Object]
   704 E C1705248:Component [Conceptual Entity]

Phrase: "(71-73"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.278: These interactions promote cell proliferation, adhesion, chemotaxis, and migration (37). 

Phrase: "These interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell proliferation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "chemotaxis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008018:Chemotaxis [Cell Function]

Phrase: "and"

Phrase: "migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.279: If CYR61 has similar functions in brain cells, our studies suggest the possibility that it could be involved in the remodeling of neuronal connections, known to be associated with muscarinic receptor signaling. 

Phrase: "If"

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "has"

Phrase: "similar functions in brain cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0678908:brain functions [Organ or Tissue Function]
   781   C0007613:cell functions [Cell Function]
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "involved in the remodeling of neuronal connections,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1160367:neuronal remodeling [Organ or Tissue Function]
   748   C0449379:connections [Intellectual Product]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1314939:Involved [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with muscarinic receptor signaling."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0034826:Muscarinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1514762:Receptor Signaling [Molecular Function]
   760   C0026815:muscarinic [Pharmacologic Substance]
   760   C0037083:Signaling [Cell Function]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C3537152:signaling [Biologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.280: CYR61 may act, in concert with integrins, as a chemotactic factor that influences neurite outgrowth in response to a stimulating acetylcholine signal. 

Phrase: "CYR61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413896:CYR61 [Gene or Genome]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "in concert"

Phrase: "with integrins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "as"

Phrase: "a chemotactic factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008013:chemotactic factor [Biologically Active Substance]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "influences"

Phrase: "neurite outgrowth in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C3158384:neurite outgrowth [Cell Function]
   770   C0085103:Neurite [Cell Component]

Phrase: "to a stimulating acetylcholine signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.281: This possibility is underscored by the known functions of brain integrins in neuronal differentiation, migration, neurite guidance, and long term potentiation (74-77). 

Phrase: "This possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "underscored by the known functions of brain integrins"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C0678908:brain functions [Organ or Tissue Function]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0205309:Known [Qualitative Concept]
   744   C0542341:Functions [Functional Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "in neuronal differentiation,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1518294:Neuronal Differentiation [Finding]
   964 E C1159970:neuron differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "migration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "neurite guidance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150600:Guidance [Health Care Activity]
   861   C1959633:Guidance [Clinical Attribute]

Phrase: "and"

Phrase: "long term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "(74-77"

Phrase: ")."
Processing 00000000.tx.282: CTGF has CYR61-related functions; 

Phrase: "CTGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0110610:CTGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CTGF [Gene or Genome]

Phrase: "has"

Phrase: "CYR61-related functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.283: in addition to that it regulates the expression of extracellular matrix components (34, 38). 

Phrase: "in addition to"

Phrase: "that"

Phrase: "it"

Phrase: "regulates"

Phrase: "the expression of extracellular matrix components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(34,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.284: Therefore, it may influence structural changes in neuronal plasticity in general, whereas NOV may support differentiated stages of neuronal systems. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "may"

Phrase: "influence"

Phrase: "structural changes in neuronal plasticity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0678594:Structural [Spatial Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "whereas"

Phrase: "NOV"

Phrase: "may"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "differentiated stages of neuronal systems."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1306673:Stages [Qualitative Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.285: Muscarinic signaling in cortex and hippocampus is impaired in Alzheimer's disease, whereas binding of ligands to mAChRs appears to be largely intact (4, 5). 

Phrase: "Muscarinic signaling in cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "impaired in Alzheimer's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "whereas"

Phrase: "binding of ligands"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C1517880:Ligand Binding [Molecular Function]
   790   C0023688:Ligands [Chemical]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to mAChRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "largely intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.286: This led to the development of cholinomimetic drugs and to the use of several acetylcholine esterase inhibitors for the therapy of Alzheimer's disease (78). 

Phrase: "This"

Phrase: "led to the development of cholinomimetic drugs"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   774   C0872152:development drugs [Biomedical Occupation or Discipline]
   748   C0013227:Drugs [Pharmacologic Substance]
   748   C0242892:cholinomimetic [Pharmacologic Substance]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1254351:Drug [Pharmacologic Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and to the use of several acetylcholine esterase inhibitors"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0001046:Acetylcholinesterase Inhibitors [Pharmacologic Substance]
   773 E C3536756:Acetylcholinesterase Inhibitor [Pharmacologic Substance]
   764   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0596537:esterase inhibitors [Pharmacologic Substance]
   764   C1524063:Use of [Functional Concept]
   742   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0042153:use [Functional Concept]
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   742   C0457083:Use [Functional Concept]
   742   C1515981:And [Idea or Concept]
   742   C1947944:Use [Intellectual Product]
   708 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "for the therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(78"

Phrase: ")."
Processing 00000000.tx.287: Future studies are required to show whether h-CYR61 expression in brain is altered in response to the degeneration of subcortical projection neurons in Alzheimer's disease or other neurodegenerative diseases, and whether treatments with cholinomimetic drugs modulate its expression.  

Phrase: "Future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "whether"

Phrase: "h-CYR61 expression in brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "altered in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0392747:Altered [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to the degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "of subcortical projection neurons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   867   C0682698:Projection neuron [Cell]
   827   C0016538:Projection [Intellectual Product]
   827   C0027882:Neurons [Cell]
   827   C0033363:Projection [Mental Process]
   827   C0348018:Projection [Spatial Concept]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "other neurodegenerative diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "whether"

Phrase: "treatments with cholinomimetic drugs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "its expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.288: ACKNOWLEDGEMENT We thank Ernest Peralta for mAChR transfected cell lines.  

Phrase: "ACKNOWLEDGEMENT"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Ernest Peralta for mAChR"

Phrase: "transfected"

Phrase: "cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.289: FOOTNOTES * This study was supported by Bundesministerium fr Bildung und Forschung, Deutsche Forschungsgemeinschaft, and Alzheimer Forschung Initiative.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by Bundesministerium fr Bildung und Forschung,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C1413574:UND [Gene or Genome]
   748   C1521721:Supported [Conceptual Entity]
   748   C2348513:Fr. [Conceptual Entity]
   748   C3538902:FR [Gene or Genome]
   714 E C0183683:Support [Medical Device]

Phrase: "Deutsche Forschungsgemeinschaft,"

Phrase: "and"

Phrase: "Alzheimer Forschung Initiative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424093:Initiative [Mental Process]
Processing 00000000.tx.290: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.291: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.292: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.293: The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) Y12084 and AF218568.  

Phrase: "The nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "reported in this paper"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030351:Paper [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1547566:Paper [Idea or Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "submitted to the GenBankTM/EMBL Data Bank"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0242356:Data Bank [Intellectual Product]
   748   C0442598:Bank [Manufactured Object]
   748   C0872261:Bank [Manufactured Object]
   748   C1511726:Data [Idea or Concept]
   748   C1515023:Submitted [Functional Concept]
   748   C3245479:data [Medical Device]

Phrase: "with accession number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1510755:Accession Number [Intellectual Product]
           Accession
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1706078:Accession [Activity]

Phrase: "("

Phrase: "s)"

Phrase: "Y12084"

Phrase: "and"

Phrase: "AF218568."
Processing 00000000.tx.294: Present address: EVOTEC Neurosciences GMBH, Schnackenburgallee 114,22525Hamburg, Germany. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "EVOTEC Neurosciences GMBH,"

Phrase: "Schnackenburgallee 114,"

Phrase: "22525Hamburg,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.295: ** To whom correspondence should be addressed: Dept. of Psychiatry Research, University of Zurich, August Forel Str. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Psychiatry Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "University of Zurich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "August Forel Str."
Processing 00000000.tx.296: 1,8008Zurich, Switzerland. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "8008Zurich,"

Phrase: "Switzerland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]
Processing 00000000.tx.297: Tel. 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]
Processing 00000000.tx.298: 41-1-634-8871; 

Phrase: "41-1-634-8871"

Phrase: ";"
Processing 00000000.tx.299: Fax: 41-1-634-8876; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "41-1-634-8876"

Phrase: ";"
Processing 00000000.tx.300: E-mail: nitsch@bli.unizh.ch. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "nitsch@bli.unizh.ch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0558269:Ch. [Professional or Occupational Group]
   812   C1552984:[Ch] [Quantitative Concept]
Processing 00000000.tx.301: Published, JBC Papers in Press, June 13,2000,DOI 10.1074/jbc.M003053200  ABBREVIATIONS The abbreviations used are: mAChRs, muscarinic acetylcholine receptors; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "June 13,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M003053200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "mAChRs,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "muscarinic acetylcholine receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.302: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.303: MAP, mitogen-activated protein kinase; 

Phrase: "MAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.304: TGF-, transforming growth factor-; 

Phrase: "TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.305: DEDA, 7,7-dimethyl-5,8-eicosadienoic acid; 

Phrase: "DEDA,"

Phrase: "7,"

Phrase: "7-dimethyl-5,"

Phrase: "8-eicosadienoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2348386:Eicosadienoic Acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.306: GF109203X, bisindolylmaleimide I; 

Phrase: "GF109203X,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]

Phrase: "bisindolylmaleimide I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0091914:bisindolylmaleimide I [Organic Chemical,Pharmacologic Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.307: GAPDH, human glyceraldehyde-3-phosphate dehydrogenase; 

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "human glyceraldehyde-3-phosphate dehydrogenase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   937   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   888   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   884   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.308: PCR, polymerase chain reaction; 

Phrase: "PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.309: bp, base pair; 

Phrase: "bp,"

Phrase: "base pair"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0600436:Base Pair [Molecular Function]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1709450:Pair [Qualitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.310: nt, nucleotide; 

Phrase: "nt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.311: PKA, protein kinase A; 

Phrase: "PKA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.312: PBS, phosphate-buffered saline.  

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.313: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.314: Perry, E., Walker, M., Grace, J., and Perry, R. 

Phrase: "Perry,"

Phrase: "E.,"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "M."

Phrase: ","

Phrase: "Grace,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Perry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.315: (1999) Trends Neurosci. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.316: 22, 273-280[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "22,"

Phrase: "273-280"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.317: Semba, K., and Fibiger, H. 

Phrase: "Semba,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Fibiger,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.318: C. 

Phrase: "C."
Processing 00000000.tx.319: (1989) Prog. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.320: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.321: 79, 37-63[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "79,"

Phrase: "37-63"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.322: Mesulam, M. 

Phrase: "Mesulam,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.323: M., Mufson, E. 

Phrase: "M."

Phrase: ","

Phrase: "Mufson,"

Phrase: "E."
Processing 00000000.tx.324: J., Levey, A. 

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.325: I., and Wainer, B. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Wainer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.326: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.327: (1983) J. 

Phrase: "(1983"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.328: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.329: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.330: 214, 170-197[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "214,"

Phrase: "170-197"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.331: Coyle, J. 

Phrase: "Coyle,"

Phrase: "J."
Processing 00000000.tx.332: T., Price, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.333: L., and DeLong, M., R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "DeLong,"

Phrase: "M."

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.334: (1983) Science 219, 1184-1190[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Science 219,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1184-1190"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.335: Levey, A. 

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.336: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.337: Natl. 

Phrase: "Natl."
Processing 00000000.tx.338: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.339: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.340: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.341: 93, 13541-13546[Abstract/Free FullText] 6. 

Phrase: "93,"

Phrase: "13541-13546"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.342: Baxter, G. 

Phrase: "Baxter,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.343: M., and Chiba, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Chiba,"

Phrase: "A."
Processing 00000000.tx.344: A. 

Phrase: "A."
Processing 00000000.tx.345: (1999) Curr. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.346: Opin. 

Phrase: "Opin."
Processing 00000000.tx.347: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.348: 9, 179-182 7. 

Phrase: "9,"

Phrase: "179-182 7."
Processing 00000000.tx.349: Fibiger, H. 

Phrase: "Fibiger,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.350: C. 

Phrase: "C."
Processing 00000000.tx.351: (1991) Trends Neurosci. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.352: 14, 220-223[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "14,"

Phrase: "220-223"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.353: Wess, J. 

Phrase: "Wess,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3640077:WES [Molecular Biology Research Technique]

Phrase: "J."
Processing 00000000.tx.354: (1993) Trends Pharmacol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.355: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.356: 14, 308-314[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "14,"

Phrase: "308-314"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.357: Brann, M. 

Phrase: "Brann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.358: R., Ellis, J., Jorgensen, H., Hill-Eubanks, D., and Joner, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ellis,"

Phrase: "J.,"

Phrase: "Jorgensen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hill-Eubanks,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Joner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.359: V.P. 

Phrase: "V.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1535597:v p [Therapeutic or Preventive Procedure]
Processing 00000000.tx.360: (1993) Prog. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.361: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.362: 98, 121-127[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "98,"

Phrase: "121-127"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.363: Fukuda, K., Higashida, H., Kubo, T., Maeda, A., Akiba, I., Bujo, H., Mishina, M., and Numa, S. 

Phrase: "Fukuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Higashida,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maeda,"

Phrase: "A.,"

Phrase: "Akiba,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bujo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mishina,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Numa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335072:NUMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1704850:NUMA [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.364: (1988) Nature 335, 355-358[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Nature 335,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "355-358"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.365: Krnjevic', K. 

Phrase: "Krnjevic',"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.366: (1993) Prog. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.367: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.368: 98, 285-292[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "98,"

Phrase: "285-292"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.369: Brown, D. 

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D."
Processing 00000000.tx.370: A., Abogadie, F. 

Phrase: "A.,"

Phrase: "Abogadie,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.371: C., Allen, T. 

Phrase: "C., Allen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.372: G.J., Buckley, N. 

Phrase: "G.J.,"

Phrase: "Buckley,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.373: J., Caulfield, M. 

Phrase: "J.,"

Phrase: "Caulfield,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.374: P., Delmas, P., Haley, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Delmas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Haley,"

Phrase: "J."
Processing 00000000.tx.375: E., Lamas, J. 

Phrase: "E.,"

Phrase: "Lamas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0999593:Lama [Mammal]
  1000   C1416775:LAMA [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.376: A., and Selyanko, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Selyanko,"

Phrase: "A."
Processing 00000000.tx.377: A. 

Phrase: "A."
Processing 00000000.tx.378: (1997) Life Sci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.379: 60, 1137-1144[CrossRef][Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "60,"

Phrase: "1137-1144"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.380: Peralta, E. 

Phrase: "Peralta,"

Phrase: "E."
Processing 00000000.tx.381: G., Ashkenazi, A., Winslow, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ashkenazi,"

Phrase: "A.,"

Phrase: "Winslow,"

Phrase: "J."
Processing 00000000.tx.382: W., Ramachandran, J., and Capon, D. 

Phrase: "W., Ramachandran,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Capon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1826455:CAPON [Gene or Genome]

Phrase: "D."
Processing 00000000.tx.383: J. 

Phrase: "J."
Processing 00000000.tx.384: (1988) Nature 334, 434-437[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Nature 334,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "434-437"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.385: Felder, C. 

Phrase: "Felder,"

Phrase: "C."
Processing 00000000.tx.386: C. 

Phrase: "C."
Processing 00000000.tx.387: (1995) FASEB J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.388: 9, 619-625[Abstract/Free FullText] 15. 

Phrase: "9,"

Phrase: "619-625"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.389: Felder, C. 

Phrase: "Felder,"

Phrase: "C."
Processing 00000000.tx.390: C., Kanterman, R. 

Phrase: "C., Kanterman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.391: Y., Ma, A. 

Phrase: "Y.,"

Phrase: "Ma,"

Phrase: "A."
Processing 00000000.tx.392: L., and Axelrod, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Axelrod,"

Phrase: "J."
Processing 00000000.tx.393: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.394: Biol. 

Phrase: "Biol."
Processing 00000000.tx.395: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.396: 264, 20356-20362[Abstract/Free FullText] 16. 

Phrase: "264,"

Phrase: "20356-20362"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.397: Von Biesen, T., Hawes, B. 

Phrase: "Von Biesen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hawes,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.398: E., Raymond, J. 

Phrase: "E.,"

Phrase: "Raymond,"

Phrase: "J."
Processing 00000000.tx.399: R., Luttrell, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Luttrell,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.400: M., Koch, W. 

Phrase: "M."

Phrase: ","

Phrase: "Koch,"

Phrase: "W."
Processing 00000000.tx.401: J., and Lefkowitz, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lefkowitz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.402: J. 

Phrase: "J."
Processing 00000000.tx.403: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.404: Biol. 

Phrase: "Biol."
Processing 00000000.tx.405: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.406: 271, 1266-1269[Abstract/Free FullText] 17. 

Phrase: "271,"

Phrase: "1266-1269"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.407: Coso, O. 

Phrase: "Coso,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.408: A., Teramoto, H., Simonds, W. 

Phrase: "A.,"

Phrase: "Teramoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Simonds,"

Phrase: "W."
Processing 00000000.tx.409: F., and Gutkind, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Gutkind,"

Phrase: "J."
Processing 00000000.tx.410: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.411: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.412: Biol. 

Phrase: "Biol."
Processing 00000000.tx.413: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.414: 271, 3963-3966[Abstract/Free FullText] 18. 

Phrase: "271,"

Phrase: "3963-3966"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.415: Conklin, B. 

Phrase: "Conklin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.416: R., Brann, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Brann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.417: R., Buckley, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Buckley,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.418: J., Ma, A. 

Phrase: "J.,"

Phrase: "Ma,"

Phrase: "A."
Processing 00000000.tx.419: L., Bonner, T. 

Phrase: "L., Bonner,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.420: I., and Axelrod, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Axelrod,"

Phrase: "J."
Processing 00000000.tx.421: (1988) Proc. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.422: Natl. 

Phrase: "Natl."
Processing 00000000.tx.423: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.424: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.425: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.426: 85, 8698-8702[Abstract] 19. 

Phrase: "85,"

Phrase: "8698-8702"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 19."
Processing 00000000.tx.427: Sandmann, J., Peralta, E. 

Phrase: "Sandmann,"

Phrase: "J.,"

Phrase: "Peralta,"

Phrase: "E."
Processing 00000000.tx.428: G., and Wurtman, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.429: J. 

Phrase: "J."
Processing 00000000.tx.430: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.431: Biol. 

Phrase: "Biol."
Processing 00000000.tx.432: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.433: 266, 6031-6034[Abstract/Free FullText] 20. 

Phrase: "266,"

Phrase: "6031-6034"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.434: Ashkenazi, A., Winslow, J. 

Phrase: "Ashkenazi,"

Phrase: "A.,"

Phrase: "Winslow,"

Phrase: "J."
Processing 00000000.tx.435: W., Peralta, E. 

Phrase: "W., Peralta,"

Phrase: "E."
Processing 00000000.tx.436: G., Peterson, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Peterson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.437: L., Schimerlik, M. 

Phrase: "L., Schimerlik,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: I., Capon, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Capon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1826455:CAPON [Gene or Genome]

Phrase: "D."
Processing 00000000.tx.439: J., and Ramachandran, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Ramachandran,"

Phrase: "J."
Processing 00000000.tx.440: (1987) Science 238, 672-675[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Science 238,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "672-675"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.441: Lopez-Ilasaca, M., Crespo, P., Pellici, P. 

Phrase: "Lopez-Ilasaca,"

Phrase: "M."

Phrase: ","

Phrase: "Crespo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pellici,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.442: G., Gutkind, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gutkind,"

Phrase: "J."
Processing 00000000.tx.443: S., and Wetzker, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wetzker,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.444: (1997) Science 275, 394-397[Abstract/Free FullText] 22. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 275,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "394-397"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.445: Bailey, C. 

Phrase: "Bailey,"

Phrase: "C."
Processing 00000000.tx.446: H., Bartsch, D., and Kandel, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bartsch,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Kandel,"

Phrase: "E."
Processing 00000000.tx.447: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.448: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.449: Natl. 

Phrase: "Natl."
Processing 00000000.tx.450: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.451: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.452: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.453: 93, 13445-13452[Abstract/Free FullText] 23. 

Phrase: "93,"

Phrase: "13445-13452"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.454: Nedevi, E., Hevroni, D., Naot, D., Israeli, D., and Citri, Y. 

Phrase: "Nedevi,"

Phrase: "E.,"

Phrase: "Hevroni,"

Phrase: "D."

Phrase: ","

Phrase: "Naot,"

Phrase: "D."

Phrase: ","

Phrase: "Israeli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240069:Israeli [Population Group]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Citri,"

Phrase: "Y."
Processing 00000000.tx.455: (1993) Nature 363, 718-722[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 363,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "718-722"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.456: Lanahan, A., and Worley, P. 

Phrase: "Lanahan,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.457: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.458: Learn. 

Phrase: "Learn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023185:learn [Mental Process]
Processing 00000000.tx.459: Mem. 

Phrase: "Mem."
Processing 00000000.tx.460: 70, 37-43[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "70,"

Phrase: "37-43"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.461: Roche, K. 

Phrase: "Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.462: W., Tu, J. 

Phrase: "W., Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532464:TU [Quantitative Concept]
   861   C2700314:TU [Fish]

Phrase: "J."
Processing 00000000.tx.463: C., Petralia, R. 

Phrase: "C., Petralia,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.464: S., Xiao, B., Wenthold, R. 

Phrase: "S."

Phrase: ","

Phrase: "Xiao,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wenthold,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: J., and Worley, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.467: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.468: Biol. 

Phrase: "Biol."
Processing 00000000.tx.469: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.470: 274, 25953-25957[Abstract/Free FullText] 26. 

Phrase: "274,"

Phrase: "25953-25957"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.471: Yamagata, K., Andreasson, K. 

Phrase: "Yamagata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Andreasson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.472: I., Sugiura, H., Maru, E., Muller, D., Irie, Y., Miki, N., Hayashi, Y., Yoshioka, M., Kaneko, K., Kato, H., and Worley, P. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sugiura,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3104930:Sugiura [Eukaryote]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Maru,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445539:Maru [Intellectual Product]

Phrase: "E.,"

Phrase: "Muller,"

Phrase: "D."

Phrase: ","

Phrase: "Irie,"

Phrase: "Y.,"

Phrase: "Miki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2681565:MIKI [Gene or Genome]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hayashi,"

Phrase: "Y.,"

Phrase: "Yoshioka,"

Phrase: "M."

Phrase: ","

Phrase: "Kaneko,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.473: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.474: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.475: Biol. 

Phrase: "Biol."
Processing 00000000.tx.476: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.477: 274, 19473-19479[Abstract/Free FullText] 27. 

Phrase: "274,"

Phrase: "19473-19479"

Phrase: "[Abstract/Free FullText"

Phrase: "] 27."
Processing 00000000.tx.478: Kauselmann, G., Weiler, M., Wulff, P., Jessberger, S., Konietzko, U., Scafidi, J., Staubli, U., Bereiter-Hahn, J., Strebhardt, K., and Kuhl, D. 

Phrase: "Kauselmann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Weiler,"

Phrase: "M."

Phrase: ","

Phrase: "Wulff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jessberger,"

Phrase: "S."

Phrase: ","

Phrase: "Konietzko,"

Phrase: "U.,"

Phrase: "Scafidi,"

Phrase: "J.,"

Phrase: "Staubli,"

Phrase: "U.,"

Phrase: "Bereiter-Hahn,"

Phrase: "J.,"

Phrase: "Strebhardt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kuhl,"

Phrase: "D."
Processing 00000000.tx.479: (1999) EMBO J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.480: 18, 5528-5539[Abstract/Free FullText] 28. 

Phrase: "18,"

Phrase: "5528-5539"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.481: Huerta, T., and Lisman, J. 

Phrase: "Huerta,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lisman,"

Phrase: "J."
Processing 00000000.tx.482: E. 

Phrase: "E."
Processing 00000000.tx.483: (1993) Nature 364, 723-725[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 364,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "723-725"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.484: Dragunow, M. 

Phrase: "Dragunow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: (1996) Behav. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Behav."
Processing 00000000.tx.486: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.487: 26, 293-299[Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "26,"

Phrase: "293-299"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.488: Von der Kammer, H., Mayhaus, M., Albrecht, C., Enderich, J., Wegner, M., and Nitsch, R. 

Phrase: "Von der Kammer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mayhaus,"

Phrase: "M."

Phrase: ","

Phrase: "Albrecht,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Enderich,"

Phrase: "J.,"

Phrase: "Wegner,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.489: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.490: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.491: Biol. 

Phrase: "Biol."
Processing 00000000.tx.492: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.493: 273, 14538-14544[Abstract/Free FullText] 31. 

Phrase: "273,"

Phrase: "14538-14544"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.494: Bork, P. 

Phrase: "Bork,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.495: (1993) FEBS Lett. 

Phrase: "(1993"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.496: 327, 125-130[CrossRef][Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "327,"

Phrase: "125-130"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.497: Lau, L. 

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.498: F., and Lam, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lam,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.499: C.-T. 

Phrase: "C.-T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.500: (1999) Exper. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Exper."
Processing 00000000.tx.501: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.502: 248, 44-57[CrossRef][Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "248,"

Phrase: "44-57"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.503: O'Brian, T. 

Phrase: "O'Brian,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.504: P., Yang, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.505: P., Sanders, L., and Lau, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.506: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.507: (1990) Mol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.508: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.509: Biol. 

Phrase: "Biol."
Processing 00000000.tx.510: 10, 3569-3577[Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "10,"

Phrase: "3569-3577"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.511: Grotenhorst, G. 

Phrase: "Grotenhorst,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.512: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.513: (1997) Cytokine Growth Fact. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cytokine Growth Fact."
Processing 00000000.tx.514: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.515: 8, 171-179[CrossRef][Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "8,"

Phrase: "171-179"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.516: Chevalier, G., Yeger, H., Martinerie, C., Laurent, M., Alami, J., Schofield, P. 

Phrase: "Chevalier,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yeger,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Martinerie,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Laurent,"

Phrase: "M."

Phrase: ","

Phrase: "Alami,"

Phrase: "J.,"

Phrase: "Schofield,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.517: N., and Perbal, B. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Perbal,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.518: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.519: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.520: 152, 1563-1575[Abstract] 36. 

Phrase: "152,"

Phrase: "1563-1575"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 36."
Processing 00000000.tx.521: Scholz, G., Martinerie, C., Perbal, B., and Hanafusa, H. 

Phrase: "Scholz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Martinerie,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Perbal,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Hanafusa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.522: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.523: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.524: Biol. 

Phrase: "Biol."
Processing 00000000.tx.525: 16, 481-486[Abstract] 37. 

Phrase: "16,"

Phrase: "481-486"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 37."
Processing 00000000.tx.526: Kireeva, M. 

Phrase: "Kireeva,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.527: L., Mo, F.-E., Yang, G. 

Phrase: "L., Mo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]

Phrase: "F.-E.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.528: P., and Lau, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.529: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.530: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.531: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.532: Biol. 

Phrase: "Biol."
Processing 00000000.tx.533: 16, 1326-1334[Abstract] 38. 

Phrase: "16,"

Phrase: "1326-1334"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 38."
Processing 00000000.tx.534: Frazier, K., Williams, S., Kothapalli, D., Klapper, H., and Grotenhorst, G. 

Phrase: "Frazier,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Williams,"

Phrase: "S."

Phrase: ","

Phrase: "Kothapalli,"

Phrase: "D."

Phrase: ","

Phrase: "Klapper,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Grotenhorst,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.535: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.536: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.537: Invest. 

Phrase: "Invest."
Processing 00000000.tx.538: Dermatol. 

Phrase: "Dermatol."
Processing 00000000.tx.539: 107, 404-411[Abstract] 39. 

Phrase: "107,"

Phrase: "404-411"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 39."
Processing 00000000.tx.540: Joliot, V., Martinerie, C., Dambrine, G., Plassiart, G., Brisac, M., Crochet, J., and Perbal, B. 

Phrase: "Joliot,"

Phrase: "V.,"

Phrase: "Martinerie,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Dambrine,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Plassiart,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brisac,"

Phrase: "M."

Phrase: ","

Phrase: "Crochet"

Phrase: ","

Phrase: "J.,"

Phrase: "and"

Phrase: "Perbal,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.541: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.542: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.543: Biol. 

Phrase: "Biol."
Processing 00000000.tx.544: 12, 10-21[Abstract] 40. 

Phrase: "12,"

Phrase: "10-21"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.545: Su, B., Cai, W., Zhang, C., Su, H., and Perbal, B. 

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Perbal,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.546: (1998) Dev. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Dev."
Processing 00000000.tx.547: Biol. 

Phrase: "Biol."
Processing 00000000.tx.548: 321, 883-892 41. 

Phrase: "321,"

Phrase: "883-892 41."
Processing 00000000.tx.549: Igarashi, A., Okochi, H., Bradham, D. 

Phrase: "Igarashi,"

Phrase: "A.,"

Phrase: "Okochi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bradham,"

Phrase: "D."
Processing 00000000.tx.550: M., and Grotendorst, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Grotendorst,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.551: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.552: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.553: Biol. 

Phrase: "Biol."
Processing 00000000.tx.554: Cell 4, 637-645[Abstract] 42. 

Phrase: "Cell 4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "637-645"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 42."
Processing 00000000.tx.555: Igarashi, A., Nashiro, K., Kikichi, K., Sato, S., Ihn, H., Fujimoto, M., Grotenhorst, G. 

Phrase: "Igarashi,"

Phrase: "A.,"

Phrase: "Nashiro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kikichi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sato,"

Phrase: "S."

Phrase: ","

Phrase: "Ihn,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fujimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Grotenhorst,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.556: R., and Takehara, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Takehara,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.557: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.558: Invest. 

Phrase: "Invest."
Processing 00000000.tx.559: Dermatol. 

Phrase: "Dermatol."
Processing 00000000.tx.560: 106, 729-733[Abstract] 43. 

Phrase: "106,"

Phrase: "729-733"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 43."
Processing 00000000.tx.561: Babic, A. 

Phrase: "Babic,"

Phrase: "A."
Processing 00000000.tx.562: M., Kireeva, M. 

Phrase: "M."

Phrase: ","

Phrase: "Kireeva,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.563: L., Kolesnikova, T. 

Phrase: "L., Kolesnikova,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.564: V., and Lau, L. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.565: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.566: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.567: Natl. 

Phrase: "Natl."
Processing 00000000.tx.568: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.569: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.570: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.571: 95, 6355-6360[Abstract/Free FullText] 44. 

Phrase: "95,"

Phrase: "6355-6360"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.572: Babic, A. 

Phrase: "Babic,"

Phrase: "A."
Processing 00000000.tx.573: L., Chen, C.-C., and Lau, L. 

Phrase: "L., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "C.-C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.574: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.575: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.576: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.577: Biol. 

Phrase: "Biol."
Processing 00000000.tx.578: 19, 2958-2966[Abstract/Free FullText] 45. 

Phrase: "19,"

Phrase: "2958-2966"

Phrase: "[Abstract/Free FullText"

Phrase: "] 45."
Processing 00000000.tx.579: Kireeva, M. 

Phrase: "Kireeva,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.580: L., Latinkic', B. 

Phrase: "L., Latinkic',"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.581: V., Kolesnikova, T. 

Phrase: "V., Kolesnikova,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.582: V., Chen, C.-C., Yang, G. 

Phrase: "V., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "C.-C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.583: P., Abler, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Abler,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0085732:Able [Organism Attribute]
   966   C1299581:Able [Finding]

Phrase: "A."
Processing 00000000.tx.584: S., and Lau, L. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.585: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.586: (1997) Exp. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.587: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.588: 233, 63-77[CrossRef][Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "233,"

Phrase: "63-77"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.589: Nitsch, R. 

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.590: M., Slack, B. 

Phrase: "M."

Phrase: ","

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.591: E., Wurtman, R. 

Phrase: "E.,"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.592: J., and Growdon, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.593: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.594: (1992) Science 258, 304-307[Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "304-307"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.595: Segal, M., and Manor, D. 

Phrase: "Segal,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Manor,"

Phrase: "D."
Processing 00000000.tx.596: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.597: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.598: (Lond.) 

Phrase: "(Lond."

Phrase: ")"
Processing 00000000.tx.599: 448, 655-676[Abstract] 48. 

Phrase: "448,"

Phrase: "655-676"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 48."
Processing 00000000.tx.600: Nitsch, R. 

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.601: M., Deng, M., Growdon, J. 

Phrase: "M."

Phrase: ","

Phrase: "Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.602: H., and Wurtman, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.603: J. 

Phrase: "J."
Processing 00000000.tx.604: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.605: Biol. 

Phrase: "Biol."
Processing 00000000.tx.606: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.607: 271, 4188-4194[Abstract/Free FullText] 49. 

Phrase: "271,"

Phrase: "4188-4194"

Phrase: "[Abstract/Free FullText"

Phrase: "] 49."
Processing 00000000.tx.608: Von der Kammer, H., Albrecht, C., Mayhaus, M., Hoffmann, B., Stanke, G., and Nitsch, R. 

Phrase: "Von der Kammer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Albrecht,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mayhaus,"

Phrase: "M."

Phrase: ","

Phrase: "Hoffmann,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stanke,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.609: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.610: (1999) Nucleic Acids Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.611: 27, 2211-2218[Abstract/Free FullText] 50. 

Phrase: "27,"

Phrase: "2211-2218"

Phrase: "[Abstract/Free FullText"

Phrase: "] 50."
Processing 00000000.tx.612: Lehrach, H., Drmanac, R., Hoheisel, R., Larin, J., Lennon, Z., Monaco, G., Nizetic, A. 

Phrase: "Lehrach,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Drmanac,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hoheisel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Larin,"

Phrase: "J.,"

Phrase: "Lennon,"

Phrase: "Z.,"

Phrase: "Monaco,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026405:Monaco [Geographic Area]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nizetic,"

Phrase: "A."
Processing 00000000.tx.613: P., Zehetner, D., and Poustka, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zehetner,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Poustka,"

Phrase: "A."
Processing 00000000.tx.614: (1990) in Genome Analysis (Davis, K. E. , and Tilghman, S. M., eds), Vol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "in Genome Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(Davis,"

Phrase: "K. E. ,"

Phrase: "and"

Phrase: "Tilghman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.615: 1 , pp. 

Phrase: "1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "pp."
Processing 00000000.tx.616: 39-81, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 51. 

Phrase: "39-81,"

Phrase: "Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY 51."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.617: Hartmann, D., Fehr, S., Meyerhof, W., and Richter, D. 

Phrase: "Hartmann,"

Phrase: "D."

Phrase: ","

Phrase: "Fehr,"

Phrase: "S."

Phrase: ","

Phrase: "Meyerhof,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Richter,"

Phrase: "D."
Processing 00000000.tx.618: (1995) Dev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Dev."
Processing 00000000.tx.619: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.620: 17, 246-255[Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "17,"

Phrase: "246-255"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.621: Jay, P., Berge'-Lefranc, J. 

Phrase: "Jay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326402:Jay [Bird]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Berge'-Lefranc,"

Phrase: "J."
Processing 00000000.tx.622: L., Marsollier, C., Mjean, C., Tavioux, S., and Berta, P. 

Phrase: "L., Marsollier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mjean,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Tavioux,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Berta,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3606807:Berta [Eukaryote]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.623: (1997) Oncogene 14, 1753-1757[CrossRef][Medline] [OrderarticleviaInfotrieve] 53. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Oncogene 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "1753-1757"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 53."
Processing 00000000.tx.624: Hughes, P., and Dragunow, M. 

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Dragunow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.625: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.626: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.627: 24, 166-178[Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "24,"

Phrase: "166-178"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.628: Andreasson, K., and Worley, P. 

Phrase: "Andreasson,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.629: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.630: (1995) Neuroscience 69, 781-796[CrossRef][Medline] [OrderarticleviaInfotrieve] 55. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuroscience 69,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C0450388:69 [Intellectual Product]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "781-796"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.631: Yamagata, K., Sanders, L. 

Phrase: "Yamagata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.632: K., Kaufmann, W. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaufmann,"

Phrase: "W."
Processing 00000000.tx.633: E., Yee, W., Barnes, C. 

Phrase: "E.,"

Phrase: "Yee,"

Phrase: "W.,"

Phrase: "Barnes,"

Phrase: "C."
Processing 00000000.tx.634: A., Nathans, D., and Worley, P. 

Phrase: "A.,"

Phrase: "Nathans,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.635: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.636: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.637: Biol. 

Phrase: "Biol."
Processing 00000000.tx.638: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.639: 269, 16333-16339[Abstract/Free FullText] 56. 

Phrase: "269,"

Phrase: "16333-16339"

Phrase: "[Abstract/Free FullText"

Phrase: "] 56."
Processing 00000000.tx.640: Lynford, G., Yamagata, K., Kaufmann, W. 

Phrase: "Lynford,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yamagata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaufmann,"

Phrase: "W."
Processing 00000000.tx.641: E., Barnes, C. 

Phrase: "E.,"

Phrase: "Barnes,"

Phrase: "C."
Processing 00000000.tx.642: A., Sanders, L. 

Phrase: "A.,"

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.643: K., Copeland, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.644: G., Gilbert, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.645: J., Jenkins, N. 

Phrase: "J.,"

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.646: A., Lanahan, A. 

Phrase: "A.,"

Phrase: "Lanahan,"

Phrase: "A."
Processing 00000000.tx.647: A., and Worley, P. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.648: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.649: (1995) Neuron 14, 433-445[Medline] [OrderarticleviaInfotrieve] 57. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "433-445"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 57."
Processing 00000000.tx.650: Oian, Z., Gilbert, M. 

Phrase: "Oian,"

Phrase: "Z.,"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.651: E., Colicos, M. 

Phrase: "E.,"

Phrase: "Colicos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.652: A., Kandel, E. 

Phrase: "A.,"

Phrase: "Kandel,"

Phrase: "E."
Processing 00000000.tx.653: R., and Kuhl, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Kuhl,"

Phrase: "D."
Processing 00000000.tx.654: (1993) Nature 361, 453-457[CrossRef][Medline] [OrderarticleviaInfotrieve] 58. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 361,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "453-457"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 58."
Processing 00000000.tx.655: Naeve, G. 

Phrase: "Naeve,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.656: S., Ramakrishnan, M., Hevroni, D., Citri, D., and Theil, L. 

Phrase: "S."

Phrase: ","

Phrase: "Ramakrishnan,"

Phrase: "M."

Phrase: ","

Phrase: "Hevroni,"

Phrase: "D."

Phrase: ","

Phrase: "Citri,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Theil,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.657: E. 

Phrase: "E."
Processing 00000000.tx.658: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.659: Natl. 

Phrase: "Natl."
Processing 00000000.tx.660: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.661: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.662: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.663: 94, 2648-2653[Abstract/Free FullText] 59. 

Phrase: "94,"

Phrase: "2648-2653"

Phrase: "[Abstract/Free FullText"

Phrase: "] 59."
Processing 00000000.tx.664: Ding, W.-Q., Larsson, C., and Alling, C. 

Phrase: "Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "W.-Q., Larsson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Alling,"

Phrase: "C."
Processing 00000000.tx.665: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.666: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.667: 70, 1722-1729[Medline] [OrderarticleviaInfotrieve] 60. 

Phrase: "70,"

Phrase: "1722-1729"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 60."
Processing 00000000.tx.668: Lau, L. 

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.669: F., and Nathans, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Nathans,"

Phrase: "D."
Processing 00000000.tx.670: (1985) EMBO J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.671: 4, 3145-3151[Abstract] 61. 

Phrase: "4,"

Phrase: "3145-3151"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 61."
Processing 00000000.tx.672: Chung, K. 

Phrase: "Chung,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.673: W., and Ahn, Y. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Ahn,"

Phrase: "Y."
Processing 00000000.tx.674: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.675: (1998) Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.676: Lett. 

Phrase: "Lett."
Processing 00000000.tx.677: 255, 155-158[CrossRef][Medline] [OrderarticleviaInfotrieve] 62. 

Phrase: "255,"

Phrase: "155-158"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 62."
Processing 00000000.tx.678: Crespo, P., Xu, N., Simonds, W. 

Phrase: "Crespo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Xu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Simonds,"

Phrase: "W."
Processing 00000000.tx.679: F., and Gutkind, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Gutkind,"

Phrase: "J."
Processing 00000000.tx.680: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.681: (1994) Nature 369, 418-420[CrossRef][Medline] [OrderarticleviaInfotrieve] 63. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 369,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "418-420"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 63."
Processing 00000000.tx.682: Mattingly, R. 

Phrase: "Mattingly,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.683: R., and Macara, I. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Macara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3428317:Macara [Eukaryote]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.684: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.685: (1996) Nature 382, 268-272[CrossRef][Medline] [OrderarticleviaInfotrieve] 64. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 382,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "268-272"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 64."
Processing 00000000.tx.686: Xin, L. 

Phrase: "Xin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422556:XIN [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.687: W., Martinerie, C., Zumkeller, W., Westphal, M., and Perbal, B. 

Phrase: "W., Martinerie,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zumkeller,"

Phrase: "W.,"

Phrase: "Westphal,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Perbal,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.688: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.689: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.690: Pathol.: 

Phrase: "Pathol."

Phrase: ":"
Processing 00000000.tx.691: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.692: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.693: 49, M91-M97 65. 

Phrase: "49,"

Phrase: "M91-M97 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450385:65 [Intellectual Product]
Processing 00000000.tx.694: Levey, A. 

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.695: I., Kitt, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kitt,"

Phrase: "C."
Processing 00000000.tx.696: A., Simonds, W. 

Phrase: "A.,"

Phrase: "Simonds,"

Phrase: "W."
Processing 00000000.tx.697: F., Price, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.698: L., and Brann, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Brann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.699: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.700: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.701: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.702: 11, 3218-3226[Abstract] 66. 

Phrase: "11,"

Phrase: "3218-3226"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 66."
Processing 00000000.tx.703: Levey, A. 

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.704: I., Edmunds, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Edmunds,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.705: M., Koliatsos, V., Wiley, R. 

Phrase: "M."

Phrase: ","

Phrase: "Koliatsos,"

Phrase: "V.,"

Phrase: "Wiley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.706: G., and Heilman, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Heilman,"

Phrase: "C."
Processing 00000000.tx.707: J. 

Phrase: "J."
Processing 00000000.tx.708: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.709: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.710: 15, 4077-5092[Abstract] 67. 

Phrase: "15,"

Phrase: "4077-5092"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 67."
Processing 00000000.tx.711: Kondo, Y., Nakanishi, T., Takigawa, M., and Ogawa, N. 

Phrase: "Kondo,"

Phrase: "Y.,"

Phrase: "Nakanishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takigawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.712: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.713: 834, 146-151[CrossRef][Medline] [OrderarticleviaInfotrieve] 68. 

Phrase: "834,"

Phrase: "146-151"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]
Processing 00000000.tx.714: Hertel, M., Tretter, Y., Alzheimer, C., and Werner, S. 

Phrase: "Hertel,"

Phrase: "M."

Phrase: ","

Phrase: "Tretter,"

Phrase: "Y.,"

Phrase: "Alzheimer,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Werner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.715: (2000) Eur. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.716: J.

Phrase: "J."
Processing 00000000.tx.717: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.718: 12, 376-380[CrossRef][Medline] [OrderarticleviaInfotrieve] 69. 

Phrase: "12,"

Phrase: "376-380"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.719: Perbal, B., Martinierie, C., Sainson, R., Werner, M., He, B., and Roizman, B. 

Phrase: "Perbal,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martinierie,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sainson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Werner,"

Phrase: "M."

Phrase: ","

Phrase: "He,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Roizman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.720: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.721: Natl. 

Phrase: "Natl."
Processing 00000000.tx.722: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.723: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.724: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.725: 96, 869-874[Abstract/Free FullText] 70. 

Phrase: "96,"

Phrase: "869-874"

Phrase: "[Abstract/Free FullText"

Phrase: "] 70."
Processing 00000000.tx.726: Guillery, R. 

Phrase: "Guillery,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.727: W. 

Phrase: "W."
Processing 00000000.tx.728: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.729: Anat. 

Phrase: "Anat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002808:Anat [Biomedical Occupation or Discipline]
Processing 00000000.tx.730: 187, 583-592[Medline] [OrderarticleviaInfotrieve] 71. 

Phrase: "187,"

Phrase: "583-592"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]
Processing 00000000.tx.731: Kireeva, M. 

Phrase: "Kireeva,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.732: L., Lam, S. 

Phrase: "L., Lam,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.733: C.-T., and Lau, L. 

Phrase: "C.-T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.734: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.735: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.736: Biol. 

Phrase: "Biol."
Processing 00000000.tx.737: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.738: 273, 3090-3096[Abstract/Free FullText] 72. 

Phrase: "273,"

Phrase: "3090-3096"

Phrase: "[Abstract/Free FullText"

Phrase: "] 72."
Processing 00000000.tx.739: Jedsadayanmata, A., Chen, C.-C., Kireeva, M. 

Phrase: "Jedsadayanmata,"

Phrase: "A.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C.-C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Kireeva,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.740: L., Lau, L. 

Phrase: "L., Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.741: F., and Lam, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lam,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.742: C.-T. 

Phrase: "C.-T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.743: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.744: Biol. 

Phrase: "Biol."
Processing 00000000.tx.745: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.746: 274, 24321-24327[Abstract/Free FullText] 73. 

Phrase: "274,"

Phrase: "24321-24327"

Phrase: "[Abstract/Free FullText"

Phrase: "] 73."
Processing 00000000.tx.747: Yang, G. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.748: P., and Lau, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.749: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.750: (1991) Cell Growth Differ. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Cell Growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "Differ."
Processing 00000000.tx.751: 2, 351-357[Abstract] 74. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "351-357"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 74."
Processing 00000000.tx.752: DeFreitas, M. 

Phrase: "DeFreitas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.753: F., Yoshida, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yoshida,"

Phrase: "C."
Processing 00000000.tx.754: K., Frazier, W. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Frazier,"

Phrase: "W."
Processing 00000000.tx.755: A., Mendrick, D. 

Phrase: "A.,"

Phrase: "Mendrick,"

Phrase: "D."
Processing 00000000.tx.756: L., Kypta, R. 

Phrase: "L., Kypta,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.757: M., and Reichardt, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Reichardt,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.758: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.759: (1995) Neuron 15, 333-343[Medline] [OrderarticleviaInfotrieve] 75. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 15,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "333-343"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 75."
Processing 00000000.tx.760: Letourneau, P. 

Phrase: "Letourneau,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.761: C., Condic, M. 

Phrase: "C., Condic,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.762: L., and Snow, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Snow,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037386:Snow [Natural Phenomenon or Process]
  1000   C1611690:Snow [Substance]

Phrase: "D."
Processing 00000000.tx.763: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.764: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.765: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.766: 14, 915-928[Medline] [OrderarticleviaInfotrieve] 76. 

Phrase: "14,"

Phrase: "915-928"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 76."
Processing 00000000.tx.767: Reichardt, L. 

Phrase: "Reichardt,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.768: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.769: (1991) Annu. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.770: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.771: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.772: 14, 531-570[CrossRef][Medline] [OrderarticleviaInfotrieve] 77. 

Phrase: "14,"

Phrase: "531-570"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 77."
Processing 00000000.tx.773: Stubli, U., Chun, D., and Lynch, G. 

Phrase: "Stubli,"

Phrase: "U.,"

Phrase: "Chun,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lynch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.774: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.775: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.776: 18, 3460-3469[Abstract/Free FullText] 78. 

Phrase: "18,"

Phrase: "3460-3469"

Phrase: "[Abstract/Free FullText"

Phrase: "] 78."
Processing 00000000.tx.777: Winkler, J., Thal, L. 

Phrase: "Winkler,"

Phrase: "J.,"

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.778: J., Gage, F. 

Phrase: "J.,"

Phrase: "Gage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456564:Gauge [Spatial Concept]
  1000   C1521879:GAGE [Immunologic Factor]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.779: H., and Fischer, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Fischer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.780: J. 

Phrase: "J."
Processing 00000000.tx.781: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.782: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.783: Med. 

Phrase: "Med."
Processing 00000000.tx.784: 76, 555-567[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "76,"

Phrase: "555-567"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

